Vivasure Medical submits premarket approval to FDA for PerQseal Elite closure system
Vivasure Medical has announced the submission of a premarket approval application to the Food and Drug Administration (FDA) for its PerQseal Elite vascular closure...
Award-winning basic science research targets ‘highly complex’ process of vascular calcification
“We were really excited to know that the SVS is supporting our research,” Sujin Lee, MD, told Vascular Specialist on receiving the SVS Foundation...
‘Rise together’: Harris urges unity in Women’s Vascular Summit presidential address
Society for Vascular Surgery (SVS) Vice President Linda Harris, MD, extolled the values of “co-elevation” in her presidential address at the 7th annual Women’s...
CGuard Prime carotid stent gains US and European approvals for stroke prevention
InspireMD has been granted premarket approval (PMA) from the Food and Drug Administration (FDA) for its CGuard Prime carotid stent system in the U.S.—news...
Gore Tag thoracic branch endoprosthesis receives expanded FDA approval for endovascular aortic arch repair
Gore has announced that the Gore Tag thoracic branch endoprosthesis (TBE) is now approved by the Food and Drug Administration (FDA) for use in...
Increased experience with off-the-shelf TAAA endograft sees reduction in complications but no effect on...
Michele Piazza, MD, informed attendees of the 2025 Vascular Annual Meeting (VAM) that increased experience with the E-nside (Artivion) off-the-shelf preloaded inner branch endograft for...
Penumbra’s STORM-PE randomized trial completes enrollment
Penumbra has announced the completion of enrollment in the STORM-PE clinical trial.
The pivotal, prospective, multicenter randomized controlled trial enrolled 100 patients to evaluate computer...
Aventus thrombectomy system gains FDA clearance for PE treatment
Inquis Medical has announced that its Aventus thrombectomy system has received 510(k) clearance from the US Food and Drug Administration (FDA) for an expanded...
New THRIVE data on CAVT technology for acute limb ischemia show ‘fewer complications, hospital...
Recent THRIVE study data show that Penumbra’s computer-assisted vacuum thrombectomy (CAVT) technology not only has the potential to improve outcomes for lower extremity acute...
SVS announces election results for new leadership
The Society for Vascular Surgery (SVS) has elected Andres Schanzer, MD, as the incoming vice president and Malachi G. Sheahan III, MD, as the...
Two-year data show continued clinical improvement with VenoValve
Implantation of the VenoValve (enVVeno Medical) continues to promote stabilization of symptoms in patients with deep venous reflux at two-year follow-up. This is the...
The people and devices that put ‘the vascular in vascular’
The people, discoveries, innovations and events that brought the vascular surgery profession to where it is today will form the subject matter for this...
International Chapter highlights pressing need to document PAD and CLTI prevalence in South Asia
There is an urgent need for epidemiological studies to map out the prevalence of chronic limb-threatening ischemia (CLTI)—and peripheral arterial disease (PAD) in general—in...
Learn from other fields to enhance your practice, vascular surgeon innovators told
“A lot of solutions to your problems exist in somebody else's operating room, or somebody else's cath lab, but you never actually go there.”...
SVS president will stake ‘reclaiming center’ in VAM 2025 address
One of the singular highlights of VAM 2025—the presidential introduction and address—will take place this morning from 11 a.m.–12 p.m. on Morial CC’s First...
Transatlantic multicenter experience highlights effectiveness of total endovascular aortic repair with F/BEVAR but 5%...
Staged total endovascular aortic repair (TEAR) utilizing arch branched and thoracoabdominal fenestrated and branched endografts is effective, but identified predictors of morbidity and mortality—including...
Greenberg Lecture encourages ‘move beyond’ binary aortic disease classification
Sherene Shalhub, MD, set out a new biologically informed framework that “captures the diverse spectrum of arterial fragility and repair outcomes across inherited and...
Impact report finds no major change in balance between CAS and CEA following Medicare...
An evaluation of trends in the utilization of carotid artery stenting (CAS) versus carotid endarterectomy (CEA) has found there to be “no major change”...
Transcatheter arterialization of the deep veins: Comparative analysis probes whether emerging modality is worth...
“We're living in a new world order” when it comes to “no-option” chronic limb-threatening ischemia (CLTI) patients, says Anahita Dua, MD. In recent years,...
Long-term VQI-VISION analysis sheds light on PVI versus bypass in aortoiliac occlusive disease
Today's Plenary Session 4—Hosted in Great Hall A, First Floor from 10:45 a.m.–12 p.m.—will feature a presentation of five-year findings from the VQI-VISION database...
Drilling into controversies in field of asymptomatic severe carotid stenosis management
Some of the enduring controversies in the management of asymptomatic severe carotid stenosis will underpin an educational session set to take place today.
The session...
Speaking in code: How a decline in Medicare reimbursement affects vascular care
Concerns were raised yesterday’s Plenary Session 2 over the recent decline in Medicare reimbursement at a national level. Querying current figures, speakers revealed discrepancies...
One-year TAMBE data highlight low mortality, importance of renal branch assessment
The four-branch Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE) device demonstrated low mortality at one year with renal artery occlusion being the predominant device-related event...
No power, no problem! VAM 2025 pivots as early-morning power outage delays meeting opening
The vascular surgery world is used to pivoting on a dime. So it was as VAM 2025 was about to commence yesterday morning,...
VQI LEAF surveillance protocol set to be unveiled during VQI@VAM
Philip P. Goodney, MD, is unveiling a pivotal monitoring tool during the Vascular Quality Initiative (VQI) Annual Meeting, VQI@VAM, today—the Long-Term EVAR Assessment and...
Crawford Forum: Empowering vascular surgeons
This year’s E. Stanley Crawford Critical Issues Forum at the 2025 Vascular Annual Meeting (VAM) in New Orleans, from 11:15 a.m.–12:15 p.m., on the...
Cost-effectiveness outcomes defy expectations in latest BEST-CLI data drop
The open surgical approach will prove to be “slightly superior” to endovascular intervention in terms of cost per life year gained, while the latter...
Taking the lead: The vascular surgeon in the pediatric vascular surgical space
It’s a bit like realigning the narrative, ever so slightly. “I want us to feel, as a collective specialty, that pediatric vascular care falls...
Helping OBL vascular surgeons fight the squeeze
SVS Section on Ambulatory Vascular Care (SAVC) set to announce set of new initiatives designed to help office-based lab (OBL) vascular surgeons combat rising...
SVS releases updated guidelines for intermittent claudication
The Society for Vascular Surgery (SVS) has issued a comprehensive update to its clinical practice guidelines for the management of intermittent claudication, urging clinicians...
Terumo announces commercial availability of Roadsaver carotid stent system
Terumo Interventional Systems has announced the early commercial availability of its US Food and Drug Administration (FDA)-approved Roadsaver carotid stent system. Indicated for use...
Wound healing in space: Vascular surgeons produce wide-ranging review
How a group of vascular surgeons is working to plug gaps in knowledge and inspire colleagues to recognize the specialty’s essential role in future...
Reality check: Study brings ‘significant’ gap between randomized and real-world vascular patient populations into...
The randomized data foundation on which clinicians base decision-making for vascular surgery patients is derived from populations that do not represent the patients they...
Survey suggests greater exposure to mini-incision carotid endarterectomy during training may dispel perceived limitations...
While a recent survey found that a majority of those who responded had performed mini-incision carotid endarterectomy (CEA) at least once in their practice...
Equivalent outcomes seen among female, male patients in real-world analysis of paclitaxel-eluting stent use
The use of a paclitaxel-eluting stent to treat femoropopliteal occlusive disease led to equivalent outcomes in male and female patients in “a diverse and...
Carotid endarterectomy outperforms stenting amid overuse of both procedures in 10-year cohort study
A retrospective, nationwide cohort study has revealed carotid endarterectomy (CEA) performed better than carotid artery stenting (CAS) in France over the course of a...
Imperative Care announces completion of enrollment in the SYMPHONY-PE study
Imperative Care has announced the completion of patient enrollment in its SYMPHONY-PE study, a pivotal investigational device exemption (IDE) trial evaluating the safety and...
Three-year VenoValve first-in-human trial data published
Envveno Medical has announced that its manuscript titled, "Three-year outcomes of surgical implantation of a novel bioprosthetic valve for the treatment of deep venous...
Endospan announces positive 30-day outcomes from TRIOMPHE IDE study
Endospan recently announced the presentation of 30-day results from the statistical dissection primary arm of the TRIOMPHE investigational device exemption (IDE) clinical study. The...
VVT Medical welcomes Antonios Gasparis to medical advisory board
VVT Medical recently announced the appointment of Antonios Gasparis, MD, to its medical advisory board.
A press release notes that Gasparis brings over two decades...
Inquis Medical’s Aventus thrombectomy system found safe and effective for patients with PE
Inquis Medical recently announced results from its AVENTUS trial evaluating the safety and efficacy of the company’s Aventus thrombectomy system.
The results were presented by...
New study validates BEST-CLI trial results, ‘suggesting generalizability’
A new propensity-matched analysis of more than 1,100 lower extremity revascularization procedures carried out in patients with chronic limb-threatening ischemia (CLTI)—which aimed to help...
‘The leader must own everything in his or her world, own every mistake and...
“We can almost be considered a specialty of colonizers, acquiring borrowed techniques. Why, then, do we see ourselves as the keepers of vascular care?...
Debate verdict: Carotid endarterectomy maintains its golden hue
The established “gold-standard” approach to carotid revascularization remained enshrined as the go-to operation as far as a 2025 Charing Cross (CX) International Symposium audience...
R3 Vascular announces first patient treated in ELITE-BTK pivotal trial
R3 Vascular recently announced that the first patient in its ELITE-BTK pivotal trial has been treated by Brian DeRubertis, chief of vascular surgery at...
CX 2025: New VenaSeal data suggest cyanoacrylate closure be added to the venous “toolkit”
Twelve-month outcomes of the VenaSeal Spectrum venous leg ulcer (VLU) trial, assessing time to ulcer healing following treatment with the VenaSeal (Medtronic) closure system,...
CX 2025: Sirolimus implant fails to meet fistula maturation endpoint in ACCESS 2 trial
Results of the ACCESS 2 study, evaluating arteriovenous fistula (AVF) outcomes following use of the Sirogen (Vascular Therapies) sirolimus-eluting collagen implant, have shown that...
CX 2025: EVAR founding fathers invoke revolutionary past to predict path ahead for aortic...
The next spring forward in aortic stent grafting will be rooted in a greater understanding of the biomechanical forces acting upon devices alongside continued...
Early feasibility study for Velocity pAVF system now fully enrolled
Venova Medical has announced the completion of patient enrollment in the company's VENOS-2 early feasibility study of the Velocity percutaneous arteriovenous fistula (pAVF) system...
From Brazil to Baylor: Oderich assumes coveted role at cardiovascular ‘powerhouse’
Following in the footsteps of some of the pioneers of cardiovascular surgery, Gustavo Oderich, MD, recently stepped into position as the Michael E. DeBakey...
The question of Vascular Surgery Board independence: Federated or free-standing?
A survey recently went out to Society for Vascular Surgery (SVS) members asking them to contribute their voice to an opinion poll over whether...
Founding fathers of EVAR set to gather to mark 40 years of aortic stent...
The 40-year history of endovascular aneurysm repair (EVAR) of the aorta wends a circuitous route, from behind the Iron Curtain in Soviet Ukraine, to...
Terumo Neuro receives FDA approval for carotid stent system
Terumo Neuro has announced that its carotid stent system has received premarket approval (PMA) from the Food and Drug Administration (FDA).
This milestone marks the...
VenoValve: Analysis finds similar improvement among both primary and thrombotic deep venous reflux patients
A new subanalysis of the SAVVE (Surgical antireflux venous valve endoprosthesis) trial found that there was no difference in the level of improvement in...
Cagent Vascular initiates patient enrollment in Serranator vs. plain balloon angioplasty OCT study
Cagent Vascular has announced its first patient enrolment in the Serranator versus plain balloon angioplasty optical coherence tomography (OCT) study.
This prospective, randomized (2:1 treatment...
SCVS 2025: Rowe becomes SCVS president
Vincent Rowe, MD, from the University of California, Los Angeles (UCLA), became the 2025–26 Society for Clinical Vascular Surgery (SCVS) president during the Society’s...
SVS, medical organizations launch comprehensive Wound Care Curriculum
The Society for Vascular Surgery (SVS), in collaboration with the Society for Vascular Nursing (SVN) and the American Podiatric Medical Association (APMA), has designed...
Novel phenotypic AAA classification may help better stratify aneurysm risk
Inspection of aortic lumen, wall and thrombus volume changes throughout the cardiac cycle enables novel classification of abdominal aortic aneurysms (AAAs) into four types...
Surmodics announces commercial release of Pounce XL thrombectomy system
Surmodics has announced the commercial release of the Pounce XL thrombectomy system for endovascular removal of acute or chronic clot from peripheral arteries.
Intended for removal...
Gore announces FDA approval and first commercial implant of large-diameter thoracic tapers
Gore recently announced the expansion of the Gore Tag conformable thoracic stent graft with Active Control system product line, following Food and Drug Administration...
SCVS 2025: TBE device provides ‘safer’ option than TEVAR for blunt thoracic injuries in...
Use of the Gore Tag thoracic branch endoprosthesis (TBE) “offers a safer alternative” to traditional thoracic endovascular aortic repair (TEVAR) with left subclavian artery...
ACC.25: Semaglutide improves walk distance for PAD patients with diabetes
Semaglutide significantly improved maximal walking distance in people with symptomatic peripheral arterial disease (PAD) and type 2 diabetes in a trial designed to evaluate...
SCVS 2025: Multicenter data show favorable role for FEVAR over chimney grafts
A multi-institutional analysis has demonstrated fenestrated endovascular aneurysm repair (FEVAR) could be a “safer and more durable option” than chimney EVAR (ChEVAR) in elective...
One-year WAVE trial results show patency advantage for Wrapsody versus PTA
Merit Medical Systems has announced that the six-month results from the randomized arm of the Wrapsody arteriovenous access efficacy—WAVE—trial are scheduled for publication in...
Study details radiation exposure learning curve among vascular trainees
The importance of radiation safety training for vascular surgery trainees was highlighted by a recent study that detailed a learning curve effect between first-...
Imperative Care expands Symphony thrombectomy portfolio with new FDA approval
Imperative Care today announced Food and Drug Administration (FDA) 510(k) clearance of the 82cm version of its Symphony 16F catheter, the company’s latest innovation...
EVC 2025: Multidisciplinary, multi-stakeholder efforts key to setting venous disease research priorities
Addressing the audience at the 28th European Vascular Course (EVC 2025) in Maastricht, The Netherlands (March 9–11), Ulka Sachdev-Ost, MD, from the University of...
Novel thrombectomy system for VTE used successfully in first tranche of first-in-human cases
SonoVascular has announced the successful completion of an initial set of eight deep vein thrombosis (DVT) cases using its SonoThrombectomy system as part of...
‘How to thrive, not just survive, as a vascular surgeon’
Outgoing Vascular & Endovascular Surgery Society (VESS) President Misty Humphries, MD, used her presidential address to outline how trainees and young vascular surgeons can...
Vascular surgery trainee autonomy driven by well-being, study finds
A new cross-sectional analysis as part of the SECOND trial found that most vascular surgery trainees are satisfied with their operative and clinical autonomy...
Obituary: Janet Powell
Janet Powell, the clinical trial investigator who played a pivotal role in several landmark abdominal aortic aneurysm (AAA) studies, has died at the...
Inari Medical, now part of Stryker, launches Artix thrombectomy system
Inari Medical, now part of Stryker, recently announced the launch of its Artix thrombectomy system. Purpose-built for the needs of the peripheral arterial system,...
Philips issues Class I recall for Tack endovascular system
Philips has recently announced that it will no longer sell its Tack endovascular system in the U.S. following a Class I recall issued by...
Stereotaxis seeks to broaden use of its robotic magnetic navigation system into multiple endovascular...
Stereotaxis has announced a Food and Drug Administration (FDA) regulatory submission for the first robotically navigated catheter designed to expand usage of robotic magnetic...
Shockwave Medical announces US launch of intravascular lithotripsy catheter
Today, Shockwave Medical announced the U.S. launch of its Shockwave Javelin peripheral intravascular lithotripsy (IVL) catheter, a platform designed to modify calcium and cross...
‘Battlefield first aid’: A peer-to-peer prescription for dealing with adverse surgical outcomes
“Battlefield first aid” after a colleague has a bad case as the cornerstone of peer-to-peer support in vascular surgery was the feature of the...
AVF: From good to great
Ruth Bush, MD, used her 2025 American Venous Forum (AVF) presidential address to highlight the organization’s elevation and path to “level 5 leadership.”
Level 5...
Open surgery, endovascular intervention and robotics: The coming ‘third revolution’ in vascular surgery
The 2025 Southern Association for Vascular Surgery (SAVS) presidential address featured the hashtag phrase #OnlyUs, an allusion to the specialty’s “unique” differentiator.
SAVS 2024–25 President...
AVF 2025: A call for ‘second-generation steps’ in venous stenting
The need for a revolutionary second generation of venous stents are among the gaps and unmet needs currently at play in deep venous surgery,...
Ketamine reduces postoperative opiate use and pain scores as part of spinal cord protection...
The introduction of ketamine into a spinal cord ischemia (SCI) protection protocol used during thoracoabdominal aortic aneurysm (TAAA) repairs led to significant reductions in...
FFRCT diagnosis of coronary ischemia with ischemia-targeted coronary revascularization more than halves five-year risk...
Preoperative diagnosis of lesion-specific ischemia using coronary computed tomography (CT)-derived fractional flow reserve (FFRCT) and ischemia-targeted coronary revascularization after carotid endarterectomy (CEA) can reduce...
Humacyte announces commercial launch of Symvess for extremity vascular trauma
Humacyte today announced the commercial launch of Symvess (acellular tissue engineered vessel-tyod) for use in adults as a vascular conduit for extremity arterial injury...
Prognostic tool for CVO stenting set to enhance therapeutic decision-making and scientific reporting
With the aims of predicting and comparing venous stent outcomes, aiding in communication with patients, and enhancing therapeutic decision-making, researchers have proposed an anatomical...
New analysis details learning curve effect behind ‘significant improvement’ in performance of PE mechanical...
A multisite hospital system analysis of the safety and procedural learning curve behind the performance of percutaneous mechanical thrombectomy for pulmonary embolism (PE) shows...
Shape Memory Medical announces first European enrolment in AAA-SHAPE pivotal trial
Shape Memory Medical today announced the first European enrollment in the AAA-SHAPE pivotal trial, the company’s prospective, multicenter, randomized, open-label trial to determine the...
Stryker completes acquisition of Inari Medical
Stryker announced today that it has completed the acquisition of Inari Medical. A press release notes that the addition of Inari brings an established...
Study demonstrates textbook outcomes occur less than a quarter of the time after CLTI...
Textbook outcomes remain “very rare” after revascularization for chronic limb-threatening ischemia (CLTI), with the main driver being an enduring inability to attain complete wound...
Countdown to New Orleans: VAM 2025 set to explore innovation
The 2025 Vascular Annual Meeting (VAM) will take place in New Orleans, Louisiana, from June 4–7, with a particular focus this year on innovation.
Key...
BEST-CLI trial spline model analysis breaks new ground in assessing the impact of CKD...
A new analysis of the BEST-CLI trial has produced the first evidence-based glomerular filtration rate (eGFR) value—30 mL/min/1.73 m2—as the cutoff below which patients...
Deep vein arterialization: Much remains to be learned but use poised to expand in...
These remain early days for transcatheter arterialization of the deep veins (TADV) in the setting of patients with severe chronic limb-threatening ischemia (CLTI), says...
InspireMD and NAMSA to partner on CGUARDIANS II pivotal clinical trial
InspireMD and North American Science Associates (NAMSA) today announced that, pursuant to a previously announced strategic outsourcing partnership, the companies are working together to conduct...
Akura Medical enrols first patient in QUADRA-PE study
Akura Medical has announced today the first patient enrolment in the QUADRA-PE study evaluating the Katana thrombectomy system in patients with acute pulmonary embolism...
ROADSTER 3 provides key evidence that ‘goes beyond registry data’ on TCAR-related stroke rates
Thirty-day results from the ROADSTER 3 study have demonstrated that transcarotid artery revascularization (TCAR) is a safe and effective approach in patients who are...
Penumbra launches Element vascular access system for VTE
Penumbra recently announced the launch of its Element vascular access system. This is the first laser-cut hypotube sheath designed for venous thromboembolism (VTE), the...
US ARC uncovers ‘dramatic’ decrease in use of prophylactic spinal drains at same time...
Despite a “dramatic” decrease in the use of prophylactic cerebrospinal fluid drains (CSFDs) for the prevention of spinal cord ischemia (SCI) in patients undergoing...
Vascular Verification Program verifies first community hospital
Intermountain Health St. Mary’s Regional Hospital in Grand Junction Colorado was awarded ACS/SVS Vascular Verification Program (Vascular-VP) designation on Nov. 19, 2024. By achieving...
Study highlights declining venous stent patency rates after one year
A systematic review and meta-analysis of over 1,500 venous stenting procedures—said to be the first study on this topic to date—has highlighted an 18%...
Data and device tweaks herald ‘practice-changing’ future for bioabsorbable scaffolds
Pending the results of several trials and “iterative changes” to device design, bioabsorbable scaffolds are set to change the treatment paradigm for lower extremity...
Deadline for inaugural SVS visiting professorship to advance young surgeons’ careers nears
The Society for Vascular Surgery’s (SVS) Young Surgeon Section (YSS) will close applications for its inaugural visiting professorship on Jan. 31. This scholarship program...
Cagent Vascular initiates the Serranator POINT FORCE observational registry
Cagent Vascular has announced the start of the POINT FORCE registry, a postmarket clinical follow-up study of the Serranator percutaneous transluminal angioplasty (PTA) serration...
Gore announces first commercial implant of Excluder conformable AAA endoprosthesis with Active Control system...
Gore recently announced the first commercial use of its Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis with Active Control system in Canada.
The news coincides...
Tracci assumes presidency of Southern Vascular
Margaret (Megan) Tracci, MD, has become the first-ever woman president of the Southern Association for Vascular Surgery (SAVS). The University of Virginia professor of...
FDA announces plans to address medical device shortage risks
The Food and Drug Administration (FDA) has issued a statement outlining measures to enhance protections against medical device shortages.
According to Michelle Tarver, director...
SVS gets moving on PAD-related grant
All those steps logged during the SVS Foundation’s exercise challenge in September will help the Foundation—and researchers—take new steps to unlock new treatments for...
ESVS publishes 2025 vascular trauma guidelines
The European Society for Vascular Surgery (ESVS) has developed new guidelines for the care of patients with vascular trauma. The 2025 clinical practice guideline...
New data support role of F/BEVAR for treatment of thoracoabdominal aortic aneurysms
A recent prospective, multicentre cohort study provides insights into early and late aortic-related mortality and rupture after fenestrated and branched endovascular aneurysm repair (F/BEVAR)...
Gore receives CE mark for lower profile Viabahn VBX endoprosthesis
Gore has announced recent CE mark of a lower profile Viabahn VBX balloon expandable endoprosthesis (VBX stent graft).
Medical Device Regulation (MDR) approval of this...
One-year SAVVE trial results are ‘most encouraging data ever produced for a bioprosthetic vein...
The one-year data from the SAVVE trial represent the “most encouraging clinical data that have ever been produced for a bioprosthetic deep vein valve”...
Researchers develop machine learning models to predict IVC filter complications
Researchers in Canada have developed machine learning (ML) models that they claim, “can accurately predict one-year IVC filter complications, performing better than logistic...
Boston Scientific to acquire IVL developer Bolt Medical
Boston Scientific has announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular lithotripsy (IVL) advanced laser-based...
Large database study finds no difference in outcomes between three carotid shunting strategies
A new Vascular Quality Initiative (VQI) data analysis, recently published in the European Journal of Vascular and Endovascular Surgery (EJVES), has found no statistically...
Study finds adverse outcomes after decreased use of paclitaxel-coated devices
A recent analysis of over 270,000 Medicare fee-for-service beneficiaries has found an increase in adverse outcomes and death after a US Food and Drug...
Study reports lack of evidence to support theory that hospital integration improves value of...
A systematic review of U.S. literature focused on analyzing the effects of mergers and acquisitions on healthcare suggests that there is a lack of...
Novel sirolimus-eluting scaffold system demonstrates ‘potential to address Achilles’ heel’ of currently available endovascular...
Ongoing studies of the Efemoral vascular scaffold system (EVSS)—previously described as a potential new paradigm in the treatment of long occlusive lesions—show that the...
How physician assistants help vascular surgery teams provide ‘continuity of care’
The key role played by physician assistants (PAs) as part of vascular surgery teams in the U.S. came into focus during the Vascular Societies’...
Vascular trainees better prepared for open aortic practice than commonly reported, new study shows
Current graduates from both vascular surgery residency and fellowship programs are well prepared for surgical practice in aortic disease whether they are performing open...
The endovascular revolution and open aortic training: ‘It’s not necessarily a crisis but it...
Jean Panneton, MD, considers himself what he terms a “blue-collar” vascular surgeon as much as one engaged in academic practice and the necessity of...
FDA approves Humacyte’s Symvess for vascular trauma
Humacyte recently shared that the Food and Drug Administration (FDA) has granted a full approval for the Symvess acellular tissue-engineered vessel.
A press release notes...
Merit Medical announces FDA approval of the Wrapsody cell-impermeable endoprosthesis
Merit Medical Systems announced today that the Wrapsody cell-impermeable endoprosthesis has received premarket approval from the US Food and Drug Administration (FDA). With this...
Positive one-year data for new venous valve portends promising future in chronic venous insufficiency...
SAVVE trial principal investigators discuss results showing 98.4% VenoValve device patency, 85% clinically meaningful benefit and an 80% rate of ulcer size reduction at...
Novel bioabsorbable perivascular wrap aims to reduce AVF failure
Ellen Dillavou, MD, division chief of vascular surgery at WakeMed Heart Center in Raleigh, North Carolina, primary investigator (PI) for the VenoStent trial, presented...
When RCTs are essential for novel vascular access device regulation
As part of a 2024 VEITHsymposium (New York City; Nov. 19–23) debate, Robert E Lee, MD, a medical officer recently retired from the Food...
Venous VQI celebrates decade milestone
At the recent VEITHsymposium (Nov. 19–23) in New York City, Marc Passman, MD, reflected on the achievements of the Society for Vascular Surgery (SVS)...
In search of the ‘holy grail’: New analysis brings aneurysm rupture prediction closer
A rupture prediction-based algorithm is set to enhance patient selection for abdominal aortic aneurysm (AAA) repair. This is according to Randy Moore, MD, a...
Endothermal ablation significantly outperforms surgery for varicose veins in long-term randomized trial
Ten-year data from the randomized HELP trial show that, while both endothermal ablation and conventional surgery are effective treatments for great saphenous varicose veins...
CPVI course: Learning the latest intricate skills and techniques to treat complex PAD
Vascular Specialist attended the SVS Complex Peripheral Vascular Interventions (CPVI) Skills Course and spoke with participants about the hands-on learning experience designed for vascular...
BIO-OSCAR SOC trial examines standard of care in PAD treatment
Biotronik today announced that it has concluded the BIO-OSCAR SOC study evaluating the baseline against which to measure the Oscar multifunctional catheter in treating complex...
Applications open for 2025 James S.T. Yao Resident Research Award
The SVS Foundation is accepting applications for the 2025 James S.T. Yao Resident Research Award, which supports emerging medical professionals researching vascular disease biology...
Microbot Medical announces FDA submission for commercialization of Liberty endovascular robotic system
Microbot Medical recently announced that it has submitted a 510(k) premarket notification to the Food and Drug Administration (FDA) for its Liberty endovascular robotic...
Artivion granted FDA humanitarian device exemption for the AMDS hybrid prosthesis
Artivion recently announced that the Food and Drug Administration (FDA) has granted a humanitarian device exemption (HDE) for use of the AMDS hybrid prosthesis...
First patient enrolled in InspireMD’s CGUARDIANS II pivotal study
InspireMD today announced that the first patient has been enrolled in the company’s CGUARDIANS II clinical trial evaluating its CGuard Prime carotid stent system in...
Innovation in vascular surgery: Balancing progress with patient safety
A debate at this year's European Society for Vascular Surgery (ESVS 2024) annual meeting (Sept. 24–27) in Kraków, Poland, centered on innovation in vascular...
‘This is just the beginning’: SVS launches patient-facing website in opening salvo of long-term...
The Society for Vascular Surgery (SVS) has launched a new patient-facing website aimed at bridging the information gap between members of the public and...
VASC.AI: Canadian vascular surgery researchers develop vascular-specific bot aimed at aiding education and clinical...
The advent of large language models such as ChatGPT (Open AI) has left little of the world untouched—and a quintet of University of Toronto...
Service: Giving back
Pioneering American Venous Forum (AVF) and Eastern Vascular Society (EVS) efforts aimed at breaking down barriers to care and educating patients in economically challenged...
Novel measure suggests 20% of elective carotid revascularizations fail to achieve a textbook outcome
One in five patients failed to achieve a textbook outcome after undergoing carotid endarterectomy (CEA), transcarotid artery revascularization (TCAR) or transfemoral carotid artery stenting...
Bentley announces first-in-human implantation of BeFlared bridging stent
Bentley has announced the successful first-in-human implantation of its recently CE-certified BeFlared stent graft system, which the company states is the world’s first dedicated...
WAVE trial AVG cohort also benefits at six months with Wrapsody
Newly released six-month results from single-arm arteriovenous graft (AVG) cohort in the WAVE (Wrapsody arteriovenous access efficacy) trial showed target lesion and access circuit...
BEST-CLI: Trial results endure in analysis of patients who presented with diabetes
Diabetes affects approximately 70% of patients with chronic limb-threatening ischemia (CLTI) and is associated with more severe presentation, driven mostly by higher rates of...
Rates of MAE and reintervention following F/BEVAR remain ‘stable,’ Aortic Research Consortium data show
Latest study out of consortium details trends and outcomes after F/BEVAR procedures carried out over an eight-year period under consortium of 10 physician-sponsored IDEs.
Despite...
Humacyte clinical results published in JAMA Surgery
Humacyte today announced the publication of clinical results evaluating the efficacy and safety of the acellular tissue engineered vessel (ATEV) in the repair of...
One-year data from VenoValve US pivotal trial emerges
Envveno Medical has announced that it will present one-year data on all patients from the VenoValve US pivotal trial today at the VEITHsymposium (19–23 November, New York,...
PMA application submitted for VenoValve device
enVVeno Medical today announced it has submitted an application with the U.S. Food and Drug Administration (FDA) seeking approval to market the VenoValve—a surgical...
Research suggests arm vein is the best alternative bypass conduit to GSV in patients...
A new analysis has found arm vein to be the most suitable alternative conduit to great saphenous vein (GSV) in chronic limb-threatening ischemia (CLTI)...
Jimenez joins JVS-CIT as DEI editor
The Journal of Vascular Surgery-Cases, Innovations and Techniques (JVS-CIT) has appointed Juan Carlos Jimenez, MD, as its new associate editor and diversity, equity and...
SVN hosts virtual roundtable on PAD awareness
On Tuesday, Sept. 24, The Society for Vascular Nursing (SVN), in collaboration with the PAD Collaborative and the American Association of Wound Care...
Class of 2024–25: VQI announces third annual set of Fellowship in Training Program awardees
The Vascular Quality Initiative (VQI) Patient Safety Organization’s Fellowship in Training (FIT) Program has announced its third class of FIT participants for 2024–25 alongside...
Vascular Research Initiatives Conference abstracts due
Abstracts for the 2025 Vascular Research Initiatives Conference (VRIC) are being accepted through Nov. 20.
VRIC, which is held in Baltimore, Maryland, this year, emphasizes...
Regional societies see presidential changing of the guards
Brajesh K. Lal, MD, assumed the Eastern Vascular Society (EVS) presidency during the 2024 EVS annual meeting. He took over from Kathleen Ozsvath, MD.
Patrick...
SVS unveils latest round of members to become Distinguished Fellows
The Society for Vascular Surgery (SVS) has welcomed 11 surgeons to its ranks of Distinguished Fellows. The new fellows have distinguished themselves by making...
CEA ‘remains useful and relevant’ in era of improving medical therapy
Findings from a retrospective analysis delivered at the recent European Society for Vascular Surgery (ESVS) annual meeting (Sept. 24–27) in Kraków, Poland, provide evidence...
The top 10 most popular Vascular Specialist stories of October 2024
In October, the most read stories from Vascular Specialist included a new leadership announcement from the American College of Surgeons (ACS); study results examining a...
Endologix announces 36-month results of DETOUR2 study
Endologix has announced the final 36-month results from the DETOUR2 study—a prospective, single-arm, international, multicentre clinical evaluation of the novel Detour system for fully...
New analysis shows patients treated with Penumbra’s CAVT technology for PE utilize fewer hospital...
Penumbra has announced new data that demonstrate patients with intermediate-risk pulmonary embolism (PE) treated with Penumbra's computer-assisted vacuum thrombectomy (CAVT) technology have a shorter...
Shockwave Javelin peripheral IVL catheter meets prespecified efficacy and safety performance goals in feasibility...
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the first clinical outcomes associated with the Shockwave Javelin peripheral intravascular lithotripsy (IVL) catheter,...
Bolt Medical announces completion of RESTORE ATK and RESTORE BTK pivotal studies investigating Bolt...
Bolt Medical has announced the completion and results of the RESTORE ATK and RESTORE BTK pivotal clinical trials investigating the company's Bolt intravascular lithotripsy...
Two-year LIFE-BTK data show sustained benefits of drug-eluting resorbable scaffold for below-the-knee arteries
Presented today, late-breaking data from the second year of the LIFE-BTK clinical trial demonstrate the long-term effectiveness of the US Food and Drug Administration...
First patient enrolled in study of integrated laser atherectomy and IVL catheter
Royal Philips has announced enrolment of the first patient in the US THOR IDE clinical trial, which will study an innovative combined laser atherectomy...
FDA grants R3 Vascular IDE approval for ELITE-BTK pivotal trial of Magnitude drug-eluting bioresorbable...
R3 Vascular today announced that the Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval to initiate its ELITE-BTK pivotal trial...
TCT 2024: Drug-eluting resorbable scaffold proves cost effective at one year in LIFE-BTK analysis
A retrospective economic analysis of the LIFE-BTK trial has demonstrated the one-year cost-effectiveness of an everolimus-eluting resorbable scaffold over angioplasty for the treatment of...
CMS grants transitional pass-through payment for Medtronic’s Symplicity Spyral and Recor’s Paradise renal denervation...
The Centers for Medicare and Medicaid Services (CMS) has granted transitional pass-through (TPT) payment for Medtronic's Symplicity Spyral renal denervation (RDN) catheter and Recor...
Endoscopic vein harvest under the microscope
Conflicting results open fresh debate around effect of vein harvesting technique on long-term patency of lower extremity bypass grafts.
Two separate analyses that looked at...
VAM 2025 abstract submission period set to open Nov. 6
Vascular surgeon-scientists may submit their research for presentation at the 2025 Vascular Annual Meeting (VAM) in June starting from Nov. 6 through Wednesday, Jan....
Former SVS president named ACS president-elect
The American College of Surgeons (ACS) elected Anton N. Sidawy, MD, as president-elect during the ACS annual business meeting on Oct. 22. He served...
Surmodics announces early results from PROWL registry of Pounce thrombectomy system
Surmodics has announced that early results of a subset of 60 real-world acute, subacute, and chronic limb ischaemia patients from its PROWL registry study...
The Japanese concept of ikigai and how mentorship might help specialty amid challenges of...
The Japanese concept of ikigai, or an individual’s reason for being, underpinned the message behind a fresh call for mentorship in vascular surgery and...
TCT 2024: PEERLESS trial finds large-bore mechanical thrombectomy superior for intermediate-risk PE
Findings from the first international randomised controlled trial (RCT) to compare patient outcomes following treatment with large-bore mechanical thrombectomy (LBMT) versus catheter-directed thrombolysis (CDT)...
TCT 2024: One-year data from SIRONA trial show similar results for sirolimus versus paclitaxel...
Data from the prospective, multicentre, investigator-initiated SIRONA randomised clinical trial demonstrated MagicTouch (Concept Medical) sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with...
NESVS 2024: Simons becomes first woman president of New England Society for Vascular Surgery
Jessica P. Simons, MD, has become the 2024–25 president of the New England Society for Vascular Surgery (NESVS). She is the first woman to...
TCT 2024: PATCH study reports initial positive results for sutureless vascular closure system
Vivasure Medical has announced initial positive results from its US IDE PATCH pivotal study evaluating the safety and efficacy of the Vivasure PerQseal closure...
Thrombolex begins enrolment in RAPID-PE study of Bashir catheter
Thrombolex has announced the enrolment of the first two patients in the RAPID-PE study using the Bashir endovascular catheter for the treatment of acute...
SVS launches Highway to Health campaign to help people maintain vascular health at every...
According to a new national survey released by the Society for Vascular Surgery (SVS), nearly one in three Americans at the highest risk for developing...
ABRE subanalysis highlights obesity ‘paradox’ in post-venous stenting outcomes
Results from a subset analysis of the ABRE study have shown that patients in three out of the six World Health Organisation (WHO) body...
CEA: The importance of doctor-patient conversations about quitting smoking for better stroke outcomes in...
A new analysis that shows current smokers who undergo carotid endarterectomy (CEA) for asymptomatic carotid stenosis are at increased risk of long-term stroke and...
Hybrid aortic arch: ‘We believe there is still a role for a versatile multiple-branched...
Mid-term results from an analysis of a series of hybrid aortic arch reconstructions utilizing overlapping single thoracic branch endoprostheses in a dual-branch configuration showed...
Female patients found to be at increased risk from adverse outcomes after an ALI...
Results from a new study highlighting that female patients are at increased risk of adverse outcomes after acute limb ischemia (ALI) lend weight to...
Study details aspects of early care improvements after publication of SVS appropriate use criteria...
An observational study of intermittent claudication (IC) practice patterns before and after publication of the Society for Vascular Surgery (SVS) appropriate use criteria (AUC)...
Endospan completes enrolment of primary arm in TRIOMPHE IDE clinical study
Endospan today announced the completion of enrolment for the primary arm of its TRIOMPHE investigational device exemption (IDE) clinical study investigating the Nexus aortic...
CVRx announces new CPT Category I codes for Barostim baroreflex activation therapy
CVRx, the company behind the Barostim baroreflex activation therapy system, recently announced that the American Medical Association (AMA) has accepted new Current Procedural Terminology...
SVS member picks up prestigious American Heart Association accolade for scientific work
A prominent surgeon-scientist and Society for Vascular Surgery (SVS) member is the 2024 recipient of the American Heart Association (AHA) Joseph A. Vita Award,...
Novel RCT framework set to improve design and reporting of endovascular infrainguinal lower-limb interventions...
Pilot testing has shown that a new framework—dubbed Endo-STAR—can be used to describe and standardise endovascular interventions for peripheral arterial disease (PAD) within a...
Pulse IVL system US pivotal trial enrolls first patient
Amplitude Vascular Systems (AVS) recently announced that it has enrolled the first patient in its U.S. pivotal trial for pulsatile intravascular lithotripsy (IVL) therapy....
‘Investing in the people of vascular surgery’
Outgoing Midwestern Vascular Surgical Society (MVSS) President Bernadette Aulivola, MD, underscored the importance of “investing in the people of vascular surgery—those learning about it...
Contego Medical’s Neuroguard IEP system receives US FDA approval for carotid revascularisation
Contego Medical today announced the US Food and Drug Administration's (FDA) premarket approval (PMA) of the Neuroguard IEP system for carotid revascularisation.
The company shares...
Research suggests potential link between strenuous physical activity and increased VTE risk in men
Published in the Journal of Thrombosis and Thrombolysis, new research with a follow-up of 27 years has found an association between high levels of...
Bioprosthetic venous valve imparts sustained clinical improvement at one year regardless of CEAP category
A new paper that drills into the impact of a novel bioprosthetic venous valve replacement by CEAP (Clinical, Etiological, Anatomical and Pathophysiological) classification shows...
InspireMD receives IDE approval from FDA for CGUARDIANS II pivotal trial
InspireMD has announced that the Food and Drug Administration (FDA) approval of the company’s investigational device exemption (IDE) application to initiate the CGUARDIANS II...
Smoking: BEST-CLI trial points to protective effect against MALE in those undergoing open bypass...
An analysis of the BEST-CLI randomized controlled trial (RCT) found that smokers with chronic limb-threatening ischemia (CLTI) should be preferentially treated with open bypass...
A team sport: A prescription for the future of vascular surgery
Outgoing Eastern Vascular Society (EVS) President Kathleen Ozsvath, MD, used her presidential swansong to address the needs of those practicing the specialty moving forward,...
Medinol announces first-in-human implantation of drug-eluting peripheral stent in Australia
Medinol has announced the successful first-in-human implantation of the ChampioNIR drug-eluting peripheral stent by Gerard S. Goh, MD, head of interventional radiology, and Thodur...
Carotid intervention linked to improved survival versus medical management in symptomatic patients
New study data suggest that the interventional treatment of symptomatic carotid artery disease may result in an improved rate of age-adjusted overall survival compared to medical...
Cook Medical creates custom-made aortic device for fenestrated FET procedure
Cook Medical this week announced that it has created a custom-made device for the frozen elephant trunk (FET) aortic procedure.
A press release details that,...
The top 10 most popular Vascular Specialist stories of September 2024
In September, the most read stories from Vascular Specialist included a change in leadership for the Midwestern Vascular Surgical Society; study results examining new treatment...
Surmodics receives FDA 510(k) clearance for Pounce XL thrombectomy system
Surmodics has announced that it has received Food and Drug Administration (FDA) 510(k) clearance for its Pounce XL thrombectomy system.
The Pounce system is indicated...
Novel AI-assisted DVT diagnostic pathway aims to ‘democratize’ point-of-care ultrasound
A new deep vein thrombosis (DVT) diagnostic pathway incorporating non-expert artificial intelligence (AI)-guided compression ultrasound could reduce workload and costs for healthcare systems...
APDVS launches vascular surgery curriculum e-book for medical students
The Association of Program Directors in Vascular Surgery (APDVS) has released a new ebook designed to enhance vascular surgery education for medical students. According...
SVS encourages participation in compensation survey
The Society for Vascular Surgery (SVS) is encouraging members to participate in the 2024 Compensation Survey, a key initiative designed to provide vascular surgeons...
Are we overtreating aortic aneurysms in the elderly?
A large meta-analysis of elective endovascular aneurysm repair (EVAR) outcomes by age has shown that three-to-five-year survival is very low in octogenarians, prompting researchers...
Eastern Vascular Society presidency transfers from Ozsvath to Lal
Brajesh K. Lal, MD, assumed the Eastern Vascular Society (EVS) presidency during the 2024 EVS annual meeting in Charleston, South Carolina (Sept. 19–22).
The professor...
Boston Scientific completes acquisition of Silk Road Medical
Boston Scientific announced the close of its acquisition of Silk Road Medical, the company behind transcarotid artery revascularization (TCAR).
"The integration of the TCAR platform into our portfolio...
SVS announces merger creating Section on Ambulatory Vascular Care
The Society for Vascular Surgery (SVS) announced the merger of its Section on Outpatient and Office Vascular Care (SOOVC) and the Community Practice Section...
Abou-Zamzam assumes Western Vascular Society reins
Ahmed Abou-Zamzam Jr., MD, has taken over the as the 2024–25 president of the Western Vascular Society (WVS).
The professor of surgery at Loma Linda...
Wrapsody WAVE trial demonstrates superior patency versus standard of care in AV fistula patients
Merit Medical has today announced positive six-month findings from the randomized arteriovenous (AV) fistula arm of its Wrapsody arteriovenous access efficacy (WAVE) pivotal trial....
Philips announces FDA approval for enhanced LumiGuide guidewire, marks 1000th patient treated with 3D...
Royal Philips today announced the introduction of the 160cm Food and Drug Administration (FDA)-approved version of its LumiGuide endovascular navigation wire. This enhanced LumiGuide...
VQI analysis of CLTI practice following BEST-CLI finds no pick up in bypass rate
A Vascular Quality Initiative (VQI) analysis of evolving practice in the wake of the BEST-CLI trial demonstrated no increase in the rate of surgical...
Muck takes over Midwestern Vascular Surgical Society presidency
Patrick Muck, MD, assumed the reins of the Midwestern Vascular Surgical Society (MVSS) at the conclusion of the 2024 MVSS annual meeting in Chicago...
Pilot study looks at undiagnosed vascular disease in homeless
A pilot study in Canadian capital Ottawa aimed at uncovering the extent of undiagnosed vascular disease among the city’s homeless population detected a subset...
Argon Medical announces launch of peripheral venous thrombectomy system
Argon Medical has today announced the launch of the Cleaner Vac thrombectomy system for the removal of blood clot from the peripheral venous vasculature.
The...
New OBL column to launch in October issue
Vascular Specialist is launching a new column in the October issue of the newspaper dedicated to issues important to—and involving—the office-based lab (OBL) setting.
Entitled...
‘Select CLTI patients may be safely treated in the office-based lab’
Results from a single-center analysis show the outpatient setting met SVS objective performance goals.
A retrospective study of endovascular interventions performed for chronic limb-threatening ischemia...
Shockwave Medical expands US peripheral IVL portfolio with enhanced catheter
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the full U.S. launch of its Shockwave E8 peripheral intravascular lithotripsy (IVL) catheter, following...
The top 10 most popular Vascular Specialist stories of August 2024
In August, the most read stories from Vascular Specialist included a research letter addressing ‘alarmingly high’ mortality rates in chronic limb-threatening ischemia (CLTI) patients; a new...
Study sheds light on vascular-specific advanced practice provider experience
In a recently conducted survey, over 200 U.S. advanced practice providers (APPs) in vascular surgery cited performing at the top of their license as...
Being a vascular nurse: Notes from SVN president ahead of Vascular Nurses Week
In recognition of Vascular Nurses Week (Sept. 8-14), Vascular Specialist spoke with Society for Vascular Nursing (SVN) President Karen Bauer, DNP. Bauer is a...
SVS Vascular Quality Initiative launches Carotid Care Quality Champion program
The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI) clinical registry today announced the Carotid Care Quality Champion recognition program.
The program honors healthcare...
Koya Medical announces full results from TEAYS study of Dayspring device
Koya Medical recently announced that full results from the TEAYS clinical study have been published in the Journal of Vascular Surgery (JVS).
The data...
VVT Medical receives endorsement letter from AVF on CPT coding guidance for ScleroSafe
VVT Medical recently announced that the American Venous Forum (AVF) has provided an official opinion letter regarding CPT coding guidance for the ScleroSafe percutaneous...
AngioDynamics announces CE mark approval in Europe for the Auryon system
AngioDynamics today announced European CE mark approval of the Auryon atherectomy system, designed for the treatment of peripheral arterial disease (PAD), including chronic limb-threatening...
Study: Social support associated with better PAD health outcomes
Patients with peripheral arterial disease (PAD) reporting lower levels of social support experience worse health outcomes, a new Yale-led study finds.
Social support is thought...
New ESC guidelines combine peripheral arterial and aortic diseases for first time, emphasising interconnectivity...
The European Society of Cardiology (ESC) has today published its 2024 guidelines for the management of peripheral arterial and aortic diseases (PAAD), evaluating these...
First-in-human study of SonoThrombectomy system completed
SonoVascular has announced the successful initiation of its first-in-human study (FIH) of the company's SonoThrombectomy system, an ultrasound-facilitated, thrombolytic-enhanced platform that utilizes multiple mechanisms...
Inari Medical updates ClotTriever XL IFU amid FDA recall notice
The Food and Drug Administration (FDA) has issued a Class I recall—the most serious type—for Inari Medical's ClotTriever XL, 30mm device due to reports...
SCVS issues call for abstracts as deadline approaches for 2025 symposium
The Society for Clinical Vascular Surgery (SCVS) has issued a call for abstracts for its 2025 Annual Symposium, with just under two weeks left...
Eastern Vascular Society set to stage day of service during 2024 annual meeting
The Eastern Vascular Society (EVS) has incorporated a day of service into its 2024 annual meeting, being held in Charleston, South Carolina (Sept. 19–22).
Leading...
SVS sets modest dues increase to drive enhanced member benefits
The Society for Vascular Surgery (SVS) announced an increase in membership dues for 2024 for Active members, a strategic move aimed at enhancing support...
‘Choosing the right devices for the right patients’: Surgeon-scientist secures NIH funding to develop...
Michael Conte, MD, recently used his 2024 Veith Lecture to call on young vascular surgeons on the peripheral arterial disease (PAD) frontlines to drive...
Physician-modified endografts ‘safe and effective’ for thoracoabdominal and complex AAA repair
Researchers have reported a 94% technical success rate among other key findings from a recent international, multicentre, single-arm cohort study of physician-modified endografts (PMEGs)...
SCOREPAD seeks to address ‘alarmingly high’ mortality in CLTI patients with underlying coronary disease
A new research letter underscores the need to improve long-term survival following lower extremity revascularization for chronic limb-threatening ischemia (CLTI), setting out a randomized...
Survey of off-label treatment of complex repair pinpoints factors behind underreported outcomes data
The potential for cost and time to be key factors in low levels of outcomes data reporting emerged during a national survey of the...
Societies seek consensus on NIVL management amid ‘paucity of rigorous data’
The diagnosis and management of non-thrombotic iliac vein lesions (NIVL) is the focus of a newly published set of consensus statements from the Vascular...
SVS urges revisions for independent cardiology certification board
The Society for Vascular Surgery (SVS) has expressed conditional support for cardiology establishing an independent certification board but objects to provisions in the current...
Centerline Biomedical receives FDA 510(k) clearance for new IOPS Viewpoint catheter
Centerline Biomedical recently announced that its Intra-Operative Positioning System (IOPS) Viewpoint catheter has received Food and Drug Administration (FDA) 510(k) clearance. The Viewpoint catheter is...
Vascular Therapies completes enrollment in the ACCESS 2 study
Vascular Therapies has today announced completion of enrollment in the ACCESS 2 trial, a Phase III prospective randomized, multicenter clinical study of Sirogen for...
SVS History Work Group’s landmark project culminates in new book
The 2024 Vascular Annual Meeting (VAM) saw the culmination of a decade-long project by the Society for Vascular Surgery's (SVS) History Project Work Group....
Silk Road celebrates milestone of 100,000 TCAR procedures
Silk Road Medical has announced the milestone of more than 100,000 transcarotid artery revascularisation (TCAR) procedures having been performed to date.
“A growing number of...
CIRSE begins CALCIO trial enrolment for treatment of CLTI with Shockwave IVL system
The Cardiovascular and Interventional Society of Europe (CIRSE) have announced that patient enrolment for the CALCIO trial has begun. CALCIO started patient enrolment on...
Thrombolex and Aidoc announce strategic partnership to advance breakthrough PE treatment
Thrombolex and Aidoc have announced a strategic partnership aimed at revolutionising the treatment of acute pulmonary embolism (PE), a press release reports.
This strategic collaboration,...
CEA and TCAR should be ‘first-line’ interventions for weekend carotid revascularization, researchers advise
Patients who undergo carotid revascularization at the weekend have increased odds of complications and mortality, with transfemoral carotid artery stenting (TFCAS) posing the highest...
Machine learning-based model could aid in determining EVAR suitability
Researchers at the University Medical Center Groningen (Groningen, The Netherlands) and the University of Twente (Enschede, The Netherlands) have developed a prediction model that...
One-year STRIDE study data show ‘meaningful’ limb salvage, mortality and QoL outcomes
One-year outcomes from the STRIDE study of the Indigo aspiration thrombectomy system (Penumbra) for lower-extremity acute limb ischemia (ALI) showed target limb salvage and...
PRESERVE II trial shows robust five-year outcomes
Five-year outcomes the PRESERVE II pivotal trial of Cook Medical’s Zenith branch iliac graft (ZBIS) demonstrate “sustained safety and effectiveness” when combined with the...
‘Well, here we are—but right now I wish I wasn’t’: Early-career errors
On Friday, June 21, the Society for Vascular Surgery (SVS) Young Surgeons Section (YSS) held their session at the 2024 Vascular Annual Meeting (VAM)....
SVS Annual Business Meeting showcases 2024 Foundation award recipients
The Society for Vascular Surgery (SVS) convened its Annual Business Meeting at the Vascular Annual Meeting (VAM) on June 22 in Chicago.
A highlight...
SVS Women’s Section delves into vascular trauma treatment intricacies amid ‘paucity of literature’
“Life over limb”—that was one of the key messages to emerge from the VAM 2024 SVS Women’s Section session that placed a lens over...
Vascular care is a ‘team sport’ founded on infrastructure, personnel and standards
The E. Stanley Crawford critical issues forum at VAM 2024 in Chicago—which featured the tagline ‘Quality Care Everywhere’—underscored the importance of standards, infrastructure, personnel...
Government Grand Rounds: The role of stakeholders in legislative and administrative engagement
Stakeholder organizations such as the Society for Vascular Surgery (SVS) play a crucial role in shaping healthcare policies and ensuring that the voices of...
Acellular tissue-engineered vessel granted FDA Regenerative Medicine Advanced Therapy designation for advanced PAD
Humacyte recently announced it has been granted Regenerative Medicine Advanced Therapy (RMAT) designation from the US Food and Drug Administration (FDA) for its investigational...
Life Seal Vascular awarded NSF SBIR grant to advance sac management technology for EVAR
Life Seal Vascular recently announced that it has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant. The funding will...
Grasping the nettle: The need to tackle PAD problem head on is huge, says...
Huge opportunities abound for vascular surgeons to take a leadership role on the frontlines of a developing peripheral arterial disease (PAD) treatment crisis in...
A calling seeded in childhood: Uniting vascular surgery for the betterment of patient care
Many attending the 2024 Vascular Annual Meeting (VAM; June 19–22) might have been unaware of the early life of 2023–24 Society for Vascular Surgery...
The top 10 most popular Vascular Specialist stories of June 2024
In June, the most read stories from Vascular Specialist included key reports from the 2024 Vascular Annual Meeting (VAM; June 19–22) covering TEVAR, CEA...
Sonovein FDA pivotal study treatments completed: Theraclion reaches key milestone on schedule
Theraclion, a French MedTech company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces today that treatments in the Food and...
Humacyte’s ATEV granted FDA Regenerative Medicine Advanced Therapy designation for advanced PAD
Humacyte recently announced it has been granted Regenerative Medicine Advanced Therapy (RMAT) designation from the US Food and Drug Administration (FDA) for its investigational...
Smoking cessation remains a ‘ripe target’ for improved medication adherence in carotid disease
New data presented at the 2024 Vascular Annual Meeting (VAM) held June 19–22 in Chicago have revealed poor overall rates of medical therapy adherence...
SVS raises alarm over healthcare consolidation in comments to FTC, DOJ, HHS
The Society for Vascular Surgery (SVS) has submitted comments to the Federal Trade Commission (FTC), the Department of Justice (DOJ) and the Department of...
Incentives and coaching offer promise for improving supervised exercise therapy completion in claudicants
Study findings were presented during Saturday, June 22’s Plenary Session 7 support current vascular guidelines advocating for effective supervised exercise therapy (SET) prior to...
Gore announces first commercial implant of Gore Tag thoracic branch endoprosthesis in Canada
Gore has announced the first commercial use of the Gore Tag thoracic branch endoprosthesis (TBE) in Canada.
The news came as Canadian government health authority...
VAM 2024: Paper exploring stroke rates in arch TEVAR emerges as winner of Poster...
The 2024 Vascular Annual Meeting (VAM) in Chicago showcased emerging talent in vascular surgery through a moderated Poster Competition held over two days of...
Endovascular CFA treatment associated with increased rate of long-term CFA-specific reintervention, study finds
A recent study suggests that endovascular treatment of the common femoral artery (CFA) is associated with an increased rate of long-term CFA-specific reintervention, regardless...
New data on TAMBE outcomes in complex aortic aneurysms revealed
The US Food and Drug Administration (FDA)-approved Gore Excluder Thoracoabdominal Branch Endoprosthesis (TAMBE) has been shown to be safe and effective at 30 days...
Patient selection may explain ‘counterintuitive’ relationship between carotid stenting volume and outcomes in new...
High stroke and death rates relating to carotid stenting in the Pacific Northwest may be driven by the selection of high-risk patients with less...
TCAR and endarterectomy both ‘reasonable’ but stenting linked to worse outcomes in kidney disease...
A study examining outcomes between different carotid revascularisation procedures has concluded that transcarotid artery revascularisation (TCAR) and carotid endarterectomy (CEA) both represent a “reasonable choice” in severe chronic...
Linda Harris elected SVS vice president
The Society for Vascular Surgery (SVS) has announced Linda Harris, MD, as its next vice president, meaning that she enters the presidential line and...
Young vascular surgeons on the PAD frontier: ‘This is the time to seize the...
Huge opportunities abound for vascular surgeons to take a leadership role on the frontlines of a developing peripheral arterial disease (PAD) treatment crisis in...
‘Implementation of EPAs marks a paradigm shift in how we prepare vascular surgeons’
As the landscape of surgical education undergoes rapid evolution, one innovation promises to redefine how future vascular surgeons are trained and certified: Entrustable Professional...
SOOVC outlines strides made to provide platform for surgeons conducting research in the OBL
The SVS sub-section on Outpatient and Office Vascular Care (SOOVC) Chair Anil Hingorani, MD, used the group’s dedicated VAM 2024 session to focus on...
Leaders in their field: SVS bestows two awards for lifetime achievement
A standing ovation, flashing lights and a praiseworthy introduction greeted the recipients of the SVS Lifetime Achievement Award yesterday morning: Peter Gloviczki, MD, and...
Women’s Section to place a lens over vascular trauma
The SVS Women's Section will host their VAM 2024 session, “Vascular Trauma: What I Need to Know in the Middle of the Night” at...
Zenith iliac branch graft ‘durable and highly effective’ in PRESERVE II study
Five-year outcomes from the PRESERVE II study support the safety and effectiveness of the investigational Zenith iliac branch graft (ZBIS, Cook Medical) in combination...
Early vascular evaluation can ‘significantly supplement’ wound healing and limit resource waste
“Our findings ultimately suggest that vascular evaluation within six weeks of wound appearance can significantly supplement wound healing in wound centers,” said Saranya Sundaram,...
New comparative study shows no differences between HeRO and fAVG
A new contemporary comparative study will be presented during Friday’s Plenary Session 5 (8–9:30 a.m., West Building, Level 3, Skyline Ballroom) by author Theodore...
‘We are in this together’: SVS president set to issue call for vascular surgery...
SVS President Joseph Mills, MD, is set to issue a rallying call steeped in classical history and decades of collected vascular surgery wisdom in...
The shift to outpatient care: ‘A good business plan is mandatory’
Daniel McDevitt, MD, spoke during the Community Practice Section at VAM 2024 on potential methods to participate in the shift to the office-based lab...
Early vascular evaluation can ‘significantly supplement’ wound healing and limit resource waste
“Our findings ultimately suggest that vascular evaluation within six weeks of wound appearance can significantly supplement wound healing in wound centers,” said Saranya Sundaram,...
The Colombian Chapter strategy: ‘We’ve got to get the word out’
The International Chapter Forum Educational Session at VAM 2024 saw Ana M. Botero, MD, chief of vascular surgery at Fundación Santa Fe de Bogotá...
Chickasaw Nation study exemplifies how diversity can boost patient access to specialized vascular care
A “feasible and reproducible” intervention bundle characterized by surveys, provider education and patient screening has demonstrated the potential to not only identify gaps in...
Karith Foster presents vision on how to transform diversity at VAM 2024
“True diversity is a good and powerful thing that should be celebrated. It's not mandatory quotas; it's intentional inclusion," said Karith Foster, chief executive...
Vascular community embraces learning from past operating room experiences in ‘My Worst Cases’
Transparency was at the forefront of a My Worst Cases session at VAM yesterday afternoon. Moderator William Robinson, MD, professor and chief in the...
‘Remarkable’ variation in international vascular care calls for better adherence to evidence-based practice
"All vascular surgeons have access to the same randomized trials and guidelines, which should harmonize international treatment patterns, but this is not always the...
Navigating clinical guidelines discrepancies between SVS, ESVS patients
Clinical guidelines from the Society for Vascular Surgery (SVS) and the European Society for Vascular Surgery (ESVS) are pivotal in directing practitioners' management of...
Overcoming barriers and finding solutions for diabetes-related amputations among underserved populations
Diabetes-related lower extremity amputations (LEA) disproportionately impact racial minorities and low-income groups. The Vascular Volunteers in Service to All (VISTA) assessment tool identified significant...
SVN wraps conference with joint PA section programming
The society for vascular nursing (SVN) is in the midst of its 42nd Annual Conference at McCormick Place, West. The conference kicked off Wednesday...
Sex-based analysis finds BEST-CLI data generalizable to female patients
A new secondary analysis of sex disparities in the best endovascular versus best surgical therapy in patients with critical limb ischemia (BEST-CLI) trial data...
Vascular community has a role to play in ensuring safety of aortic devices
Physician-sponsored Investigational Device Exemption (IDE) trials have an important role to play in the continued development and refinement of aortic endovascular devices, attendees of...
Attendees welcomed to ‘more inclusive, more innovative, and more educational’ VAM
“I urge each one of you to seize this unique opportunity to not only enhance your patient care but also elevate your careers,” SVS...
Full smorgasbord of vascular surgery to be showcased during Friday’s International Fast Talk Session
On Friday morning, June 21 (6:30–7:15 a.m. in the West Building, Level 1), VAM 2024 attendees will have the chance to take in an...
Toe and flow session aims to break down barriers to multidisciplinary limb salvage teams
“If you had cancer you would go to a cancer center where you would get a multidisciplinary approach,” SVS President Joseph L. Mills, MD,...
Sex-based analysis finds BEST-CLI data generalizable to female patients
A new secondary analysis of sex disparities in the best endovascular versus best surgical therapy in patients with critical limb ischemia (BEST-CLI) trial data...
TCAR and endarterectomy both ‘reasonable’ but stenting linked to worse outcomes in kidney disease...
A study examining outcomes between different carotid revascularization procedures has concluded that transcarotid artery revascularization (TCAR) and carotid endarterectomy (CEA) both represent a “reasonable...
Patient selection may explain ‘counterintuitive’ relationship between carotid stenting volume and outcomes in new...
High stroke and death rates relating to carotid stenting in the Pacific Northwest may be driven by the selection of high-risk patients with less...
One-year results confirm safety and efficacy results of conformable AAA device in highly angulated...
Results of a sub-study from the pivotal Investigational Device Exemption (IDE) trial assessing Gore’s Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis have shown...
Community affairs: Optimizing, protecting and enhancing clinical practice
The SVS Community Practice Section (CPS) has put together an extensive 90-minute program for Thursday afternoon at VAM.
The session, entitled Community Practice Section: Optimizing...
Vascular surgery trainees face the future armed similarly with both open and endovascular skills
The BEST-CLI trial underscores the importance of ensuring trainee competence in open peripheral revascularization as well as endovascular treatment. Indeed, the trial results have...
Radiation safety session seeks to address variability and improve access to education
“Variability is a source of inferior quality, poor outcomes and harm,” says Anil Hingorani, MD, vascular surgeon at New York University (NYU) Langone in...
APP united: Society for Vascular Nursing and SVS PA Section to host immersive program
The Society for Vascular Nursing (SVN) is again hosting its 42nd Annual Conference June 19–20 at McCormick Place alongside VAM 2024. This year’s meeting...
Analysis will kickstart conversation on F/BEVAR outcomes
New data presented during Friday's Plenary Session 6 (10–11 a.m. in the West Building, Skyline Ballroom) will shed light on trends in the adoption...
Artificial intelligence: Breakfast session explores opportunities and risks for vascular surgery
The advent of artificial intelligence (AI) in vascular surgery holds great promise to optimize the delivery of care, with prospective uses including patient selection...
Pediatric vascular trauma: ‘Collaboration really matters in this space’
The focus of yesterday’s American Pediatric Surgical Association (APSA)-SVS task force’s spring quarterly interest group meeting at VAM 2024 was the “incredibly crucial” topic...
Endovascular CFA treatment associated with increased rate of long-term CFA-specific reintervention, study finds
A recent study suggests that endovascular treatment of the common femoral artery (CFA) is associated with an increased rate of long-term CFA-specific reintervention, regardless...
Unmet needs and paradigm shifts: VESS scientific sessions set to plumb the vasculature for...
Selected research to be presented during the Wednesday afternoon, June 19, series of Vascular and Endovascular Surgery Society (VESS) Scientific Sessions (from 1:30 p.m....
Toe and flow session aims to break down barriers to multidisciplinary limb salvage teams
If you had cancer you would go to a cancer center where you would get a multidisciplinary approach,” SVS President Joseph Mills, MD, tells...
SVS, AVF bring the latest innovations in venous disease treatment to VAM
During the first day of VAM 2024, the Society for Vascular Surgery (SVS) and American Venous Forum (AVF) have co-sponsored a session on the...
Data and discussion forefront carotid session at ‘pivotal moment’
Contemporary management of carotid disease after the Centers for Medicare and Medicaid Services (CMS) carotid artery stenting (CAS) decision memo and prior to CREST-2...
VAM 2024: Putting out the fires of intraoperative vascular emergencies
A 2024 Vascular Annual Meeting (VAM 2024) Education Session taking place on Wednesday, June 19 (3:15–4:45 p.m. in the West Building, Level 1) will...
Vascular-VP: ‘The blueprint for what a quality vascular program should look like’
Some of the benefits to quality care provision ensuing from participation in the American College of Surgeons (ACS) and SVS Vascular Verification Program (Vascular-VP)...
Drilling down on the roots of pathologic inflammation and wound healing challenges in diabetic...
This year’s James S. T. Yao Resident Research Award winner looks at novel therapeutic target for non-healing diabetic wounds. Kevin D. Mangum, MD, PhD,...
SVS resident and student program boosts interest in vascular surgery amid workforce crisis
Against the backdrop of a national shortage in the vascular surgery workforce, a recent study has found that the Society for Vascular Surgery (SVS)...
Rutherford lecture at world federation session set to feature vascular low frequency disease consortium...
The director of the Vascular Low Frequency Disease Consortium (VLFDC) is set to be among the headline presenters at this year’s World Federation of...
Dedicated session offers insight on ebbs and flows of SVS, ESVS guidelines
An education session set to take place in the afternoon of Wednesday, June 19 (3:15–4:45 p.m. in the West Building, Level 1), will examine...
Pediatric vascular care in focus: Raising awareness of supportive care processes
In 2021, the Society for Vascular Surgery (SVS) and the American Pediatric Surgical Association (APSA) established a task force dedicated to optimizing pediatric vascular...
Pushing the boundaries of vascular care: VQI meeting kicks off at VAM
The Vascular Quality Initiative (VQI) is hosting its two-day annual conference at the 2024 Vascular Annual Meeting (VAM 2024) from June 18–19, drawing healthcare...
VAM 2024: Presidential welcome
It is with great excitement and anticipation that I welcome you to the Vascular Annual Meeting (VAM), taking place from June 19–22 in the...
Boston Scientific announces agreement to acquire Silk Road Medical
Boston Scientific has announced that it has entered into a definitive agreement to acquire Silk Road Medical, a medical device company involved in producing...
Verified vascular! Quality care in vascular disease
The Society for Vascular Surgery (SVS) and American College of Surgeons (ACS) Vascular Verification Program (Vascular-VP) will be a central focus on the opening...
CEA vs TCAR: Surgeons should be familiar with both procedures and ‘collaborate as needed’
When it comes to the ongoing debate of carotid endarterectomy (CEA) versus transcarotid artery revascularization (TCAR) in the treatment of carotid artery stenosis, operators...
VAM 2024: Enhancing clinical practice and patient interaction in CLTI
A key event on informed decision-making in chronic limb-threatening ischemia (CLTI) promises to be a highlight of the 2024 Vascular Annual Meeting (June 19–22). Funded...
SVS launches registration for 3rd annual CPVI Skills Course
The Society for Vascular Surgery (SVS) has officially launched registration for the annual Complex Peripheral Vascular Initiatives (CPVI) Skills Course. The first course launched...
‘The forgotten stepchild of vascular surgery’: The quest to push forward basic science research...
The 2024 Venous Symposium (May 8–11) in New York City was highlighted by keynote speaker Peter Pappas, MD, regional medical director and program director...
First post-FDA approval implant of Duo venous stent system announced
Royal Philips today announced the first implant of the Duo venous stent system, indicated to treat symptomatic venous outflow obstruction in patients with chronic...
AVS receives IDE approval from FDA for pivotal intravascular lithotripsy study
Amplitude Vascular Systems (AVS) announced today that it has received an investigational device exemption (IDE) from the Food and Drug Administration (FDA) to begin...
VAM 2024: Changes to carotid stenting landscape in United States set to be discussed
Sean P. Lyden, MD, chairman of the Department of Vascular Surgery at Cleveland Clinic’s Heart, Vascular and Thoracic Institute in Cleveland, Ohio, will discuss...
The top 10 most popular Vascular Specialist stories of May 2024
In April, the most read stories from Vascular Specialist include new data from the C-GUARDIANS pivotal investigational device exemption (IDE) trial presented at the...
BEST-CLI and the BASIL trials: Motion sees audience move in favor of endovascular therapy...
During the 2024 Charing Cross (CX) International Symposium in London, England (April 23–25), a Great Debate that pitted four global peripheral arterial disease (PAD)...
Shape Memory Medical announces first patient treated in the AAA-SHAPE randomised controlled pivotal trial
Shape Memory Medical recently announced that the first patient has been treated in the AAA-SHAPE pivotal trial.
AAA-SHAPE (Abdominal aortic aneurysm sac healing and prevention...
Aspirex achieves 78% two-year primary patency rate in P-MAX postmarket observational study
At the Leipzig Interventional Course (LINC) 2024 (28–31 May, Leipzig, Germany), Michael Lichtenberg (Arnsberg Vascular Clinic, Arnsberg, Germany) shared for the first time a...
The role of deep venous arterialization comes under scrutiny
"Every so often in vascular disease, disruptive technologies come along and the question really is, ‘Is this going to make a big impact on...
FastWave Medical announces successful 30-day first-in-human data on peripheral IVL technology
FastWave Medical has announced the 30-day results of its first-in-human (FIH) study using the company's differentiated peripheral intravascular lithotripsy (IVL) technology.
This was a...
SVS approves FY 2024-2025 budget, sets priorities
The Society for Vascular Surgery (SVS) has unveiled its strategic plans for fiscal year 2024–2025. On April 2, the SVS Executive Board (EB) and...
APDVS says goodbye to two long-term leaders during spring meeting
The 2024 Association of Program Directors in Vascular Surgery (APDVS) convened in Chicago April 5–6 for their annual spring meeting, which held the record...
SVS Foundation awards announced
The SVS Foundation has announced recipients for the 2023–2024 awards cycle. The slew of awardees is headed by the winner of the S.T. Yao...
‘I’m a big fan of firsts’: Nationally renowned speaker on DEI set to headline...
Karith Foster, chief executive of Inversity Solutions, is set to headline the inaugural Society for Vascular Surgery (SVS) Keynote Speaker Series at the 2024...
‘What if we could translate the most durable Dacron repair into a minimally invasive...
Imagine a world in which the enduring Dacron graft, birthed by vascular pioneer Michael DeBakey, MD, some 70 years ago as an open repair...
LINC 2024: C-GUARDIANS data represent lowest event rates in published trials of CAS, TCAR...
New data from the C-GUARDIANS pivotal investigational device exemption (IDE) trial support consideration of carotid artery stenting (CAS) with the CGuard embolic prevention stent...
PAD guideline update from ACC, AHA and others centers multispecialty care
New multisociety clinical practice guidelines for the management of lower extremity peripheral arterial disease (PAD) have been published online in the Journal of the...
We are not ‘and vascular’: SVS set to launch ambitious new phase in branding...
SVS secretary details the spirit and the cause behind the next phase of the Society’s branding campaign aimed at helping vascular surgery become an...
Studies highlight need for tailored treatment options for women with peripheral arterial disease
New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral arterial disease (PAD), including endovascular therapy and...
‘We need to continue to be deliberate’: Dedicated society for women vascular surgeons formed
The inaugural president spoke to Vascular Specialist about the newly formed International Society for Women Vascular Surgeons ahead of this year’s Women’s Vascular...
‘Who let a vascular surgeon in the room?’: Leadership in the face of turf...
Leading vascular surgeons from across the globe contributed pearls of wisdom on how to go about tackling inevitable turf battles from other specialties practicing...
The top 10 most popular Vascular Specialist stories of April 2024
In April, the most read stories from Vascular Specialist include new research on Chat generative pre-trained transformer (GPT) technology and its application within vascular...
US FDA approves expanded indication for Gore Excluder conformable device
Gore has announced US Food and Drug Administration (FDA) approval of an expanded indication for the Gore Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis....
JVS-VL papers go under the microscope
On the final day of the 2024 International Vein Congress (April 18–20) in Miami, Florida, Joseph P. Hart, MD, associate professor of surgery and...
New randomised data show cyanoacrylate glue performs strongly on patient satisfaction
Patients undergoing cyanoacrylate glue closure for superficial venous disease reported higher periprocedural satisfaction than those who were treated via surgical stripping, data from a...
CMS considers new approaches to quality payment program with MVPs
The Centers for Medicare & Medicaid Services (CMS) are exploring strategies to enhance the Quality Payment Program (QPP), underscoring an effort to boost healthcare...
SVS membership empowers surgeons in and out of the OR
The SVS emphasizes the role vascular surgeons play in advancing treatments for vascular diseases, offering a range of benefits through its membership to support...
End of an era: Schanzer and Robinson leave legacy of VAM innovation
As this year's Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM) approaches, it marks the end of an era for Andres Schanzer, MD,...
Vascular surgery Entrustable Professional Activities available to view
The American Board of Surgery (ABS) has unveiled the 15 proposed core Entrustable Professional Activities (EPAs) that will be evaluated in vascular surgery residents.
They...
The ability of ChatGPT to further patient education and aid surgeons
ChatGPT 4.0 was able to provide a mean accuracy rating of 4.4 on a Likert scale of 5 (1=very poor; 5=excellent) across 15 patient-level...
Statewide performance metric ‘profoundly’ increases rate of EVAR surveillance
A statewide collaborative between 35 hospital systems and a large insurance provider showed that the implementation of a performance metric linked with financial reimbursement...
Abbott’s Esprit BTK scaffold system given US FDA approval for CLTI treatment
Abbott has announced that the US Food and Drug Administration (FDA) has approved the Esprit BTK everolimus-eluting resorbable scaffold system (Esprit BTK system), a...
Interim analysis provides early window into real-world Alto stent graft outcomes
In a podium-first presentation on the final day of the 2024 Charing Cross (CX) International Symposium (23–25 April, London, UK), Sean Lyden (Cleveland Clinic,...
Questions linger: BASIL-3 does not find for drug-eluting technologies for CLTI
In the UK National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA)-funded BASIL-3 randomised controlled trial (RCT), neither drug-coated balloon (DCB)...
Prosthetic valve implantation shows “vast” improvements in deep chronic venous insufficiency
“The surgical challenges of repairing deep venous reflux have been present for more than a generation. It is worth reflecting on the fact that...
Penumbra announces FDA clearance of Lightning Flash 2 for the treatment of PE
Penumbra has announced the US Food and Drug Administration (FDA) clearance and launch of Lightning Flash 2, the next generation computer assisted vacuum thrombectomy (CAVT)...
CX united: Vascular world set to converge with challenging cases
The World Federation of Vascular Societies (WFVS) is bringing the vascular world together at CX 2024 to chew over both challenging cases and leadership...
Paclitaxel controversy: Yes, device restrictions did cause harm
“Unfortunately, we are doing worse for our patients today,” were the sobering thoughts of Eric Secemsky (Boston, United States) during a late-breaking presentation in...
SVS launches Vascular Board Certification Model Task Force
The Society for Vascular Surgery (SVS) Executive Board has established the Vascular Board Certification Model Task Force to deliver a final report entitled “Free-standing...
SVS announces candidates for 2024–25 vice president
The Society for Vascular Surgery (SVS) has announced Linda Harris, MD, and Palma Shaw, MD, as the candidates for the upcoming election for SVS...
Latest iteration of SVS program seeks to help foster development of resilient leaders
As the Society for Vascular Surgery (SVS) prepares to launch its fifth cohort of the Leadership Development Program (LDP), anticipation is high among aspiring...
Research provides ‘stepping stone’ for future application of AI in vascular surgery
New research on Chat generative pre-trained transformer (GPT) technology and its Vascular Education and Self-Assessment Program (VESAP) success rate provides insight into the future...
Physician-assembled unitary stent graft platform for debranched TAAA repair found safe and effective
Researchers behind a seven-year retrospective analysis of a physician-developed unitary stent graft system for endovascular debranched aortic repair of various thoracoabdominal aortopathies reported a...
How intersociety collaboration to promote private practice could help vascular surgery amid workforce crisis
Dawn M. Coleman, MD, chief of vascular surgery at the Duke University School of Medicine in Durham, North Carolina, focused on the likely major...
Bad reading: How to claw back negative revenue?
Five frequently performed vascular surgeries at a prominent New Orleans-based health system between 2019 and 2022 yielded an average yearly decrease in net revenue...
Study details link between increased functional status and improved survival in prosthesis-fitted amputees
Increasing functional status in vascular patients fitted with a prosthesis after amputation was incrementally associated with improved survival, a retrospective analysis of a 10-year...
Greenhalgh legacy set to continue at CX 2024
Though the 2024 edition of the Charing Cross (CX) International Symposium (April 23–25) in London, England, marks a new era, it will be tinged...
The top 10 most popular Vascular Specialist stories of March 2024
In March, the most read stories from Vascular Specialist include a new analysis which suggests of a ‘lack of reach’ of vascular voices within...
FlowTriever device found to dramatically improve breathing among intermediate-risk acute pulmonary embolism patients
SCVS 2024 saw Zachary AbuRahma, DO, an assistant professor of vascular surgery at West Virginia University and the Charleston Area Medical Center in Charleston,...
Novel ultrasound-facilitated thrombectomy with microbubbles shows promise in acute porcine model for DVT treatment
Evaluation of the safety and performance of a novel pharmaco-mechanical procedure for acute deep vein thrombosis (DVT) in two pigs demonstrated a significant reduction...
Johnson & Johnson to acquire Shockwave Medical
Johnson & Johnson is to acquire Shockwave Medical, it has been announced today.
Under the terms of the transaction, Johnson & Johnson will acquire all...
New data show single-session Indigo aspiration system without overnight thrombolytics is safe and effective...
During the Society of Interventional Radiology (SIR) 2024 annual meeting (23–28 March, Salt Lake City, USA), newly presented data from a subgroup analysis of...
SVS announces VAM keynote speaker series
Registration for the 2024 Vascular Annual Meeting (VAM 2024) launched on March 20 and promotions teased a new annual VAM fixture: the SVS Keynote...
Study hints at long-term cost-effectiveness of CDT and PMT over oral anticoagulation for moderate...
During a presentation at the 2024 European Vascular Course (EVC; March 3–5) in Maastricht, The Netherlands, Anna Pouncey, MD, a clinical research fellow for...
Getinge and Cook Medical enter US commercial distribution agreement for iCast covered stent
Getinge and Cook Medical today announced an exclusive sales and distribution agreement for the iCast covered stent system, which recently received Food and Drug...
First-in-human study of Pounce thrombectomy system in acute iliofemoral DVT demonstrates 12-month PTS rate...
Twelve-month outcomes from the Pounce venous thrombectomy system (Vetex Medical) first-in-human study evaluating its use in the treatment of acute iliofemoral deep vein thrombosis...
Endovascular showdown: CX 2024 sets the stage for BASIL-3 first-time data presentations
At the Charing Cross (CX) Symposium 2024 (23–25 April, London, UK), Andrew Bradbury (University of Birmingham, Birmingham, UK) and the BASIL-3 team of triallists...
FDA Breakthrough Device designation granted for DynamX BTK for use in CLTI treatment below...
Elixir Medical has announced Breakthrough Device designation by the Food and Drug Administration (FDA) for its novel DynamX BTK System, an implant for use...
Personalized, precision medicine is key to the future of aortic repair
Predicting longevity in patients who may be candidates for aortic repair is challenging. This, coupled with a high and unchanging long-term postoperative mortality rate,...
Bentley, Cook Medical enter US distribution agreement for BeBack device
Cook Medical and Bentley today announced a distribution agreement for the BeBack crossing catheter in the U.S., with Cook assuming commercial responsibilities for the...
SCVS 2024: Bismuth becomes 2024–25 Society for Clinical Vascular Surgery president
Jean Bismuth, MD, took over as Society for Clinical Vascular Surgery (SCVS) president during the organization's 51st Annual Symposium in Scottsdale, Arizona (March 16–20).
The...
Hans-Henning Eckstein: 1955–2024
Hans-Henning Eckstein, the vascular surgeon who played a leading role in the SPACE and SPACE 2 randomised controlled trials on the treatment of carotid...
First patient enrolled in IDE study of Aquedeon Medical’s Duett vascular graft system
Aquedeon Medical has announced the initiation of an investigational device exemption (IDE) clinical trial to study the Duett vascular graft system.
A press release reveals...
Multi-society PAD Pulse Alliance aims to highlight importance of patient education
Society for Vascular Surgery (SVS) experts are spearheading initiatives as part of the multispecialty PAD Pulse Alliance and its Get a Pulse on PAD...
VRIC 2024 to hear from leading light on role of immunity and inflammation in...
Filip Swirski, PhD, a leading figure in cardiovascular immunology research, will deliver this year’s Alexander W. Clowes Distinguished Lecture at the 2024 Vascular Research...
New data underscore physician experience levels required to derive benefit from transfemoral carotid artery...
Data from a new study that maps out the levels at which adverse postoperative events decrease following transfemoral carotid artery stenting (TfCAS) based on...
US FDA Breakthrough Device designation granted for Biotronik’s Freesolve BTK resorbable magnesium scaffold
Biotronik has been granted Breakthrough Device designation (BDD) from the US Food and Drug Administration (FDA) for the Freesolve below-the-knee (BTK) resorbable magnesium scaffold...
Vascular external support system use found to boost key functional outcomes for surgical arteriovenous...
Alik Farber, MD, professor of surgery and radiology at Boston University, is set to present the results of a multicenter U.S. study at the...
VAM abstract submissions hit near-historic high
A nearly record-breaking 794 Abstracts were submitted for the SVS 2024 Vascular Annual Meeting (VAM 2024). The abstracts were scored by the VAM Program...
Longer fasting before venography appears to impact stent size selection, new study finds
During the 2024 American Venous Forum (AVF) annual meeting in Tampa, Florida (March 3–6), Kurt S. Schultz, MD, a general surgery resident at the...
Vascular surgery resident reflects on Match Day experience
Integrated vascular surgery resident Eric Smith, MD, tells Vascular Specialist how he handled the lead up to Match Day.
For medical students hoping to specialize...
New analysis points to lack of vascular surgical voices in news coverage of vascular...
A new study set to be aired at the 2024 Society for Clinical Vascular Surgery (SCVS) annual meeting (March 16–20) in Scottsdale, Arizona, sheds...
IVUS use in claudicants not associated with improved outcomes, claims data show
The use of intravascular ultrasound (IVUS) for the treatment of claudication doubled over a four-year period but there was “no clear relationship between IVUS...
CLOUT registry: Interim two-year rates of PTS ‘significantly lower’ than those in historical DVT...
Rates of post-thrombotic syndrome (PTS) among deep vein thrombosis (DVT) patients treated with the ClotTriever thrombectomy system (Inari Medical) who are logged in the...
Single-center analysis suggests improved longer-term outcomes with endarterectomy versus TCAR
A large, single-center analysis has found that, despite parity between the two procedures in terms of perioperative clinical outcomes, carotid endarterectomy (CEA) was associated...
ISC 2024 examines TCAR ‘explosion’ alongside advances in intensive medical therapy
This year’s International Stroke Conference (Feb. 7–9) in Phoenix, Arizona, hosted discussions on the current state of play in carotid stenosis treatment—and, most notably,...
The top 10 most popular Vascular Specialist stories of February 2024
In February, the most read stories from Vascular Specialist include a study of metformin and its potential as the first-ever medical treatment that can...
AVF 2024: Outgoing president addresses history, future direction of American Venous Forum
At the 2024 American Venous Forum (AVF) in Tampa, Florida (March 3–6), Glenn Jacobowitz, MD, professor of vascular and endovascular surgery at NYU Langone...
Non-pneumatic compression device performed better than advanced pneumatic compression for lower extremity lymphedema
A new study presented during the 2024 American Venous Forum (AVF) in Tampa, Florida (March 3–6), that compared a novel non-pneumatic compression device with...
Adoption of AI into workflow associated with faster time to assessment of PE patients
An abstract presented at the 2024 American Venous Forum (AVF) annual meeting (March 3–6) revealed that, in the treatment of patients with pulmonary embolism...
VESS 2024: Determining success in vascular surgery across the generations
Outgoing Vascular & Endovascular Surgery Society (VESS) President Mark Conrad, MD, used the 2024 VESS presidential address to illustrate how he got into vascular...
Frank J. Veith joins ViTAA Medical Solutions’ board of directors
ViTAA Medical Solutions has announced the appointment of Frank J Veith, MD, professor of surgery at the Cleveland Clinic Lerner College of Medicine of...
Endologix initiates postmarket study of the Detour system
Endologix has announced the initiation of the Percutaneous transmural arterial bypass (PTAB)1 postmarket study. This study marks the beginning of a comprehensive postmarket study...
EACTS and STS guidelines recognize aorta ‘as an organ in its own right’
New guidelines from the European Association for Cardio-Thoracic Surgery (EACTS) and the Society of Thoracic Surgeons (STS) have, for the first time, recognized the...
FORS-powered LumiGuide 3D imaging technology is rolled out at specialized centers in U.S. and...
Andres Schanzer, MD, has hailed it "one of the most exciting changes" seen in imaging during the course of his career. Philips’ LumiGuide "human...
U.S. study highlights racial and ethnic disparities in the placement of ‘overused’ IVC filters
A nationwide U.S. study, recently published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL), showed that Black patients had the highest...
Mechanical thrombectomy demonstrates superior outcomes to anticoagulation in DVT patients, analysis of RCT and...
Mechanical thrombectomy using the ClotTriever device (Inari Medical) for iliofemoral deep vein thrombosis (DVT) was found to be “associated with significantly” lower Villalta scores...
Large administrative databases enter crosshairs as comparative analysis shows percutaneous mechanical thrombectomy as superior...
The pitfalls of large administrative databases came to the fore during the presentation of a propensity-match scoring analysis demonstrating that percutaneous mechanical thrombectomy (MT)...
Nitinol stents placed in iliac veins “not associated with prolonged back pain,” study finds
In a retrospective review of over 600 patients who underwent iliac vein stent placement, the development of back pain was found to be unrelated...
Consortium led by vascular surgeon-scientist secures $6.4 million funding to develop sustainable alternative to...
The European Union Horizon Europe, with joint funding from UK Research Innovation, has awarded the NetZeroAICT Consortium €6 million ($6.4 million) in funding to...
VAM 2024 pricing now available
Pricing information for the 2024 Vascular Annual Meeting (VAM 2024) is now available. The event, scheduled in Chicago from June 19–22, is promoted as...
As temporal trends in hemodialysis access creation emerge, notion of AV fistula superiority comes...
The 2024 Southern Association for Vascular Surgery (SAVS) annual meeting (Jan. 24–27) hears three separate talks—two scientific papers and one from an invited guest...
Landmark BEST-CLI trial gains recognition as top cardiovascular advance in 2023
The American Heart Association (AHA) has named the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb ischemia) trial one of...
AAA and complex repair: ‘We need more evidence,’ says UChicago chief
A randomized controlled trial (RCT) of open repair versus endovascular aneurysm repair (EVAR) for the treatment of abdominal aortic aneurysms (AAAs), as well as...
Trial assessing AI-powered tissue microsensor technology in PAD begins enrollment
Sensome has announced enrollment of the first patients into a feasibility clinical study using the Clotild smart guidewire in peripheral arterial disease (PAD). Clotild was designated...
More than half of medical students altered Match ranking order after post-virtual interview site...
Amid the build-up to residency Match Day 2024, the Association of Program Directors in Vascular Surgery (APDVS) has delivered data from a VISIT (Vascular...
Breakthrough Device designation granted for Efemoral scaffold system designed to treat CLTI
Efemoral Medical has announced the granting of Food and Drug Administration (FDA) Breakthrough Device status for its novel Efemoral vascular scaffold system (EVSS) designed...
SAVS 2024: A journey to the heart of DEI like no other
David L. Cull, MD, delivers a captivating presidential address, laying bare his own challenging journey as a vascular surgeon and the hidden lessons on...
The top 10 most popular Vascular Specialist stories of January 2024
In January, the most read stories from Vascular Specialist include a U.S. Aortic Research Consortium analysis of F/BEVAR preoperative risk factors in AAAs/TAAAs; a...
Re-evaluating aortoiliac endarterectomy: Case series shows ‘acceptable durability’
The uncommonly performed aortoiliac endarterectomy—one of the open procedures on which the vascular surgical specialty was founded—provides acceptable durability in aortoiliac occlusive disease patients...
‘Get a Pulse on PAD’: Multi-society public awareness campaign launched
The Society for Vascular Surgery (SVS), in partnership with three other medical societies operating in the vascular disease space that form the PAD Pulse...
Measuring plaque inflammation via SCAIL scores may improve carotid stenosis risk stratification
The use of a relatively novel scoring system, referred to as Symptomatic carotid atheroma inflammation lumen-stenosis (SCAIL), has produced favourable predictive qualities versus the...
UK MHRA update: Paclitaxel-coated device increased mortality risk is withdrawn for PAD
Following a review, the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) has updated guidance on the use of paclitaxel-coated devices stating that such devices...
Serration angioplasty associated with reduced recoil in infrapopliteal arteries compared with plain balloon angioplasty
A study comparing the extent of early infrapopliteal recoil after serration and plain balloon angioplasty has found the former produces “substantially less” arterial recoil...
SVS points to 2023 achievements, challenges in coming year
The Society for Vascular Surgery (SVS) reflects on a year marked by notable achievements on multiple fronts. In a communication to members in mid-December,...
First patient enrolled in HERCULES randomized trial comparing ESAR and EVAR
The first patient has been enrolled into the HERCULES trial, which compares endosuture aneurysm repair (ESAR) to standard endovascular aneurysm repair (EVAR) in the treatment of abdominal aortic...
Could metformin be first-ever medical treatment that is effective at managing aneurysm disease?
There is a global interest in assessing whether metformin, which has a long track record of safety and efficacy, is relatively inexpensive and is...
How the best leaders ensure psychological safety at work
My limited understanding of psychological safety is when people feel safe expressing differing opinions, and thoughts in the workplace. Amy Edmondson, a pioneer in...
First patient treated in ZFEN+ fenestrated endovascular graft study
Cook Medical has announced the first patient treated in the clinical study of the Zenith Fenestrated+ endovascular graft (ZFEN+) in the U.S. The procedure was...
Mentor Match available for all SVS members
The SVS has expanded its Mentor Match program, which is now available to all SVS members in good standing. The program aims to connect...
SOOVC releases handbook for outpatient care
The SVS Sub-Section on Outpatient and Office Vascular Care (SOOVC) has released the anticipated Office-Based Lab (OBL) Handbook to guide practitioners and aid with...
Viabahn VBX stent graft receives FDA approval
Gore has announced recent Food and Drug Administration (FDA) approval of a lower profile Viabahn VBX balloon expandable endoprosthesis (VBX stent graft) for the treatment...
Endospan releases early TRIOMPHE IDE study results at Society of Thoracic Surgeons annual meeting
Endospan shared 30-day results from the first 22 patients enrolled in the TRIOMPHE investigational device exemption (IDE) study in a late-breaking presentation at the...
Southern Vascular elects first woman president-elect
The Southern Association for Vascular Surgery (SAVS) elected Margaret (Megan) Tracci, MD, to become its first ever woman president for the 2025–26 cycle.
Tracci,...
Gore receives FDA approval for breakthrough endovascular device in complex aortic aneurysms
Gore has announced Food and Drug Administration (FDA) approval for the Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE), which the company states is the first...
Coding: Increasing complexity and lost RVUs—a drop in the ocean?
A vascular surgery team at Audie L. Murphy VA Medical Center in San Antonio, Texas, uncovers “staggeringly low” numbers of correctly coded billing for...
Midterm CARAS study results show cerebral ischaemic event incidence “should not be underestimated”
The final publication of midterm results from the observational CARAS study suggest that cerebral ischaemic event (CIE) incidence in asymptomatic carotid stenosis patients “should...
University of Pittsburgh awards $100,000 grant to SVS member for AI-based healthcare project
Last October, the University Pittsburgh’s Clinical and Translational Sciences Institute hosted its 10th Pitt Innovation Challenge (PinCh), providing a total of $550,000 in prizes,...
International collaboration unveils updated PAD guidelines in diabetic foot ulcers
The International Working Group on the Diabetic Foot (IWGDF), the European Society for Vascular Surgery (ESVS) and the Society for Vascular Surgery (SVS) have...
First procedures announced in study of novel peripheral IVL system
FastWave Medical has announced the successful completion of enrollment for its first-in-human (FIH) study with the company’s peripheral intravascular lithotripsy (IVL) technology.
The prospective, single-arm...
First patients enrolled in VBX FORWARD clinical study
Gore has announced that the first patients have been enrolled in the Gore VBX FORWARD clinical study, a global prospective, multicenter, randomized controlled trial to compare...
U.S. Aortic Research Consortium maps out F/BEVAR preoperative risk factors for one-year mortality in...
A series of preoperative risk factors—including currently smoking, chronic kidney disease (CKD), congestive heart failure (CHF), aneurysm size greater than 7cm, more advanced...
The utility of renal stenting in hemodialysis patients: One in five found to come...
A fifth of patients among a chronic kidney disease (CKD) cohort on hemodialysis—a rare subset pulled from a large repository of national data—were able...
BEST-CLI: A year down the road
A dedicated session at the 2023 VEITHsymposium (Nov. 14–18) in New York City aimed to unpack the ways in which clinical practice and attitudes...
No increased risk of complications found with transradial access for carotid artery stenting
Carotid artery stenting (CAS) delivered via transradial artery access has demonstrated no increased risk of stroke, death, myocardial infarction, transient ischaemic attack, or access...
FDA approves ENGULF US pivotal trial of Hēlo thrombectomy system
Endovascular Engineering (E2) has announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for its ENGULF US pivotal trial.
The study will...
SCAI, SIR, SVS jointly publish proceedings from multispecialty peripheral IVUS roundtable
Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ultrasound (IVUS) in lower extremity revascularization procedures were released today in the...
Centers for Medicare & Medicaid Services grants Transitional Pass-Through payment for Endologix’s Detour system
Endologix recently announced that the Centers for Medicare & Medicaid Services (CMS) has granted a Transitional Pass-Through (TPT) payment for the Detour system, effective...
VAM travel scholarships open doors for underrepresented medical students
The Society for Vascular Surgery (SVS) Resident and Student Outreach Committee (RSOC) is accepting applications through Jan. 8, 2024, for the Diversity Medical Student...
Vascular Specialist’s top stories of 2023
Which stories captured the attention of the vascular community over the course of the past year? Read our summary of the trending articles from...
Corner Stitch: On the vascular trainee opportunities on the conference calendar
Christopher Audu, MD, surveys the 2024 meeting landscape, highlighting prime opportunities for trainees to showcase their research.
It is abstract submission, and this month I...
Yao family and SVS Foundation establish James S.T. Yao Resident Research Award
In a tribute to the late James S.T. Yao, MD, PhD, a luminary in the field of vascular surgery, the Yao family and the...
Nominations open for 2024 SVS Excellence in Community Practice Award
The Society for Vascular Surgery (SVS) is calling for nominations for its Excellence in Community Practice Award, which recognizes outstanding leadership within the community...
First patient treated in ARISE II study of ascending stent graft
Gore has announced the first patient implantation of the company's ascending stent graft in the ARISE II trial, describing this as an exciting step...
Personalized postoperative anticoagulation needed to curb lower-limb amputations
“We’re going to see more and more amputations if we don’t figure out the right post procedure thromboprophylaxis regime ASAP,” Anahita Dua, MD, warned...
JVS-VL to be open access beginning in January
The Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL) will move from a subscription model to one of open access—freely available online—on Jan....
SVS members pitch in to help patients kick the smoking habit
SVS members are taking advantage of the new Smoking Cessation Toolkit and resources from the Vascular Quality Initiative (VQI), adding them to existing programs...
Ego, logistics, money: Overcoming barriers to a successful wound care program
Proper integration of primary care physicians (PCPs) in the multidisciplinary care of vascular wounds is going to play an increasingly important role as the...
Society for Vascular Surgery addresses latest mainstream media reports on atherectomy
The Society for Vascular Surgery (SVS) has issued a statement addressing the latest reports published by ProPublica on atherectomy use in the U.S.
The nonprofit...
SVS receives CMSS grant to advance diagnostic excellence
The Society for Vascular Surgery (SVS) has received a $100,000 grant from the Council of Medical Specialty Societies (CMSS) to promote diagnostic excellence across...
Humacyte submits Biologics License Application to FDA seeking approval of Human Acellular Vessel
Humacyte today announced that it has submitted a Biologics License Application (BLA) to the Food and Drug Administration (FDA) seeking approval of the Human...
Less vain and more vein: Evaluating the perceptions of venous disease amongst the vascular...
Our biases permeate the fabric of our very being, as they weave their way into our training and practice. It is clear that complex...
‘There is no reliable way to measure carotid stenosis—methods have changed and tend to...
The recent move to expand Medicare coverage of carotid stenting formed the basis of a recent debate over the wisdom of the decision taken...
Need for ‘clear, well-defined guidelines’ in patient selection for surgical implantation of baroreflex activation...
The emergence of a baroreflex activation therapy device for heart failure patients is drawing in the assistance of the open surgical expertise of vascular...
Bylaws referendum approved by SVS voting members
The voting members of the SVS have approved amendments to the Society bylaws following a referendum that closed on Nov. 20. The proposed changes...
SVS makes fresh call for active participation in compensation survey
The Society for Vascular Surgery (SVS) has made a fresh call for members to participate in a compensation survey, a collaboration with Phairify, that...
Changing course: The natural history of tibial claudication comes under scrutiny as interventions for...
In the end, reflected Michael S. Conte, MD, “it’s not the evidence.” The leading vascular surgeon and peripheral arterial disease (PAD) expert made the...
Enrollment complete in APEX-AV study of mechanical aspiration system for acute PE
Patient enrollment is now complete in the APEX-AV trial evaluating the safety and efficacy of the AlphaVac F1885 (AngioDynamics) multipurpose mechanical aspiration system for...
The top 10 most popular Vascular Specialist stories of November 2023
In November, the most read stories from Vascular Specialist include a reassessment of which carotid revascularization treatment modality is best after the recent Centers...
Intravenous anesthesia delivery during varicose vein treatment proves safe and reduces pain scores, researcher...
A new intravenous anesthesia delivery technique used during endothermal ablation for varicose veins demonstrated comparatively low pain scores according to first-in-human (FIH) data recently...
VOYAGER PAD analyses shed light on use of rivaroxaban in high-risk patient populations
New analyses from the VOYAGER PAD clinical trial in both high-risk and fragile patients and those with and without comorbid coronary artery diseases (CAD)...
TRANSCEND 36-month data “continue to demonstrate safe and effective performance” of SurVeil DCB
Peter Schneider (University of California San Francisco, San Francisco, USA) recently presented 36-month data from Surmodics' TRANSCEND clinical trial at the VEITHsymposium 2023 (14–18...
VAM abstract submissions window opens
VAM program chair Andres Schanzer, MD, makes a call for cutting-edge new science for next year’s meeting in Chicago.
Researchers who want to present new...
Change: A driving force behind SVS advocacy initiatives
Change is a constant in life, and advocacy is no exception. The healthcare landscape is always evolving, and the SVS Advocacy Council is working...
The pulmonary arterial tree—it is time we branch out
Nicolas Mouawad, MD, chief of vascular surgery at McLaren Health System in Bay City, Michigan, urges vascular surgeons to “get out of their comfort...
Twelve-month first-in-human data from Xeltis’ aXess haemodialysis vascular conduit trial presented at VEITHsymposium 2023
Xeltis has announced "highly encouraging" 12-month results from its first-in-human (FIH) aXess vascular conduit trial. The data were presented by Frans Moll (University Medical...
Randomized trial set to elucidate value of image fusion technology for aortic repair
An ongoing UK National Institute for Health and Care Research (NIHR)-funded randomized controlled trial seeks to illuminate the value of an image fusion guidance...
Impact of the CMS proposed rule on the QPP for 2024
This summer the center for medicare and Medicaid Services (CMS) published its annual Physician Fee Schedule and Proposed Rule for calendar year 2024, and...
Two-year SWING data ‘continue to show promise’ for sirolimus DCB in treating BTK disease
Two-year data from the SWING trial, a first-in-human study of the safety and performance of the Sundance sirolimus drug-coated balloon (DCB; Surmodics), have been...
Specialty representation at all levels of a healthcare organization is ‘increasingly important’ in value-based...
A 14-year effort to achieve departmental status for vascular surgery at a large healthcare system in Southern California resulted in significant gains for the...
NIH-funded research on the use of AI in vascular surgery: A decade in the...
Vascular surgeon-scientist Elsie Gyang Ross, MD, recently secured coveted funding through the National Institutes of Health (NIH) Research Project Grant Program (R01)—a rare feat...
SVS executive director elected to executive council of Council of Medical Specialty Societies
The Society for Vascular Surgery (SVS) Executive Director Kenneth M. Slaw, PhD, has been elected to executive council of the Council of Medical Specialty...
Carotid disease: Getting to the right decision
The recent move by the Centers for Medicare & Medicaid Services (CMS) to expand coverage for carotid artery stenting brought with it the requirement...
DETOUR1 and DETOUR2 pooled analysis of bypass system reveals primary rate of 68.1% through...
Endologix has announced results from a pooled analysis of the DETOUR1 and DETOUR2 studies evaluating percutaneous transmural arterial bypass (PTAB) with the Detour system.
The Detour system...
PROMISE II 12-month data show durable outcomes with the LimFlow system in no-option CLTI...
One-year results from the PROMISE II US pivotal trial demonstrate the durability of outcomes of transcatheter arterialisation of the deep veins (TADV) using the...
The top 10 most popular Vascular Specialist stories of October 2023
Last month, the most popular stories from Vascular Specialist included The Centers for Medicare & Medicaid Services (CMS) confirmation of carotid artery stenting coverage expansion;...
LimFlow announces agreement to be acquired by Inari Medical
LimFlow announced today that it has entered into a definitive agreement to be acquired by Inari Medical.
A press release details that, under the terms...
Computer-assisted vacuum thrombectomy system for patients with pulmonary embolism demonstrates ‘rapid, statistically significant’ improvement...
Patients undergoing computer-assisted vacuum thrombectomy with the Indigo Aspiration System (Penumbra) for pulmonary embolism (PE) showed 2.7% rates of both major adverse events (MAEs)...
CLTI: European cohort study provides ‘strong positive evidence’ for surgery over endovascular approach, supporting...
A recently published study has shown that lower limb bypass surgery offered a significantly higher probability of amputation-free survival and wound healing compared with...
For Diabetes Month, diabetes resources for SVS members, patients
November is National Diabetes Month. Because SVS members treat patients with the condition—and its complications—the Society has numerous educational resources available.
“Diabetes and Vascular Disease”...
Akura thrombectomy system for PE appears safe and demonstrates reduction of RV/LV ratio in...
Results from a first-in-human, prospective, single-arm study of the Akura Medical thrombectomy system (Akura Medical) for pulmonary embolism (PE) were revealed this week at...
No relationship found between DW-MRI lesions and long-term stroke risk following carotid revascularisation
A secondary analysis of existing clinical trial data has indicated that new ischaemic brain lesions detected via diffusion-weighted magnetic resonance imaging (DW-MRI) following carotid...
Six-month outcomes from phase-one trial of anti-inflammatory drug to assess benefit in acute DVT...
The open-label phase of the DEXTERITY-AFP trial investigating the Bullfrog microinfusion device—which involves the perivenous injection of the anti-inflammatory drug dexamethasone to improve patency...
One-year CLOUT data demonstrate low rate of PTS following treatment with ClotTriever
David Dexter (Sentara Vascular Specialists, Norfolk, USA) shared one-year data from the CLOUT registry this week at The VEINS 2023 (28–30 October, Las Vegas,...
New varicose vein management guidelines released
The SVS, in collaboration with the American Venous Forum (AVF) and the American Vein and Lymphatic Society (AVLS), has unveiled part two of...
SVS unveils proposal outlining changes to Society bylaws
Voting members of the SVS will have the opportunity to consider a bylaws referendum, with key amendments related to membership and the composition of...
REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system compared to mechanical...
Data from the REAL-PE study were presented this week at TCT 2023 (23–26 October, San Francisco, USA) demonstrating that patients treated for pulmonary embolism...
Thrombolex announces new insights from the RESCUE trial with the Bashir endovascular catheter
Thrombolex has announced never-before-reported major reductions in obstruction in all of the segmental pulmonary arteries (PA), based on independent core lab data analysis of...
Highlighting original work by women: Peer-review title blazes new trail in vascular surgery
The September issue of Annals of Vascular Surgery featured 37 original, peer-reviewed scientific papers whose lead authors and researchers are women vascular surgeons. Here,...
Women’s champion: Freischlag marks out value of diversity and surgeons as hospital leaders
Julie A. Freischlag, MD, used her turn as honorary guest lecturer at the 2023 Midwestern Vascular Surgical Society (MVSS) annual meeting to make a...
TCT 2023: LIFE-BTK breathes life into drug-eluting resorbable scaffolds in breakthrough for below-the-knee arteries
Results of the LIFE-BTK randomized controlled trial have just been presented at TCT 2023 (Oct. 23–26) in San Francisco. The data show that, in...
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and death that helped...
Data from a patient-level meta-analysis—a factor in the Food and Drug Administration’s (FDA) recent change of position on the use of paclitaxel-coated devices to...
Survey suggests venous work less valued than arterial interventions
The majority of more than 300 vascular surgeons who responded to a recent survey indicated that they perceive the management of venous disease to...
NESVS 2023: Cambria takes over as New England SVS president
Robert Cambria, MD, recently took over as president of the New England Society for Vascular Surgery (NESVS). He was passed the presidential baton by...
Prepare to submit research for VAM 2024
Organizing a Vascular Annual Meeting (VAM) takes a whole lot of time and a whole lot of long-range planning.
Thus, members of the SVS Postgraduate...
Multicenter study points to favourable safety and efficacy of radial access for peripheral interventions
New research examining the safety and efficacy of using radial access for peripheral artery interventions has found that radial access allows early ambulation and...
NESVS 2023: Novel IVC filter retrieval device slashes procedural time and radiation exposure during...
An inferior vena cava (IVC) filter retrieval device dubbed the next-generation in removal of the venous thromboembolism-fighting tools could substantially cut procedural times and...
Vascular branding: Determining a vascular surgeon’s value
A vascular surgeon's value includes far more than direct revenues from procedures performed, said SVS member Robert Tahara, MD, recently. He told surgeons to...
SVS Foundation Board of Directors welcomes two new members to its leadership team
The SVS Foundation's Board of Directors announced the appointment of two new board members, Edith Tzeng, MD, and Palma Shaw, MD, at the board’s...
Vascular Health Step Challenge emerges as beacon of awareness and action
This September, 533 people put their feet to the ground to raise awareness about peripheral arterial disease (PAD) as part of the SVS Foundation’s...
SVS webinar covers insights learned from experiences of mass-casualty disasters
A mass shooting in Las Vegas. A bombing at the finish line of the Boston Marathon. A shooting at a Fourth of July parade....
CMS confirms broadened Medicare coverage of carotid artery stenting in final decision
The Centers for Medicare & Medicaid Services (CMS) has released its final decision regarding National Coverage Determination (NCD) 20.7 covering carotid artery stenting (CAS),...
Rates of stroke, death and myocardial infarction post-TCAR do not differ by patient sex
While sex disparities regarding the outcomes of carotid revascularization have “long been a concern,” new prospective data published in the Journal of Vascular Surgery...
SVS varicose vein guideline webinar set for Oct. 10
A virtual roundtable on Oct. 10 will cover the new Society for Vascular Surgery (SVS) varicose veins guidelines. Set for 6–7:30 p.m. CDT, the...
From the editor: Sex, lies, and carotid stents
First, a disclaimer. This commentary is woefully short of sex-related content. Not even the wholesome gender-based outcomes stuff. So, if that key term brought...
Enrollment of first patient in Neuroguard carotid stent system trial announced
Contego Medical has announced enrollment of the first patient in the prospective, multicenter PERFORMANCE III trial aimed at further evaluating the safety and effectiveness of the...
Obituary: Roger M. Greenhalgh (Feb. 6, 1941–Oct. 6, 2023)
Roger Malcolm Greenhalgh, MD, the surgeon internationally renowned for his unparalleled contribution to vascular education, training and research, died peacefully on Oct. 6. He...
EVS 2023: New data chart underrepresentation of women at the head of national clinical...
The underrepresentation of women vascular surgeons in national clinical trial leadership formed the central theme of data coming out of a new study that...
George Lavenson, Vietnam and Gulf War veteran, advocate for carotid disease screening in seniors,...
George S. Lavenson Jr., lovingly referred to as “Doc” by his many friends, died Saturday, Aug. 19, 2023, on the beautiful island of Maui,...
MVSS 2023: Human Acellular Vessel proves ‘safe, effective bypass conduit’ in complex CLTI cohort
An investigator-sponsored clinical study conducted at the Mayo Clinic in Rochester, Minnesota, of the investigational Human Acellular Vessel (HAV) in patients with chronic limb-threatening...
MVSS president outlines why vascular surgery is special and how ‘people need to know...
Outgoing Midwestern Vascular Surgical Society (MVSS) President Jeffrey Jim, MD, used his recent presidential address to call upon vascular surgeons to spread the word...
Expiation, Karl Wallenda, Oppenheimer and us
On March 22, 1978, Karl Wallenda went up on a high wire in Puerto Rico strung between two high-rise buildings. There was no safety...
The top 10 most popular Vascular Specialist stories of September 2023
Last month, the most read stories from Vascular Specialist included data releases from the recent Midwestern Vascular Surgical Society (MVSS) using direct revascularization of segmental...
EVS 2023: Putting artificial intelligence to use in vascular practice
The potential for large language-learning models like ChatGPT to take over tedious writing tasks such as emails and parts of PowerPoint presentations—or even be...
WVS 2023: President emphasizes importance of ‘tolerance’ in vascular specialty
Outgoing Western Vascular Society (WVS) President Wei Zhou, MD, used her presidential address to put out a call for the vascular specialty to embrace...
JVS-VL peer-review title launches virtual special issue on diversity topics
The Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL) has launched its first virtual special issue on diversity, equity and inclusion (DEI) in...
SVS History Digital Archive Task Force calls for notabilia
The SVS History Digital Archives Task Force is soliciting contributions as it aims to present a curated collection to SVS members and the medical...
Amplifying advocacy: SVS tool for vascular influence on the federal stage
In the dynamic arena of healthcare advocacy, the Society for Vascular Surgery (SVS) stands as a champion, harnessing the power of amplification to thrust...
Preventing spinal cord ischemia: Novel techniques for direct segmental artery revascularization show promise, WVS...
A vascular surgery team from the University of Southern California (USC) in Los Angeles demonstrated the feasibility of multidisciplinary direct revascularization of segmental arteries...
VasQ AVF creation device receives FDA clearance
Laminate Medical Technologies has announced their flagship device, the VasQ external vascular support, has been cleared by the Food and Drug Administration (FDA) for...
New clinical data support AI solution for improved PE detection and care coordination
Viz.ai has announced new clinical data supporting advancements in pulmonary embolism (PE) detection. Two studies have demonstrated the real-world clinical efficacy of Viz.ai’s PE module to...
‘Voices of Vascular’ attracts national recognition with diversity award
“Voices of Vascular,” an initiative to highlight the diverse voices within the SVS, has earned the Society and the SVS Foundation a Profile of...
Why CMS should still not extend reimbursement indications for carotid stenting or other carotid...
This commentary—authored by Anne Abbott, PhD, MBBS, Lawrence Schott, MD, Lan Gao, MMed, PhD, Hrvoje Budincevic, MD, PhD, Rishad Faruqi, MD, Tatjana Rundek, MD,...
WVS 2023: Western Vascular Society presidency passes from Zhou to Fujitani
Roy M. Fujitani, MD, president of the University of California, Irvine (UCI) Medical Center medical staff, took over as Western Vascular Society (WVS) president...
SVS-ACS Vascular Verification Program marks release of new standards for outpatient vascular centers
The Society for Vascular Surgery (SVS) and the American College of Surgeons (ACS) have released new standards for outpatient vascular centers to help them...
SAVS makes travel scholarship applications call for 2024 meeting
The Southern Association for Vascular Surgery (SAVS) has put out a call for applications from medical students and general surgery residents for 20 travel...
VRIC 2024 set for May 15
The 2024 Society for for Vascular Surgery (SVS) Vascular Research Initiatives Conference (VRIC), which concentrates on basic and translational vascular science, will take place...
Popliteal artery lesions: Two-year results from European DCB catheter registry announced
“We face a scarcity of data evaluating endovascular therapy for isolated popliteal artery lesions, known as a difficult vessel bed to treat as we...
When women are PIs: A story foretold on the vascular frontlines
“Multifactorial” issues persist in gender representation in vascular leadership and trial enrollment, leading women vascular surgeons tell Vascular Specialist.
"We would have fewer untoward side...
Humacyte announces positive top line results from Phase 2/3 trial of Human Acellular Vessel...
Humacyte has announced positive top line results from its V005 Phase 2/3 trial of the Human Acellular Vessel (HAV) in vascular trauma repair.
A...
SVS launches national smoking cessation initiative
The Society for Vascular Surgery’s Patient Safety Organization (SVS PSO) has formally launched a national smoking cessation initiative. It includes tools and resources to help physicians,...
FDA approves LimFlow system for ‘no-option’ CLTI patients
The Food and Drug Administration (FDA) today announced approval of LimFlow therapy—a novel and minimally invasive procedure designed to bypass blockages in arteries of...
MVSS 2023: Aulivola takes over Midwestern Vascular reins
Bernadette Aulivola, MD, the division director of vascular surgery and endovascular therapy at Loyola University in Maywood, Illinois, took over as president of the...
EVS 2023: Ozsvath assumes Eastern Vascular presidency
Kathleen Ozsvath, MD, a vascular surgeon at St. Peters Health Partners in Albany, New York, took over as president of the Eastern Vascular Society...
FDA clears AAA-SHAPE trial for IDE approval
Shape Memory Medical recently announced that the Food and Drug Administration (FDA) has granted investigational device exemption (IDE) for the company to begin a...
Multi-society guidelines on varicose vein management published
The Society for Vascular Surgery (SVS), American Venous Forum (AVF), and American Vein and Lymphatic Society (AVLS) have released the second and final part...
Vascular Nurses Week shines spotlight on vital role in patient care and innovation
In a world in which both medical breakthroughs and technological advancements seem to dominate the healthcare landscape, it’s easy to overlook the unsung heroes...
SVS urges members to take part in compensation survey—and bolster results
Organizers behind an SVS-commissioned financial compensation survey are calling on more members to fill out the short list of questions so that they can...
CMS: Proposed reduced conversion factor would cut vascular surgeon reimbursements
The Centers for Medicare & Medicaid Services (CMS) in mid-July released two payment-related proposed rules—the highly-anticipated calendar year (CY) 2024 Medicare Physician Fee Schedule...
Submit ideas for VAM 2024 educational sessions
Organizers of VAM 2024 want members to consider what the modern-day vascular surgeon needs to know for optimal patient care and professional success. What’s...
SVS members rally to respond to CMS carotid stenting coverage proposal
Nearly one-third of the public comments submitted to the Centers for Medicare & Medicaid Services (CMS) on a controversial proposed coverage decision affecting carotid...
Empowering vascular surgery to promote five pivotal healthcare bills before Congress
Welcome back to Government Grand Rounds, a campaign aimed at expanding vascular surgeons’ understanding of—and comfort with—the SVS’ many advocacy tools. In the dynamic...
Coding and complex PAD: Register today for two SVS courses
Limited spots remain open for two popular SVS courses coming in October: the Complex Peripheral Vascular Interventions (CPVI) Skills Course on Oct. 1–2 and...
Step off Friday for SVS Vascular Health Step Challenge
The month of September begins Friday and with it, the SVS Foundation’s Vascular Health Step Challenge.
The initiative challenges participants to walk 60 miles—representing the...
First US patient enrolled in SOCRATES short neck AAA trial
The first U.S. patient has been treated as part of the SOCRATES trial (Short neck AAA randomized trial—ESAR and FEVAR), which compares the safety...
The price of a cup of coffee
In the wake of the coverage of inappropriate vascular interventions in the mainstream press, guest editorialist Adam Tanious, MD, tackles the thorny issue of...
Endovascular stablization system for infrarenal AAAs gains FDA Fast Track designation
Nectero Medical announced that the Food and Drug Administration (FDA) has granted Fast Track designation for the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST)...
Venous stenting and the IVC: ‘Persistent problems’ in the setting of post-thrombotic syndrome
The question of “persistent problems” with venous stenting among post-thrombotic syndrome (PTS) patients emerged as a key talking point during the recent Deep Venous...
Congress considers incremental steps towards Medicare payment reform
There is no doubt that the Medicare payment system needs reform. At this moment, the SVS is aiming to inspire reform through all facets...
First patient treated in global strategic collaboration involving Cydar Maps technology
Cydar Medical has announced the successful treatment of the first patient in a strategic collaboration with Medtronic. The collaboration, which spans 40 sites across...
Clinical performance of Human Acellular Vessel amid war in Ukraine presented at military research...
Clinical outcomes of Humacyte's investigational Human Acellular Vessel (HAV) were presented at the Military Health System Research Symposium in Kissimmee, Florida (Aug. 14–17), following...
Child-bearing age ‘should not be a contraindication to venous stenting’
In a recently published study, dedicated venous stents performed well through pregnancy and postpartum, and a protocol including the use of low-dose antiplatelets in...
Study finds no correlation between IVC filter placement position and device complications
Researchers report that inferior vena cava (IVC) filter placement position relative to the level of the most inferior renal vein was not associated with...
Learn coding intricacies at October workshop on reimbursement
The SVS will host the SVS Coding and Reimbursement Workshop this fall, providing a comprehensive program designed to equip vascular surgeons and their support...
Your SVS: Executive Board sets course for year
Phase II of a national branding campaign for vascular surgery and three new task forces are just two of several initiatives the SVS’ Executive...
UCLA-SVS review course is this month
Time is running out to plan attendance at the annual course, A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery,...
Corner Stitch: Supplementing our formal learning as vascular trainees
As a vascular surgery trainee, there are multiple aspects of vascular surgery that I’ve had the opportunity to learn about. And to be honest,...
Breaking ground: A trial to improve the care of uncomplicated type B aortic dissection
Because high-quality evidence from large, prospective multicenter trials on the best treatment of uncomplicated type B aortic dissection (uTBAD) is scarce, SVS members Firas...
VQI Fellows in Training program marks one year
The Vascular Quality Initiative (VQI) Fellows in Training (FIT) program is a success, said leaders as they provided a one-year review.
FIT introduces residents and...
SVS members get ready for second annual vascular health awareness event
September's Vascular Health Step Challenge is fast-approaching, and SVS members are preparing to step up to meet it.
The challenge benefits the SVS Foundation,...
SVS responds to CMS proposed coverage expansion for carotid stenting
The Society for Vascular Surgery (SVS) and its affiliated Patient Safety Organization (PSO)/Vascular Quality Initiative (VQI) have submitted a formal response to the Centers...
WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study completes enrolment
Merit Medical has announced that it has completed enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective,...
SCVS president becomes chair of American Board of Surgery
The American Board of Surgery (ABS) has named Society for Clinical Vascular Surgery (SCVS) President M. Ashraf Mansour, MBBS, as its 2023–24 chair. He...
Light-activated drug-coated balloon granted FDA approval for clinical study
Alucent Biomedical has announced that the Food and Drug Administration (FDA) granted an investigational device exemption (IDE) for a U.S. clinical study of AlucentNVS,...
‘Vascular surgery should be a key member of pulmonary embolism response teams’
“PERT care is the coalition of the willing,” quipped Dennis Gable, MD, a vascular surgeon at Texas Vascular Associates in Plano, Texas. He was...
SVS urges members to make voices heard on CMS carotid stenting coverage expansion
The SVS has created a template to help members transmit comments to the Centers for Medicare & Medicaid Services (CMS) regarding proposed major adjustments...
‘FDA’s mission to bring safe and effective vascular surgery devices to market remains steadfast’
The Vascular and Endovascular Devices Team (VEDT) in the Food and Drug Administration (FDA) Office of Cardiovascular Devices appreciates the Vascular Specialist editorial board's...
The top 10 most popular Vascular Specialist stories of July 2023
In the previous month, Vascular Specialist delivered a range of leading commentary from the Society for Vascular Surgery (SVS) in response to the New...
Newest JVS peer-review title appoints editor-in-chief
The Journal of Vascular Surgery (JVS) has announced the appointment of Anahita Dua, MD, as the editor-in-chief of the Journal of Vascular Surgery-Vascular Insights...
Financial viability, appropriate use and patient safety in the operation of outpatient facilities
The number of office-based facilities has been increasing steadily over the past several years—and more vascular surgeons may be considering becoming involved in operating...
Comments sought on CMS proposed coverage expansion for carotid stenting
SVS members are encouraged to submit comments—due Aug. 10—to the Centers for Medicare & Medicaid Services (CMS) on its proposed national coverage determination on...
New study reports positive performance of AI-powered assessment of biomarkers for growth prediction of...
The characterization of aortic tissue by means of three key biomechanics-based biomarkers bundled into a compound Regional Areas of Weakness (RAW) Map showed “very...
Vascular surgery added as named specialty to influential national hospital rankings
U.S. News & World Report has renamed the specialty formerly known as “Cardiology & Heart Surgery” to include vascular surgery in its national rankings of...
Humacyte completes enrolment in Phase II/III trial of Human Acellular Vessel for vascular trauma...
Humacyte today announced completion of enrollment in its Phase II/III vascular trauma trial (V005) that is expected to support a Biologics License Application (BLA)...
SVS Foundation adds two surgeons to board of directors
The Society for Vascular Surgery (SVS) Foundation has announced the appointment of Bernadette Aulivola, MD, and Vikram Kashyap, MD, to its board of directors. Both...
The Golden Larva syndrome: Is it real?
Failure is part of the process that leads to success. Occasional failures may sting but we must recognize the adage that failure is a...
Nectero Medical receives FDA clearance of IND application to initiate Phase II/III clinical trial...
Nectero Medical today announced that the US Food and Drug Administration (FDA) has granted investigational new drug (IND) clearance for the company to initiate...
Endologix announces first patients treated with the Detour system
Endologix has shared in a press release that the first patients underwent percutaneous transmural arterial bypass (PTAB) using the Detour system since Food and Drug...
SVS coding workshop coming in October
The SVS’ 2023 Coding and Reimbursement Workshop will help participants learn about accurate coding and reimbursement for vascular surgery. The intensive two-day program will...
Crawford panel looks at opportunities to plug and extend vascular surgery workforce pipeline
This year’s E. Stanley Crawford Critical Issues Forum zeroed in on the pipeline of sources feeding the vascular surgery ranks. Incoming SVS President Joseph...
SVS responds to New York Times article on overuse of vascular interventions
In an official Society response, SVS President Joseph Mills, MD, tackles recent coverage in the mainstream media of inappropriateness in vascular care.
There have been...
The numbers are in: VAM 2023 adds up to another SVS classic
Landmark meeting (June 14-17) with nearly 1,400 vascular professionals moves the needle with program innovations, slew of new science and jam-packed agenda.
With more content...
Second edition of VSITE review text released
The second edition of a hit trainee-created textbook primarily aimed at those taking the Vascular Surgery In-Training Exam (VSITE) has hit the shelves.
The Vascular...
SVS seeks volunteers to write position paper
Society for Vascular Surgery (SVS) members have until July 31 to apply to serve on a new SVS writing group to develop a position...
Study finds similar rates of VTE in both flying and non-flying surgical patients
Uncertainty underlying the magnitude of risk posed by long distance air travel in venous thromboembolism (VTE) patients has created the need for a deeper,...
Long-awaited FDA update finds data do not support excess mortality risk for paclitaxel-coated devices
In a letter to healthcare providers dated July 11, 2023, the Food and Drug Administration (FDA) communicates that the risk of mortality associated with...
VESAP5 expires July 14
The SVS’ fifth edition of the Vascular Education and Self- Assessment Program (VESAP5) expires at 9 a.m. CDT July 14 and with it, the...
Review urges development of protocols to reduce hypersensitivity reactions after cyanoacrylate varicose vein treatment
Despite being considered “generally safe,” cyanoacrylate can cause local reactions in up to 25% of patients, disproportionately affecting women, Asian race and thin patients...
The top 10 most popular Vascular Specialist stories of June 2023
Last month, Vascular Specialist garnered readers' attention with an array of commentary on the BEST-CLI and BASIL-2 trials; the medical editor's interview with vascular...
Surmodics receives FDA approval for the SurVeil drug-coated balloon
Surmodics has announced the receipt of Food and Drug Administration (FDA) approval for the SurVeil drug-coated balloon (DCB).
A company press release notes that the...
FDA approves study of ZFEN+ for treatment of aortic aneurysms
The Food and Drug Administration (FDA) has granted approval for Cook Medical to initiate an investigational device exemption (IDE) study on the Zenith fenestrated+...
SVS mourns death of Past President Kenneth Wayne Johnston
The Society for Vascular Surgery (SVS) mourns the death of Kenneth Wayne Johnston, an SVS member, former president and recipient in 2009 of the...
Risk of cancer-related VTE recurrence ‘significantly lower’ using NOACs compared with low molecular weight...
Delivering results and recommendations from a systematic review and meta-analysis of novel oral anticoagulants (NOACs) versus low molecular weight heparin (LMWH) in the prevention...
Vascular Verification Program registers first four hospitals in US—including UCSF
UC San Francisco Medical Center (UCSF) is among the first four hospitals in the U.S. to be verified as part of the American College of...
Assessing the needs of young vascular patients
In the past 18 months, a joint taskforce studying the needs of pediatric vascular patients has made great strides, conducting a needs assessment, identifying...
New analysis probes BEST-CLI trial against real-world setting data
A new analysis of chronic limb-threatening ischemia (CLTI) treatment outcomes was presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions...
Primary patency after venous stenting best in NIVL patients, study finds
A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders....
Bias and the silver bullet: Gender partiality seen within AI algorithms for AAA identification
Artificial intelligence (AI) has become a central focus within various spheres, from commerce to medicine—including applications in patient care. Sharon Kiang, MD, talks to...
Advocacy exists to serve: Surgeons, patients and our mission
One of the most gratifying aspects of working to advocate for surgeons is that, at its heart, this is completely transparent and is done...
Physical pain a risk factor for vascular surgery trainee burnout, survey reveals
A recent survey has indicated that physical pain is “prevalent” among vascular surgery trainees and represents a risk factor for burnout. Eric Pillado, MD,...
VAM attendees chime in on BEST-CLI and BASIL-2
VS@VAM journalist Will Date and videographer Jean-Philippe Bensoussan caught some VAM 2023 foot traffic outside the BEST-CLI and BASIL-2: Debate, Analysis and Implementation session...
‘Vigilant’ surveillance and low threshold for further interventions ‘crucial’ following rescue of prior EVAR...
The findings of a recent study on reinterventions and sac dynamics after fenestrated endovascular aneurysm repair (FEVAR) with a physician-modified endograft (PMEG) for index...
Two-year DETOUR2 study results presented at VAM 2023
Endologix has announced the 24-month results of the DETOUR2 study, presented at VAM 2023, the annual meeting of the Society for Vascular Surgery (SVS),...
SVS announces new vice president and treasurer following 2023 election
The Society for Vascular Surgery (SVS) has announced the latest additions to its officer roll following the 2023 elections for Society vice president and...
Nephrologist insights for vascular surgeons at hemodialysis access session
Friday afternoon in Potomac D will see VAM play host to a series of presentations on access for hemodialysis that will offer education on...
Improved fistulas and cost-effectiveness promised in plenary 5 abstract presentation
Friday morning’s Plenary Session 5 (8:00–9:30 a.m.) is set to feature new data on an external support device that may deliver more functional arteriovenous...
Future research needed to ‘optimize’ use of imaging technologies during aortic procedures
Imaging technologies in the aortic space will be a key feature of Saturday’s Plenary Session 8 (11:15 a.m. to 12:30 p.m.) in Potomac A/B,...
Study shows performance on the vascular qualifying examination does not predict performance on the...
A national cohort study of vascular trainees taking the Vascular Qualifying Examination (VQE) and the Vascular Certifying Examination (VCE) found performance during the former...
Novel drug candidate for slowing AAA growth demonstrates safety in humans
The local delivery of a glucose-derived compound in small- and medium-sized abdominal aortic aneurysms (AAAs) has been deemed safe, with “promising” early efficacy data...
BEST-CLI investigators implore a move beyond endo vs. open ‘battle’ in the name of...
The principal investigators behind the BEST-CLI trial struck a conciliatory tone during the inaugural Frank J. Veith Distinguished Lecture yesterday morning in which they...
Generational divide: Do baby boomers and millennials see eye-to-eye on vascular surgery training needs?
Older-generation vascular surgeons are keen to hone their endovascular skills, while the younger generation are looking to develop their capacity to treat aortic pathologies—but...
Special VAM session underscores ‘complementary’ nature of open and endovascular strategies in CLTI patients
A dedicated session at VAM 2023 saw speakers and delegates gather to debate, analyse and consider the implementation of the BEST-CLI and BASIL-2 randomized-controlled...
Presidential address: ‘The annual meeting is only part of our story’
Friday morning will see Michael C. Dalsing, MD, MBA, deliver what is an annual hallmark of the VAM program—the SVS Presidential Address.
From 11:00 a.m.–12:15...
Carotid revascularization capable of improving mood in depressed patients with carotid atherosclerosis
A prospective study has demonstrated that carotid intervention can improve mood in depressed patients with advanced carotid disease, in addition to enabling cognitive improvements...
The global burden of CLTI: ESVS President points toward need for new global vascular...
Early-bird VAM 2023 attendees yesterday gained broad insight into the issues facing vascular surgeons around the world, with the tone set from the opening...
Cross-specialty approach to embolization ‘provides the best care for patients’
Shang Loh, MD, is chief of vascular surgery and endovascular therapy at Penn Presbyterian Medical Center in Philadelphia and professor of clinical surgery at...
Learn the who, the when and the what of treating deep vein thrombosis
Between additional available therapies, multiple new devices now on the market and evolving research supporting thrombus removal, Patrick Muck, MD, and Madhavi Meka, MD,...
VAM 2023: Vascular Quality Initiative launches national smoking cessation drive
The SVS Patient Safety Organization (SVS PSO) has launched a national smoking cessation initiative.
SVS PSO Associate Medical Director Gary Lemmon, MD, and SVS PSO...
Risk assessment models “no better than coin toss” for predicting bleeding in patients considered...
A study of two risk assessment models (RAMs) for predicting the bleeding risk in patients considered for pharmacologic prophylaxis to prevent venous thromboembolism (VTE)...
Opening ceremony heralds ‘power’ of VAM attendance
SVS President Michael Dalsing, MD, officially opened the 2023 Vascular Annual Meeting (VAM) yesterday morning, telling attendees at the early morning Opening Ceremony: “For...
VAM 2023: Vascular trauma session to highlight the current role of endovascular therapy
A focused session on vascular trauma yesterday took a deep dive into emerging issues and controversies in the field.
Moderated by Sherene Shalhub, MD, of...
Prediction model offers new option for forecasting AAA growth
A predictive model incorporating 3D shape features such as aneurysmal flow lumen and outer wall structure extracted from computed tomography (CT) imaging can improve...
VAM 2023: ‘What I wish I knew before retirement’ talk gives insight into adaptation...
Reflecting on the positives and negatives of retirement, Peter Gloviczki, MD, from the Mayo Clinic, previously in Rochester, Minnesota, now in Scottsdale, Arizona, and...
VAM 2023: Endovascular thermal septotomy for chronic post-dissection aortic aneurysm
Aidin Baghbani-Oskouei, MD, and Gustavo S. Oderich, MD, from the University of Texas Health Science Center at Houston, Texas, detail the endovascular thermal septotomy...
CEA associated with less reintervention than stenting in first six months-study
A durability study that looks at reintervention risk among patients treated with carotid endarterectomy (CEA) versus carotid artery stenting (CAS) procedures established that CEA...
Special invited research presentations offered at VAM
VAM traditionally includes presentations from specially invited translational researchers that are performing cutting-edge work focused on vascular disease. All are held during plenary sessions.
“These...
Study weighs up total transfemoral and upper extremity approaches for F/BEVAR
In a prospective, non-randomized study, researchers found that a total transfemoral approach was associated with lower rates of cerebrovascular events and improved outcomes compared...
Onco-vascular session set to offer ‘clinical pearls’ in ‘new’ area of vascular surgery
Randall DeMartino, MD, is Division Chair of Vascular and Endovascular Surgery at the Mayo Clinic in Rochester, Minnesota, and a co-moderator of a session...
Analyses offer a deeper dive into BEST-CLI trial data
As the vascular community continues to digest key insights from the BEST-CLI randomized controlled trial (RCT), attendees of Plenary Session 3 at the Vascular...
VAM 2023: SVS descends on Capitol Hill
Nearly 50 SVS members took advantage of VAM’s location near Washington, D.C., visiting Capitol Hill Tuesday to discuss legislation related to vascular surgery with...
VAM 2023: Slew of special SVS section sessions set for Thursday
The SVS includes five special sections for different member groups, including physician assistants, women, young surgeons, surgeons in community practice and the Subsection on...
Crawford panel focuses minds on challenges facing vascular surgery workforce numbers
Yesterday's E. Stanley Crawford Critical Issues Forum, which looked at ways to address the pipeline of sources feeding the vascular surgery pool of talent,...
Sex-related disparities in lower-extremity revascularization outcomes brought into focus
Women are more likely to undergo reintervention after lower extremity revascularization for peripheral arterial disease (PAD) compared to male patients with similar limb salvage...
Endothelial cell granted superhero status in invited research presentation
“The endothelial cell is the superhero of the vascular system,” Kathryn L. Howe, MD, PhD, FRSCS, a vascular surgeon-scientist at the University of Toronto...
Significant life and limb gains for claudicants who stop smoking before lower-extremity bypass
Long-term overall survival (OS) and amputation-free survival (AFS) are outcomes that rebound in claudicants who quit smoking prior to elective surgery—and they mirror those...
VAM is ‘in the room where it happens’
To borrow from the hit musical “Hamilton,” VAM 2023 takes place right near Washington, D.C., the seat of power, and “the room where it...
Safety benefits mean TCAR may be preferable approach in radiation-induced carotid stenosis
A study set to be presented at VAM (14–17 June, National Harbor, USA) has found that the long-term outcomes of transcarotid artery revascularization (TCAR)...
Base revascularization strategy on effectiveness in restoring adequate and durable limb perfusion, BEST-CLI subanalysis...
The results of a subanalysis of the BEST-CLI trial found that patients with chronic limb-threatening ischemia (CLTI) who were deemed suitable for open lower-extremity...
Global perspectives take center stage in second annual WFVS session at VAM
“The intellectual exchange of information and a better understanding of unique global perspectives has brought the leading societies closer,” Palma Shaw, MD, MBA, secretary...
Integrated vascular surgery program features may optimize trainee wellness and decrease attrition
Today’s program at the 2023 Vascular Annual Meeting (VAM) will feature the presentation of an abstract by R. Debbie Li, MD, Loyola University Medical...
VAM 2023: Learn at lunchtime
The Society for Vascular Surgery has added four lunchtime learning sessions to the VAM opening day.
Topics are both clinical and non-clinical, ranging from planning...
Study finds carotid stent fracture rate to be negligible but long-term research needed
Presenter Neeta Karani, MD, from Bronson Healthcare, Kalamazoo, Michigan, is set to elucidate findings that consider the incidence of carotid stent fractures and their...
‘First’ study to identify endothelial cell-cell communication via bidirectional secretion of extracellular vesicle cargo...
Award-winning vascular resident talks about the science behind her work, which her mentor says is “moving the needle on every front.”
University of Toronto surgeon-scientist...
VAM 2023: President-elect zeroes in on complexity of issues within vascular surgery pipeline
The Vascular Annual Meeting (VAM) E. Stanley Crawford Critical Issues Forum this year probes the problems and the challenges facing the vascular surgery workforce...
More research needed but lithotripsy plus TCAR ‘an answer’ in certain carotid disease patients
Earlier this year, researchers debuted single-center experiences indicating that intravascular lithotripsy (IVL) may be able to expand transcarotid artery revascularization (TCAR) into patients with...
The essential ‘need’ for vascular surgeons in pulmonary embolism treatment paradigm
The specter of pulmonary embolism (PE) as a common and lethal disease process—with mortality of massive PE static at about 50% for decades while...
VQI@VAM: Quality takes center stage at VQI meeting, initiative making much out of zero
Over the past several months, the Society for Vascular Surgery’s Vascular Quality Initiative (VQI) hit some important milestones, including registering procedure number 1,000,000 in...
VQI@VAM: Social media helps promote safe technique, study finds
A social media campaign promoting educational videos proved efficient and cost-effective, and similar campaigns will be useful for quality improvement projects directed toward medical...
BEST-CLI vs. BASIL-2: Different questions yield different answers
Medical editor Malachi Sheahan III, MD, takes a look at seemingly conflicting results from the landmark BEST-CLI and BASIL-2 trials, and asks what they...
‘Nobody believed us’: Vascular giant discusses overcoming skeptics to make specialty-defining breakthroughs
Malachi Sheahan III, MD, Vascular Specialist’s medical editor, speaks to living legend and limb-salvage pioneer Frank J. Veith, MD, on the contents of his...
BASIL-2 and BEST-CLI: A tale of two limb trials
Optimal treatment of patients with chronic limb-threatening ischemia (CLTI) has been an ongoing debate within the vascular community, fueled by growing numbers of patients,...
VAM 2023 beckons
Our annual gathering is almost here. After months of planning, our premiere educational event in vascular surgery, the Vascular Annual Meeting (VAM), opens June...
FDA seeks to ‘modernize’ clinical trials with new draft guidance
The Food and Drug Administration (FDA) has released draft guidance with updated recommendations for good clinical practices (GCPs) aimed at modernizing the design and...
‘Sonolysis is back’ after safely reducing endarterectomy stroke risk in randomized trial
Positive results from a clinical trial involving a novel therapeutic procedure known as sonolysis—deployed during a carotid endarterectomy (CEA)—were presented at the recent European...
The top 10 most popular Vascular Specialist stories of May 2023
Last month, Vascular Specialist most piqued reader interest with a commentary from the editor-in-chief on why he supports the decision by the Southern Association for Vascular...
Vascular surgery moves to assess trainees’ competence with EPAs
For surgeons, “EPA” means not the “Environmental Protection Agency” but “Entrustable Professional Activity”—and they’re going to change surgery training. A pilot rollout for vascular...
SVS Foundation announces 2023 student fellowship awards
The Society for Vascular Surgery (SVS) Foundation has announced the winners of the 2023 Student Research Fellowship Awards.
The award is for undergraduate college and...
SVS webinar discusses BEST-CLI and early impacts on practice
A recording of the inaugural “SVS Presents” virtual educational session, on the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb...
Interim data find ‘no evidence of benefit’ for carotid revascularization additional to optimized medical...
Interim results from the ECST-2 randomized controlled trial (RCT) have shown no evidence that carotid stenosis patients with a low-to-intermediate stroke risk, treated with...
FLAME, FLASH and ongoing PEERLESS trials collect ‘compelling’ data for FlowTriever device
Speaking on the FLAME, FLASH and PEERLESS trials that each collected data on the FlowTriever (Inari Medical) device for the treatment of pulmonary embolism...
Urban residents have smaller risk of mortality from chronic limb-threatening ischemia
A new study using data from millions of patients hospitalized across the U.S. has determined whether population density and associated urban versus suburban versus...
Advance: Navigating the policy and political processes on Capitol Hill
The underlying processes associated with advocacy—whether legislative, regulatory or political—are arduous and complex. As a result, measures of “success” are often characterized by progress...
We can honor the past without living in it
Malachi Sheahan III, MD, peels back the layers on why a decision by the Southern Association for Vascular Surgery (SAVS) to replace its signature...
Insights from largest chronic limb-threatening ischaemia study to inform quality of care improvements
Data from a cohort of one million patients with chronic limb-threatening ischaemia (CLTI) were recently presented as late-breaking clinical research at the Society for Cardiovascular...
JETi registry provides “remarkable results” for peripheral thrombectomy system
Presenting “remarkable results” from the JETi registry—a prospective, multicenter, observational study which collected real-world data on the safety, performance and clinical benefits of the...
EndoAVF found usually less cost effective compared with sAVF
The Society for Clinical Vascular Surgery (SCVS) 50th Annual Symposium (25–29 March, Miami) hosted a series of abstract presentations. Among them was one by...
Correct coding for IVUS during venous and arterial interventions
The use of intravascular ultrasound (IVUS) can provide helpful information for assessment of pre- and post-intervention vascular status and, thus, is an important part of...
Happiness, well-being and culture are key ingredients for seeking ‘eudaimonia’
Although researchers describe eudaimonia as the practice of virtues like courage, wisdom, good humor, moderation and kindness, some have translated the writings of Greek...
Medical therapy gains highlight need to reassess carotid surgery
“The time has definitely come to look at the evidence, and redo these studies,” posited Alun Davies, MD, from Imperial College London in London,...
Five-year results of the LEOPARD trial published in the Journal of Vascular Surgery
Endologix has announced the online publication of the final five-year results of the LEOPARD trial in the Journal of Vascular Surgery (JVS). The study's...
CX 2023: Statins save lives after aortic repair regardless of dose
Statin treatment after aortic repair is associated with improved long-term survival, while dose does not matter. This was the key message from a first-to-podium...
Corner Stitch: Navigating the technology landscape as a vascular trainee
I vividly recall sitting in the back of the conference room as a medical student and marvelling at the various approaches that could be...
New analysis of chronic limb-threatening ischaemia patients places BEST-CLI trial into context within real-world...
A new analysis of chronic limb-threatening ischaemia (CLTI) treatment outcomes was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography &...
A vascular mission: Defying assumptions in the fight against amputation in disadvantaged areas
Lyssa Ochoa, MD, is used to the assumptions. One: ”What a nice program you have.” Another: “It must be so nice that you can...
New ‘biopsychosocial’ roadmap set out to address PAD treatment and mental health impacts
A recent proposal has called for “whole-person, multidisciplinary interventions” after an interrogation of the interplay between lower extremity peripheral arterial disease (PAD) and mental...
Reinterventions after physician-modified endovascular grafts ‘non-detrimental’ to long-term survival
For the treatment of juxtarenal aortic aneurysms, reinterventions after physician-modified endovascular grafts (PMEGs) are non-detrimental to long-term survival. This is one of the main...
Study finds no correlation between TEVAR timing and uncomplicated type B aortic dissection outcomes
With proper patient selection, short-term outcomes of thoracic endovascular aortic repair (TEVAR) in acute uncomplicated acute type B aortic dissection (uTBAD) are similar irrespective...
Efforts to move towards routine patch closure or eversion endarterectomy among all carotid surgeons...
A nationwide cohort study of over 9,000 patients shows that the “controversial” practice of arteriotomy closure for carotid endarterectomy (CEA) is associated with an...
Primary patency after venous stenting best in NIVL patients, study finds
A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders....
CX 2023: Venous, we have a perception problem
Venous disease care has a problem with optics in the context of growth in the number of venous procedures and the spectre of inappropriate...
Study finds anatomic positioning and physical activity type can cause device fatigue in the...
A recent multicentre, prospective study has found that stent deformations are greater in the common iliac vein with higher levels of hip flexion, as...
Corner Stitch: Spotlight on VESS 2023
This month, Corner Stitch highlights one of the papers recently presented at the Vascular and Endovascular Surgery Society (VESS) 2023 winter meeting in Whistler,...
Letter to the editor: The virtue of a social media presence for surgeons in...
Dear editor,
I recently read an article in Vascular Specialist regarding the new age of the “vascular surgery influencer” that discussed how the world of...
FDA approves dissection and transection indication expansion for RelayPro stent graft system
Terumo Aortic announced that the Food and Drug Administration (FDA) has granted approval of the RelayPro thoracic stent graft device for the treatment of...
The top 10 most popular Vascular Specialist stories of April 2023
In April 2023, Vascular Specialist readers were drawn to an interview dissecting the role robotics play, and can play in the future, in vascular...
Xeltis presents six-month first-in-human data on aXess graft
Xeltis has presented “highly-encouraging” six-month data from its first-in-human (FIH) aXess vascular graft trial at the 13th Congress of the Vascular Access Society (VAS;...
Cook Medical treats first patient in first-in-human clinical trial for venous valve
Cook Medical recently announced that the first patient has been treated in a clinical study to evaluate a new venous valve designed for treating...
Help fund future of vascular health by serving on SVS Foundation Board of Directors
The Society for Vascular Surgery (SVS) Foundation seeks applicants to fill a pair of two-year terms on the Foundation Board of Directors. The term...
Government Grand Rounds: Educating through advocacy
Since the initial launch of the Cancer Moonshot in 2016, the cancer community has made tangible progress towards ambitious goals, including accelerating scientific discovery...
Navigating the red tape: A case for hybrid ORs in the VA
The United States military has access to the most cutting-edge equipment to perform its duties, so we should expect nothing less for its veterans....
Research on aortic size index as predictor of AAAs in men vs women highlights...
Seeking a better understanding of why women with ruptured abdominal aortic aneurysms (AAAs) have worse outcomes when compared with men, a new study champions...
Women’s Vascular Summit 2023: The ‘changing’ landscape of AAAs in women
Since conducting an initial U.S. population-based study of gendered abdominal aortic aneurysm (AAA) trends spanning 40 years, Indrani Sen, MBBS, an assistant professor of...
Vascular community split over ‘death’ of traditional carotid stenting
A debate between two prominent carotid interventionists—Peter Schneider, MD, professor of vascular and endovascular surgery at University of California San Francisco in San Francisco,...
BASIL-2 points towards endovascular-first revascularization strategy in CLTI patients
A question from Manj Gohel, MD, from Cambridge University Hospitals in Cambridge, England, on what the 2023 Charing Cross (CX) International Symposium audience should...
VAM 2023: Gala organizers seek auction donations
The “Great Gatsby Gala” Committee is turning its attention to gathering auction items to entice bidders in both the Live and Silent auctions.
The sky’s...
Showcasing a ‘rewarding field’: student-trainee program at VAM deals with full spectrum of vascular...
Besides being able to attend the scientific and educational sessions at the Vascular Annual Meeting (VAM), medical students and general surgery residents have an...
First implant of custom-made thoracoabdominal hybrid device in North America announced
Terumo Aortic announced the first North American implant of a custom-made hybrid device, Thoracoflo.
A press release noted that the device is used to treat...
A call to arms: Reuse of mature venous conduits urged
“Recycle that vein!”—that was the appeal from the authors of a new study that trialled the explantation of mature arteriovenous fistulas (AVFs) from patients...
Surmodics announces successful first patient use of Sublime radial access microcatheter
Surmodics has announced that Ankur Lodha, MD, an interventional cardiologist at the Cardiovascular Institute of the South in Lafayette, Lousiana, and Pradeep Nair, director...
FDA approves IDE for pivotal study of high-intensity focused ultrasound platform
The Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application for the VEINRESET multicenter pivotal study that will evaluate Sonovein...
VAM educational sessions set to cover gamut of clinical and vascular practice matters
With sessions covering a wide swath of topics important to vascular surgeons, including many proposed by Society for Vascular Surgery (SVS) members themselves, participants...
May Vascular Research Initiatives Conference program takes shape
With an emphasis on cells—structural and immune—the program for the May 10 Vascular Research Initiatives Conference (VRIC) in Boston next month is taking shape.
VRIC...
Intentional mentorship and pushing beyond representation
Chicago medical student Maria Paz, BS, discusses intentional mentorship—and why she believes it matters.
When I started medical school, I never imagined that the most...
SVS member named 2023 Presidential Leadership Scholar
Society for Vascular Surgery (SVS) member Anahita Dua, MD, has been named a Presidential Leadership Scholar for 2023.
She is one of 60 scholars in...
SVS announces officer candidates for 2023 election
The 2023 Society for Vascular Surgery (SVS) Nominating Committee has announced the candidates for the 2023 officer election. They are:
For SVS vice president,...
On 45th anniversary, CX Symposium chairman credits Chicago vascular surgical tandem for enduring success
The occasion of a seminal meeting held in Chicago by former Society for Vascular Surgery (SVS) Presidents John J. Bergan, MD, and James S.T....
Society of Black Vascular Surgeons builds bridges, connects international dots
A decade ago, if he were asked to name 10 Black vascular surgeons, says one African American vascular chief, he could have come up...
Robotic surgery: ‘We’ve missed the boat on this,’ says Houston vascular chief
An emerging program at Houston Methodist aims to help prod those practicing in the vascular surgical space deeper into the field of robotic surgery.
The...
SVS Vascular Quality Initiative passes milestone 1,000th-center mark
The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI) clinical registry recently announced it has achieved another milestone, with more than 1,000 centers...
Initial case series indicates lithotripsy can help TCAR expand into high-risk patients
Lithotripsy may hold the key to enabling more carotid artery disease patients who require calcification treatment to undergo stent placement via a transcarotid artery...
Trainees: Cases sought for three VAM sessions
Vascular trainees and medical students are invited to submit their best cases for three sessions at the Society for Vascular Surgery (SVS) Vascular Annual...
SVS-ACS verification program: Key former SVS president predicts need for additional reviewers
Former SVS President Anton Sidawy, MD, hopes the launch of the Society for Vascular Surgery (SVS) and the American College of Surgeons (ACS) “Vascular Verification...
Creating an AI-based tool to help clinicians perform precision AAA analysis
For University of Calgary, Alberta, Canada, vascular surgeon Randy Moore, MD, the route to a world of precision care for individual abdominal aortic aneurysm...
Tackling health insecurity ‘from the top down and the bottom up’
The feeling of being “uncertain, anxious and vulnerable” defines a creeping health insecurity problem riddling parts of the U.S. patient population—demographics who are underserved...
Award-winning paper finds F/BEVAR ‘feasible and safe’ in patients with failed aortic repairs
Presenting award-winning new research, Andrea Vacirca, MD, a research fellow at The University of Texas Health Science Center in Houston (UTHealth Houston), revealed how,...
The top 10 most popular Vascular Specialist stories of March 2023
In March 2023, the Vascular Specialist stories grabbing readers' attention were a response to a February letter addressing vascular surgeons' use of social media; an...
Former SVS President William Abbott, 1997–98, dies at 86
William Martin Abbott, MD, former president of the Society for Vascular Surgery (SVS), died peacefully in his home Jan. 9 after a brief illness....
SCVS 2023: DAPT linked to better post-TCAR outcomes versus other drug regimens
Recent data presentations have revealed reduced risks of stroke and mortality among transcarotid artery revascularization (TCAR) patients who receive dual antiplatelet therapy (DAPT)—both preoperatively...
Computational model found to predict early aortic abdominal aneurysm rupture
In Physics of Fluids, by AIP Publishing, researchers from the Indian Institute of Technology (BHU) Varanasi and Indian Institute of Technology Kanpur made a...
SCVS 2023: DAPT shows higher survival rate in patients with low WIfI scores, study...
A retrospective cohort study presented at the 2023 Society for Clinical Vascular Surgery (SCVS) Annual Symposium in Miami (March 25–29) has found lower-extremity bypass...
Getting medical devices to market: The future might not be now, says regulatory expert
The development of medical devices in the vascular space faces increasing challenges amid moves afoot at the Food and Drug Administration (FDA), according to...
Results from PROMISE II pivotal trial published, reinforcing ‘ transformational value’ of deep vein...
Results from the PROMISE II pivotal trial investigating transcatheter arterialization of the deep veins using the LimFlow system in so-called no-option chronic limb-threatening ischemia...
DAPT linked to better post-TCAR outcomes versus other drug regimens
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid disease...
SCVS 2023: Endovascular-first or -only approach to all CLTI patients ‘is not evidence-based care’
Michael S. Conte, MD, one of the foremost experts in the field of peripheral arterial disease (PAD), took attendees of the 2023 annual meeting...
Short neck AAAs: ‘Choosing what is best for the patient’
Navigating cases of abdominal aortic aneurysm (AAA) with short neck anatomy poses a serious challenge to vascular surgeons, but the list of potential options...
Pay SVS dues to receive SVS benefits, including VAM discount
With registration for the 2023 Vascular Annual Meeting (VAM) right around the corner, those people who have not paid their SVS 2023 dues have...
First US patient enrolled in Gore Viafort vascular stent pivotal study
W L Gore & Associates (Gore) has announced that the first U.S. patient has been enrolled in a prospective, randomized, multicenter, single-arm study with...
Getinge receives FDA premarket approval for the iCast covered stent system
Getinge‘s iCast covered stent system has received premarket approval from the Food and Drug Administration (FDA) for the treatment of patients with iliac arterial...
Act now to keep CME credits, SVS urges members
Society for Vascular Surgery (SVS) members should act now so they do not lose earned continuing medical education (CME) credits.
The American Board of Surgery...
Study highlights need for ‘continuous comparative assessments’ to guide endograft treatment decisions
A recent study comparing outcomes of endovascular aneurysm repair (EVAR) patients has reported no statistically significant differences in mortality or secondary rupture rates between...
STEVECO trial calls into question randomization in the venous stenting field
Recruitment proved to be a major challenge for the STEVECO (Stent versus conservative treatment in patients with deep venous obstruction) randomized controlled trial (RCT),...
‘Time matters’: New study finds novel EHR workflow improves timeliness in vascular care
A novel, order-initiated workflow facilitated by the electronic health record (EHR) has been shown to improve timeliness of care for vascular surgery patients, decreasing...
Analysis finds no difference in TCAR outcomes between academic, community hospitals
A new study found no difference in perioperative outcomes and incidence of adverse events at follow-up after transcarotid artery revascularization (TCAR) between academic and...
SVS, ACS launch new quality verification program
The Society for Vascular Surgery (SVS) and the American College of Surgeons (ACS) have launched the “Vascular Verification Program (Vascular-VP)," an ACS Quality Program...
Bioprosthetic venous valve: ‘We want to know that this is really working’
A key investigator in efforts to tackle chronic venous insufficiency (CVI) with an bioprosthetic venous valve replacement talks about progress being made with surgical...
Letter to the editor: The vascular influencer
Dear editor,
Reading “Likes, dislikes and reposts: The new age of the vascular surgery influencer,” by Drs. Jean Bismuth (@jeanbismuth) and Jonathan Cardella (@yalevascular), they...
Viz.ai receives FDA 510(k) clearance for abdominal aortic aneurysm AI algorithm
Viz.ai recently announced it has received Food and Drug Administration (FDA) 510(k) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm (AAA)....
ABCs for the treatment of lower-extremity acute DVTs
Ashish Gupta, MD, outlines his ABCs for confronting and treating patients with acute deep vein thrombosis (DVT) of the lower extremity, and how he...
From the SVS president: Supporting one another
The Society for Vascular Surgery (SVS) has a vision that is unwavering. We desire quality vascular care for all patients by providing our members...
SCVS 2023: Four decades of AAAs in the US: Rare epidemiological study establishes women...
Abdominal aortic aneurysm (AAA) diagnosis and repair occurs among women almost 10 years later than in men—with similar age-adjusted mortality—the 2023 Society for Clinical...
Vesteck completes first-in-human use of several Suture-Tight devices
Vesteck scientific advisory board members along with key opinion leaders from around the world have successfully completed the first three in-human cases with the...
Shockwave Medical announces US launch of new peripheral IVL catheter
Shockwave Medical announced the full U.S. commercial availability of the Shockwave L6 peripheral intravascular lithotripsy (IVL) catheter following clearance by the Food and Drug Administration (FDA).
A...
SVS member elected to RUC committee
SVS member David Han, MD, has been re-elected to the American Medical Association (AMA) Relative Values Scale (RVS) Update Committee (RUC). Han’s two-year term...
Corner Stitch: What I wish I had known in vascular training
Welcome newly matched vascular surgery residents into the fold! I am just over six months into my first attending position after completing my residency...
Government Grand Rounds: Culture of engagement
Welcome back to Government Grand Rounds, where the Society for Vascular Surgery (SVS) Advocacy Council discusses how sustained advocacy engagement is important for all...
SVS launches web-based perioperative care guide
The Society for Vascular Surgery (SVS) has launched its “Management Guide on the Perioperative Care of Patients with Vascular Disease,” a multidisciplinary resource for...
Venous stenting: ‘We need to evaluate use, appropriateness and clinical indication’
An analysis of venous stent usage trends in the United States from 2014 through 2021 showed a “significant increase” in stents per day placed...
Distal embolic protection linked to significantly better outcomes in carotid stenting
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death...
Algorithm predicts females have higher risk for kidney damage after aneurysm repair
When receiving treatment for abdominal aortic aneurysm (AAA), female patients have a higher risk for kidney damage after endovascular repair, a Michigan Medicine study...
VAM 2023: Early-bird registration opens
Meeting registration and hotel reservations opened March 15 for the Society for Vascular Surgery (SVS) 2023 Vascular Annual Meeting (VAM). This year’s premiere educational...
EU ministers approve changes to MDR transition timetable
The European Union’s Council of Ministers has today adopted a resolution to extend the deadline for the certification of medical devices under the Medical...
New VOYAGER PAD analysis confirms consistent benefit of low-dose rivaroxaban plus aspirin following lower...
Data from a new prespecified analysis of the phase III VOYAGER PAD clinical trial show that low-dose rivaroxaban plus aspirin resulted in a 33%...
‘Voices of Vascular’ series celebrates Women’s History Month
The contributions of the Society for Vascular Surgery’s women members take center stage this month as part of the SVS Foundation’s “Voices of Vascular”...
ACC 2023: Large bore mechanical thrombectomy reduces adverse outcomes in high-risk PE patients
Large bore mechanical thrombectomy with the FlowTriever system (Inari Medical) in patients with high-risk pulmonary embolism (PE) was associated with a significantly lower occurrence...
Apply for Brandeis health policy program by March 15
Society for Vascular Surgery (SVS) members have until March 15 to apply for a scholarship to attend the Executive Leadership Program in Health Policy...
RESCUE trial shows reduction in segmental and main pulmonary artery occlusions
Robert A. Lookstein, MD, who is executive vice chair, Diagnostic, Molecular and Interventional Radiology at the Icahn School of Medicine at Mount Sinai Hospital...
‘SVS Presents’ provides enhanced learning opportunities
The Society for Vascular Surgery (SVS) will debut “SVS Presents” April 12, a monthly webinar series that provides an evening of educational programming for...
AVF 2023: Results from first US trial of Sonovein delivered
The 2023 annual meeting of the American Venous Forum (AVF) heard the final results from the first U.S. trial of the emerging varicose vein...
The top 10 most popular Vascular Specialist stories of February 2023
In February 2023, the hits with Vascular Specialist readers included positive safety and efficacy findings from the PRESERVE trial; the announcement of the scientific program...
VESS 2023: pMAC score found to be ‘important predictor’ of CLTI revascularization outcomes
Having observed a strong relationship between calcification and subsequent limb loss, a research team led by investigators from the University of California San Francisco...
AVF 2023: FLASH registry suggests ‘favorable safety and effectiveness profile’ in high-risk PE patients
Among 61 high-risk pulmonary embolism (PE) patients followed through to the 30-day visit in the U.S. cohort of the FLASH registry, no mortalities were...
AVF 2023: Investigators report update on three-year first-in-human results for bioprosthetic venous valve
Researchers in Colombia behind the first-in-human study of a novel bioprosthetic venous valve designed to treat chronic venous insufficiency (CVI) reported three-year results among...
AVF 2023: One-year analysis of CLOUT registry reveals ‘significant and sustained’ long-term clinical improvements
Interim one-year outcomes from the multicenter, prospective, single-arm CLOUT registry investigating use of the ClotTriever thrombectomy system in all-comer patients with deep vein thrombosis...
New study demonstrates IVC filters ‘safe and effective’ in treating venous thromboembolism
Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...
‘Urgent action needed’ to improve implementation of guideline-directed medical therapy for PVI
Almost one-half of the patients receiving a peripheral vascular intervention (PVI) in the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry between...
BioGenCell begins recruitment for clinical trial of stem cell-based treatment for preventing limb amputation
BioGenCell has announced that it is recruiting for an international clinical trial to assess the company's stem cell-based therapy for chronic limb-threatening ischemia patients...
SVS DEI Committee launches ‘Voices of Vascular’ series
To help celebrate the diversity in the vascular surgery specialty, the Society for Vascular Surgery Diversity, Equity and Inclusion Committee has launched “Voices of...
More than a research project: The vascular trainee’s role in tackling disparities in peripheral...
One of my earliest clinical experiences with vascular disease was as a high school student shadowing at a busy urban hospital in Detroit. A...
March’s free-access articles in JVS, JVS-VL
The March issues of the Journal of Vascular Surgery (JVS) and JVS: Venous and Lymphatic Disorders (JVS-VL) include eight articles that will be available...
VAM 2023 meeting set to take place as exclusively in-person event
A block party on opening day, session recordings available daily and—of course—the educational and scientific sessions for which the Society for Vascular Surgery’s Vascular...
Strategic planning session outlines SVS priorities for coming year
Key leaders from the society for Vascular Surgery (SVS) gathered in mid-January for a two-day Strategic Board of Directors (SBOD) meeting to work through...
Likes, dislikes and reposts: The new age of the vascular surgery influencer
The brave new world of social media, with its TikToks and Kardashians, has now invaded our once-sane specialty. No, this is not a veiled...
The case for aggressive intervention on symptomatic carotid web
The lead investigator behind new research from a center in Louisiana outlines how his new study—believed to be the largest single-institution analysis of symptomatic...
New Government Grand Rounds series highlights how perspective matters in advocacy
Matthew Sideman, MD, and Megan Marcinko, MPS, unveil new advocacy column aimed at drilling into the actions of Congress, and how they impact vascular...
Biotronik launches Oscar multifunctional peripheral catheter
Biotronik has announced the Food and Drug Administration (FDA) 510(k) clearance and CE mark of its Oscar (One Solution: Cross. Adjust. Restore) multifunctional peripheral...
SVS annual meeting introduces early-bird registration
The SVS is introducing a three-tiered pricing plan for the 2023 Vascular Annual Meeting (VAM). Early-bird rates start when registration opens March 15.
The cost...
Five-year outcomes of ESAR in patients with short neck
Cohort analysis shows no migrations, a low rate of ruptures, and positive sac regression, researchers say.
Five-year outcomes in patients with short neck abdominal aortic...
Educate, educate, and educate again: The continuing quest for appropriate venous care
Prominent venous disease experts discuss venous stenting, appropriate care, and the pursuit of refined data and better education in a space where part of...
VRIC: ‘High value placed on supporting young researchers,’ 2022 trainee awardee says
Warm and inviting. Plenty of engagement at each presentation. A straightforward format that allows everyone to participate at all presentations. Sense of unity. Great...
The top 10 most popular Vascular Specialist stories of January 2023
In January 2023, most popular among the Vascular Specialist readers were several stories from the recent Southern Association for Vascular Surgery meeting, including a report of data shared to demonstrate...
Patients with claudication receive more ‘aggressive’ surgical management in high-competition regions, study finds
Demonstrating the “susceptibility” of care delivery to regional market competition, M. Libby Weaver, MD, presented the case that intermittent claudication (IC) is a “novel...
New book penned by vascular icon charts career in surgery, revolutionary spirit
A new memoir penned by former Society for Vascular Surgery (SVS) President and vascular surgery leader Frank J. Veith, MD, which touches on...
Equivalency to clinical practice ‘varies considerably’ across recent carotid intervention trials
The transferability to real-world clinical practice of contemporary randomized controlled trials (RCTs) investigating carotid artery stenosis interventions “varies considerably,” according to a recent analysis...
SVS: Pay 2023 dues to avoid lapse in benefits
Members, have any of you missed your most recent issue of Journal of Vascular Surgery (JVS)? If so, it could be because your 2023...
Abbott announces agreement to acquire Cardiovascular Systems
Abbott and Cardiovascular Systems (CSI) have announced a definitive agreement for Abbott to acquire CSI. Under terms of the agreement, CSI stockholders will receive...
Spotlight: SVS members take up new positions, make endowment
Sean Lyden, MD, is now chief medical consultant for VESTECK and has joined the VESTECK Scientific Advisory Board. VESTECK is an early-stage medical device...
SVS Foundation board approves latest pilot programs to help underserved
The SVS Foundation has awarded grants to two Society for Vascular Surgery (SVS) members to help them serve the underserved as part of the...
Sex found to be ‘important variable’ in study and treatment of carotid atherosclerosis
A systematic review and meta-analysis have demonstrated “convincing evidence” that sex differences exist in carotid atherosclerosis, with all types of plaque features—including those relating...
Vascular surgery oral boards text seeks to fill certifying void
Think of it as the omega of the vascular surgical textbook literature, quips Andrew M. Wishy, DO. As a training resource, it fits neatly...
PRELUDE-BTK subanalysis highlights superior lumen gain, greater volumetric blood flow using serration angioplasty
Cagent Vascular has announced the results of a comparative subanalysis of the PRELUDE-below-the-knee (BTK) study versus plain balloon angioplasty.
The study was led by Marianne...
Sudanese vascular association readies for first-ever conference
The Sudanese Association of Vascular Surgeons (SudAVaS) has announced the scientific program behind its first-ever international conference, marking the occasion by celebrating the “first...
First patient enrolled in DEFIANCE trial of the ClotTriever system in DVT
Inari Medical announced that the first patient has been enrolled in DEFIANCE, a prospective randomized controlled trial (RCT) comparing the clinical outcomes of patients...
SVS Foundation: Get ‘Gatsby’ Gala tickets today
Tickets—both individual and for tables—are selling faster than a Gin Rickey during Prohibition for the Society for Vascular Surgery (SVS) Foundation’s “Great Gatsby Gala,”...
VESAP5: Now up to 25% off
With the expiration of the fifth edition of the Vascular Education and Self-Assessment Program (VESAP5) in July, the Society for Vascular Surgery (SVS) is...
NIH funding for vascular surgeon-scientists: ‘We need more funded vascular surgeons and better coverage...
Presenting at the 2023 Southern Association for Vascular Surgery (SAVS) annual meeting in Rio Grande, Puerto Rico, Amin A. Mirzaie—a pre-medical student at Emory...
High-risk venous stasis ulceration patients show similar healing rates after multi-modal surgical therapy
A single-center evaluation of contemporary, multi-modal surgical therapy for venous stasis ulceration (C6 disease) suggests high-risk patients showed similar healing rates at one year,...
Has the risk in the value-based payment model been sold as another ‘shiny new...
Value-based payments (VBP), or “volume to value,” was the new buzz word over a decade ago, promising yet another chimera in ways to reimburse...
Back to basics: All the things I love about vascular surgery
Recently, after completing a difficult open aortic operation with my attending, a bright M3 asked me, “Why vascular surgery?” The question didn’t catch me...
‘Unique’ vascular meeting set to update surgeons, prioritize audience debate
Prioritizing “entertaining and informative” sessions, the 29th Annual Pennsylvania Hospital Vascular Symposium and the 3rd Annual Pennsylvania Hospital/University of Pennsylvania Non-invasive Vascular Laboratory Symposium...
Get FIT: Applications for VQI Fellowship in Training program open
The Fellowship in Training (FIT) from the Society for Vascular Surgery’s Vascular Quality Initiative (SVS VQI) introduces residents and fellows in vascular-focused programs to the...
The year in review: 2022 was an amazing 12 months for SVS
Despite any number of challenges, the Society for Vascular Surgery (SVS) had a hugely successful 2022 and looks forward to a bright 2023.
Executive Director...
SAVS reveals 2023–24 officeholders, including new president-elect
The Southern Association for Vascular Surgery (SAVS) officially announced its 2023–24 slate of officeholders following the conclusion of the recent SAVS annual business meeting.
The...
New SVS series zeroes in on government’s impact on vascular surgery
Starting next month, the Society for Vascular Surgery (SVS) will begin a series of articles focusing on how the actions of Congress and regulatory...
BEST-CLI: Analysis finds correlation between WIfI stage four CLTI and reports of poorer mental...
The BEST-CLI dataset has revealed a correlation between wounds, ischemia and foot infection (WIfI) stage and poorer quality of life due to mental, rather...
Surmodics provides regulatory update related to FDA premarket approval application for SurVeil
Surmodics recently announced it has received a letter from the Food and Drug Administration (FDA) related to its premarket approval (PMA) application for the...
Bentley launches rebranded crossing catheter
Germany-based endovascular device company Bentley announced the launch of the BeBack crossing catheter—formerly known as the GoBack—designed for the treatment of heavily calcified lesions...
Human-tissue engineered blood vessels remain durable at six years in PAD patients, latest study...
Mid-term results from a phase II study of surgical bypass using the Human Acellular Vessel (HAV) demonstrated an overall secondary patency rate at 72...
JVS group: Further changes in store for 2023
The planned changes for 2023 for the Journal of Vascular Surgery publications continue the momentum that began in mid- 2022. As former Editor-in-Chief Peter...
SVS unveils latest addition to JVS family of publications
The year 2023 promises to be one of change for the Journal of Vascular Surgery (JVS) family of publications, including the introduction of a...
SVS ends 2022 with latest ‘Week of Action’ to prevent Medicare payment reductions
The Society for Vascular Surgery (SVS) issued its thanks to December “Week of Action” participants.
Once again, SVS members showed incredible support for the Society’s...
SVS Foundation: ‘Gatsby’ Gala tickets on sale
Book your trip to the Roaring Twenties early, and save some money, perhaps for auction items. Early-bird ticket sales for the Society for Vascular Surgery...
SAVS 2023: President reveals upcoming change to Society seal
Southern Association for Vascular Surgery (SAVS) President William D. Jordan Jr., MD, used a portion of his 2023 Presidential Address to outline ways in...
SVS Foundation changes name of program aimed at providing care for underserved patients
The Society for Vascular Surgery (SVS) Foundation program formerly known as VISTA has a new name. VISTA—an acronym for Vascular Volunteers In Service To...
The top 10 most popular Vascular Specialist stories of December 2022
Among the most-read Vascular Specialist stories in December 2022 were the promising results from a postmarket surveillance study of a paclitaxel DCB; the Society...
SAVS 2023: Study points toward CKD patients who would most benefit from renal artery...
A new study probing which chronic kidney disease (CKD) patients would benefit most from renal artery stenting points toward those who experience a more...
SAVS 2023: Planned and unplanned vascular assists found to improve outcomes
An award-winning paper presented at the 2023 Southern Association for Vascular Surgery (SAVS) annual meeting in Rio Grande, Puerto Rico, established an association between...
Membership clears bylaws changes
The Society for Vascular Surgery (SVS) voting membership voted to approve proposed changes to the bylaws that will change the composition of the Society’s...
Deadlines coming for scholarships, grants, awards
Deadlines arrive by March 1, with some as early as this month, for a number of Society for Vascular Surgery (SVS) and SVS Foundation...
Viz.ai launches AI-powered Viz Vascular Suite
Viz.ai has announced the launch of Viz Vascular Suite—artificial intelligence (AI)-powered software enabling vascular care teams to automatically detect and triage care for suspected pulmonary...
Medtronic announces first enrollment in head-to-head global randomized trial evaluating durability of EVAR
Medtronic has announced the first patient enrollment in the ADVANCE trial, a head-to-head randomized controlled trial of two leading aortic stent graft systems, the...
ESVS AAA guidelines alert recommends ‘enhanced surveillance’ in patients treated with Nellix device
In a newly released “focused update” to their 2019 recommendations, the European Society for Vascular Surgery (ESVS) abdominal aortic aneurysm (AAA) guidelines writing committee...
Deadline extension: VRIC 2023 abstracts now due Jan. 18
The Jan. 11 deadline to submit research abstracts on vascular disease and treatment for the 2023 Vascular Research Initiatives Conference (VRIC) has been extended...
SVS webinar on 3D printing showcases how technology could affect current and future practice
The recording of the Society for Surgery (SVS) webinar on three-dimensional (3D) printing in vascular surgery is now available on the SVS website.
The SVS...
Penumbra launches Lightning Flash mechanical thrombectomy system
Penumbra have announced the Food and Drug Administration (FDA) clearance and launch of its Lightning Flash mechanical thrombectomy system.
“Lightning Flash features Penumbra’s novel Lightning intelligent...
Medicare payments: Congress fails to #StopTheFullCut
Despite intense pressure from the entire healthcare provider community, Congress failed to include provisions in its year-end legislative package to fully prevent Medicare payment...
Envision, private equity and patient care: Substituted values 2.0
He was only 41, already burdened with multiple health problems. Diabetes, hypertension and renal failure had put him on dialysis, caused the amputation of...
Summit dedicated to tackling key issues related to women’s vascular health and female workforce...
Linda Harris, MD, is a prolific attendee on the national and regional vascular meeting circuit, a noteworthy academic vascular surgeon with trainees and papers...
Vascular community starts process of wrestling with findings from BEST-CLI
One of the earliest multispecialty public gatherings of the vascular community following the release of the first results from the BEST-CLI randomized controlled...
Learning culture, errors and Melinda French Gates
Workplace culture is fascinating to observe because it is nebulous and hard to measure. There is also often a perceived gap between the existing...
Varicose vein registry analysis finds women benefit from endovenous ablation with fewer complications
An evaluation of the Vascular Quality Initiative’s (VQI) Varicose Vein Registry (VVR) carried out by the Midwestern Vascular Surgical Society (MVSS) has found women...
Meta-analysis of PTS finds one in five at risk of long-term symptoms following isolated...
A meta-analysis is first to report the pooled risk of post-thrombotic syndrome (PTS) after isolated distal deep vein thrombosis (DVT). Researchers revealed a one-in-five...
Women’s Vascular Summit: Diving into issues around women’s vascular health and the female workforce
The Women’s Vascular Summit was established five years ago with the twin purposes of delving deeper into the issues that surround women’s vascular health...
SVS mourns passing of former president
Society for Vascular Surgery (SVS) members are mourning the death of James (Jimmy) S.T. Yao, MD, 88, former SVS president and Lifetime Achievement Award...
Students and residents: Attend VAM 2023 on a scholarship
Medical students and general surgery residents have the chance to change their lives. Perhaps they are still seeking some direction for their medical careers. Perhaps...
‘Impressive’ 12-month Flex vessel prep data presented at VEITHsymposium
VentureMed Group, a medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for peripheral arterial disease (PAD), announced...
VSGBI spotlights data-driven financial incentives for PAD revascularization
The President’s Symposium at the Vascular Society of Great Britain and Ireland (VSGBI) annual scientific meeting (Nov. 23–25) in Brighton, England, saw Rob Sayers,...
SVS issues membership dues reminder
To avoid a lapse in their benefits, Society for Vascular Surgery (SVS) members are encouraged to pay their 2023 member dues by Dec. 31.
These...
Paclitaxel DCB performs well in ‘challenging anatomy’ of femoropopliteal in-stent restenosis, VQI registry data...
The IN.PACT Admiral drug-coated balloon (DCB) shows promising results in treating femoropopliteal in-stent restenosis (ISR) in a Society for Vascular Surgery (SVS) Vascular Quality...
Voting on SVS bylaws revisions ends Dec. 18
Active and Senior Society for Vascular Surgery (SVS) members in good standing have until Dec. 18 to cast their ballots to change the composition...
Efemoral Medical closes financing round to fund ongoing study of its vascular scaffold system
Efemoral Medical has today announced the closing of its $4.9 million preferred Series A1 round. Supported by existing investors as well as an experienced...
EU Commission to propose delay to MDR implementation
Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the transition period for the implementation of the European Union’s (EU) Medical Device...
Endologix receives FDA approval of PMA supplement for AFX2 system
Endologix recently announced that it has received Food and Drug Administration (FDA) approval for a premarket approval (PMA) supplement relating to the AFX2 system.
According...
Corner Stitch: A reflection on 2022…
This month's column chronicles the exciting year we’ve had here at Corner Stitch. As the section editor, I’ve been most proud of the various...
The 10 most popular Vascular Specialist stories of November 2022
Among November's most read Vascular Specialist stories were updates from the BEST-CLI trial in the form of new data and funding; a guest...
WVS 2022: New evidence of radiation reduction benefit emerges
Surgical augmented intelligence in the form of 3D mapping during complex aortic procedures can decrease radiation exposure, fluoroscopy time and contrast use when combined...
EVS 2022: Weaving magic in academic vascular surgery at JVS
Past Journal of Vascular Surgery (JVS) group editor-in-chief Peter Gloviczki, MD, invoked his hobby of magic to help illustrate what it requires to take...
Veterans Affairs: A call to surveillance
For many of those injured in combat, the transition in care from the Military Health System (MHS) to the Veterans Health Administration (VHA) can...
MVSS 2022: Study finds no link between frailty score and surgical site infection
A vascular surgery-specific composite frailty score was not associated with with risk of surgical site infection in patients undergoing lower-extremity revascularization in a review...
EVS 2022: New study shows ‘encouraging increase in academic footprint of female-driven research’
How does vascular surgery compare to other specialties in the growth of gender diversity in published research? “Are we leaders in the field, or...
For SVS Foundation Gala, prepare to return to the Roaring 1920s
Attendees at the 2023 SVS Foundation Gala will be taking a trip 100 years back in time—to the Roaring Twenties and Prohibition.
The “Great Gatsby...
Conference watch: Submit research to VRIC, VAM
Submissions already are open for 2023 Vascular Research Initiatives Conference (VRIC), which will be May 10, 2023, in Boston. The conference includes abstract sessions,...
Vascular trainee-developed VSITE review book sees sales soar
A new review textbook developed by a vascular surgery resident with the aim of helping fellow trainees prepare for milestones like the Vascular Surgery...
SVS 10-year research goals: Why create research priorities?
As was the case with the 2011 set, researchers hope the updated priorities will serve as a starting point to align research efforts within...
SVS reveals research priorities for next decade
The Society for Vascular Surgery (SVS) Research Council has updated its top 10 research priorities, originally published in 2011, with patient-centered outcomes and personalized...
SVS vascular leaders: Cohort four of Leadership Development Program selected
Twenty-nine people have been selected for development as future leaders of the profession and the Society for Vascular Surgery (SVS).
They represent cohort four of...
NESVS 2022 Presidential Address: ‘We can create a bold new future for vascular surgery:...
“Collaborate, innovate, mentor, champion DEI and relish the opportunity to form deep connections with our amazing patients.” This was the key take-home message...
BEST-CLI: Optimal medical therapy adherence ‘well below’ recommended level at baseline
A significant proportion of patients enrolled in the BEST-CLI trial did not meet optimal medical therapy (OMT) guideline-based recommendations at the time of their...
Dec. 12 webinar to examine 3D printing for vascular imaging
Society for Vascular Surgery (SVS) members can learn some of the ins and outs of three-dimensional (3D) printing for vascular imaging at a webinar...
Roundtable on varicose veins guidelines set for Dec. 6
A virtual, multidisciplinary and interactive roundtable discussion on varicose veins will be held Dec. 6.
The free roundtable, set for 6 to 7:30 p.m. CST,...
Vascular surgeons: The ‘oncologists’ of the surgical arena
Like any good presentation I feel obligated to start with my disclosures: 1) I am married to a woman who decided to pursue a...
Swiss parliament votes to accept FDA-approved medical devices
The Swiss Federal Assembly has voted in favor of accepting medical devices with the Food and Drug Administration (FDA) marketing authorization in Switzerland.
A motion...
Diversifying clinical trials: ‘There needs to be some kind of cultural competency’
The COVID-19 pandemic exposed lingering mistrust in the U.S. healthcare system among patients from minority communities as physicians continue to confront the conundrum of...
Eastern Vascular gathering challenged to forge next generation of evolution
Evolution was the core theme of the Presidential Address Robert Rhee, MD, delivered from the Eastern Vascular Society (EVS) annual meeting stage in Philadelphia...
Bright future predicted for JVS internship program
This month on Corner Stitch, Christopher Audu, MD, profiles a new and innovative program offered by the Journal of Vascular Surgery (JVS). It’s called...
Miss the SVS webinars? Take advantage of the recordings
The Society for Vascular Surgery (SVS) hosts a number of Town Halls, roundtables and webinars for the benefit of its members.
In the past few...
Deadline extension: SAVS extends travel scholarship application cut-off for 2023 meeting
The Southern Association for Vascular Surgery (SAVS) has announced a deadline extension to Dec. 5 for 20 travel scholarships that are available to medical...
VAM 2023: Apply for international scholars program by Dec. 31
Young vascular surgeons from outside the United States and Canada have until Dec. 31 to apply for scholarships to attend the 2023 Vascular Annual...
Spotlight: SVS members in the news
Several SVS members have been making moves recently, attracting recognition in the form of awards and promotions.
Katherine Gallagher, MD, of the University of Michigan,...
Viz.ai announces positive new data from large aortic dissection AI real-world study
Viz.ai recently announced new data from a large aortic dissection artificial intelligence (AI) real-world study that supports the use of its AI technology for the detection...
First-in-human patients continue to benefit from VenoValve at average of three years post-surgery, new...
Positive long-term, three-year observational data from a cohort of patients that participated in the previously concluded VenoValve (Envveno Medical) first-in-human clinical trial were recently...
Complete SVS member priorities survey by Nov. 22
To help the Society for Vascular Surgery (SVS) chart a path into the future, members—and non-members alike—are asked to complete an ongoing survey by...
SWING trial 12-month data: Novel sirolimus DCB shows ‘great promise’ in ‘challenging’ CLTI population
The Sundance (Surmodics) sirolimus drug-coated balloon (DCB) has an “excellent” safety profile in a “challenging, real-world, predominantly CLTI population,” and has a primary...
VEITHsymposium panel probes ‘value’ of artificial intelligence in vascular surgery
A session at the 2022 VEITHsymposium in New York City (Nov. 15–19) focused on new concepts, machine learning, and artificial intelligence (AI) in vascular...
The top 10 most popular Vascular Specialist stories of October 2022
The most-read Vascular Specialist stories in October covered an investigation of thoracic endovascular aortic repair (TEVAR) timing presented at the Eastern Vascular Society (EVS)...
Veterans Day: Remembering Korea, ‘accidental pioneers’ and M*A*S*H
During November—Nov. 11, specifically—the United States salutes and honors all those who have served this country in its armed forces. This November, the Society...
New diversity, equity and inclusion pillar signals additional priority for SVS Foundation
The Society for Vascular Surgery (SVS) Foundation has been guided by the three long-term pillars of research and innovation, community vascular care and patient...
Chocolate Touch DCB for treatment of peripheral arterial disease receives FDA approval
Genesis MedTech Group announced that the Food and Drug Administration (FDA) has approved the Chocolate Touch drug-coated balloon (DCB) percutaneous transluminal angioplasty (PTA) catheter...
NESVS Robert R. Linton Lecture features complex aortic masterclass from Europe
World-leading aortic surgeon Stéphan Haulon, MD, from the Aortic Centre at Hôpital Marie Lannelongue in Paris, France, took attendees of the 2022 New England...
SOOVC sub-section introduces two awards
The Society for Vascular Surgery's sub-section for those who provide service in outpatient settings has created two professional development opportunities for its members, a...
CMS: An update on quality measures for vascular surgery
An upcoming national reporting change/addition from the Centers for Medicare and Medicaid Services (CMS) includes three important elements of which Society for Vascular Surgery...
SVS adds ‘service’ criterion to Distinguished Fellows process
The Society for Vascular Surgery (SVS) has added service to the Society as an important component of its Distinguished Fellows process, an honor annually...
First data from BEST-CLI bring surgical bypass into the forefront of discussion for patients...
The first results from the BEST-CLI randomized controlled trial (RCT) of 1,830 patients show that surgical bypass with adequate single-segment great saphenous vein (GSV)...
SVS asking members to expand diversity in Nominating Committee
The Society for Vascular Surgery (SVS) will ask voting-eligible members to consider three revisions to article X of the SVS bylaws that would take...
Amplifi vein dilation system continues to show promise following latest first-in-human study update
An update from the first-in-human study assessing the Amplifi vein dilation system (Artio Medical) was delivered by Surendra Shenoy, MD, from Washington University School of...
Virtual visits versus in-person: Telemedicine study detects ‘substantial’ cost savings for patients
Virtual consultations appear comparable to care received in-person when it comes to clinical outcomes as well as patient and practitioner satisfaction, a systematic review...
‘Significant’ increase in atherectomy use in US largely driven by office-based procedures, VQI data...
In the United States, atherectomy use in peripheral vascular interventions (PVIs) “more than doubled” from 2010 to 2019, with office-based procedures a “major driver”...
Disrupt PAD III observational study results confirm safety and effectiveness of IVL in complex...
The final 1,373-patient cohort analysis from the Disrupt PAD III observational study (OS) demonstrates consistent intravascular lithotripsy (IVL; Shockwave Medical) outcomes in complex and...
End-stage CLTI: Deep-vein arterialization procedure demonstrates amputation-free survival rate of 66% at six months
Six-month results from the PROMISE II trial of the LimFlow deep-vein arterialization system showed an overall amputation-free survival of 66%—“well above” the primary endpoint...
BEST-CLI attracts $3.3m funding injection to continue data analysis
The Novo Nordisk Foundation has made a $3.3 million contribution toward the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb...
CEA, TCAR ‘continue to show superior outcomes’ to transfemoral stenting
Researchers led by a vascular team in Indianapolis found that carotid endarterectomy (CEA) remains the most-used strategy in carotid revascularization, with CEA and transcarotid...
SurVeil DCB demonstrates sustained durability of safety, efficacy endpoints in TRANSCEND
In the TRANSCEND clinical trial, the SurVeil drug-coated balloon (DCB; Surmodics) demonstrated "excellent efficacy and safety" out to 24-month follow-up. This is according to...
New analysis: Four multicenter trials support primary use of drug-coated balloons over bare metal...
A patient-level, propensity-adjusted comparison of three-year results from a quartet of prospective, multicenter trials support the primary use of drug-coated balloons (DCBs) versus bare...
‘Excellent’ three-year results presented for the BioMimics 3D stent in longer lesions
At the 2022 Vascular Interventional Advances (VIVA) meeting (Oct. 31–3 Nov. 3), Michael Lichtenberg, MD, from Arnsberg Clinic, Arnsberg, Germany, reported a subgroup analysis...
Mechanical thrombectomy for DVT: Randomized data needed to boost growing evidence base
Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022 (Oct. 30–31) in Las Vegas—the latest results...
Abre stent data show ‘struggle to maintain patency’ among post-thrombotic syndrome patients
The Abre venous stent demonstrated three-year primary patency rates of 97.1%, 76.5% and 70.4% respectively for non-thrombotic iliac vein lesion (NIVL), acute deep vein...
An open letter to the National Rifle Association
Hello,
I think it is time we talked about guns. I know you don’t like to discuss these things after a school shooting, so I...
A recent snapshot of pediatric vascular trauma injuries
A study of major pediatric vascular injuries delivered in the Vascular and Endovascular Surgery Society (VESS) Paper Session during the 2022 Vascular Annual Meeting...
Study: Combined antiplatelet, NOAC use linked to worse limb outcomes after suprainguinal bypass
A new analysis that found combined antiplatelet and novel oral anticoagulant (NOAC) therapy after suprainguinal bypass was associated with worse limb outcomes and equivalent...
Gore completes first-in-human implants of Viafort vascular stent
W. L. Gore today announced the first implants of its investigational Gore Viafort vascular stent as part of a recently initiated pivotal clinical study for...
The top 10 most popular Vascular Specialist stories of September 2022
September's top stories featured news of a trial to evaluate women's experience of early endovascular aneurysm repair, and of a special women-focused edition...
MVSS 2022: Research on hemodialysis access surgery attracts inaugural Midwestern Vascular disparities award
The authors behind a new study that found “significant differences” in hemodialysis vascular access outcomes after first-time arteriovenous (AV) fistula or graft creation “directly related” to...
‘Week of Action’ raises awareness of SVS advocacy activities
From sending emails to lawmakers, posting on social media to amplify legislative issues, and donating to the Society for Vascular Surgery Political Action Committee...
Regional vascular presidents measure state of specialty
Vincent Rowe, MD, and Raghu Motaganahalli, MD, delivered Presidential Addresses at the Western Vascular Society (WVS) and the Midwestern Vascular Surgical Society (MVSS) that...
Slew of regional vascular societies welcome new leaders for 2022–23
A number of regional vascular societies across the U.S. and Canada introduced their 2022–23 slew of officers during their annual meetings across the fall...
CX Aortic Vienna: Onus on industry to meet clinician desire for devices that function,...
The need for vascular companies to home in on developing longer-lasting devices—perhaps even ones that adapt over time to match patients’ changing anatomies—was underscored...
Vascular practice: Financial wellness is focus of Nov. 2 SVS webinar
Responding to members’ requests for more information on financial education, a nationally known estate and tax attorney will provide information and guidance on financial...
SVS weighs in on 2023 Medicare payment rules for physicians and hospital outpatient services
The Society for Vascular Surgery (SVS) has submitted comment letters in response to the proposed rules issued by the Centers for Medicare and Medicaid...
NESVS 2022: Study illustrates relationship between increased distance from medical center and higher treatment...
Research detailing that patients traveling farther for complex aortic surgery have higher procedural costs, postoperative imaging costs, and comprehensive one-year costs was among the...
Signal-to-noise ratio: Thoughts on fine-tuning feedback during vascular surgery training
I recently took the Registered Physician in Vascular Interpretation (RPVI) exam. While studying for it, one of the concepts that stood out was the...
Prepare to submit research for VAM, VRIC 2023
The Society for Vascular Surgery (SVS) wants members’ research on vascular disease for the 2023 Vascular Research Initiatives Conference (VRIC) and the 2023 Vascular...
SVS prepares for important member survey to be held in November
The Society for Vascular Surgery (SVS) will survey members in November to continue to track demographic changes, how members would like the SVS to...
SVS officer elections 2022: A glimpse into the electorate
The SVS Executive Board highlights details of the most recent Society for Vascular Surgery (SVS) elections to inform members and further strengthen the process.
In...
Only a few seats remain for CPVI hands-on skills course
Only a few spots remain available for the Society for Vascular Surgery’s new Complex Peripheral Vascular Intervention (CPVI) Skills Course. Today—Thursday, Oct. 20—is the...
EVS 2022: Study suggests lower rates of aortic rupture, mortality after TEVAR for uncomplicated...
Thoracic endovascular aortic repair (TEVAR) carried out for uncomplicated type B aortic dissections (TBAD) saw worse mortality and aortic-related outcomes when performed in the...
Mortality drops for acute type A aortic dissection, still high for patients not receiving...
The chance of a patient surviving after an acute type A aortic dissection has improved significantly, but mortality remains high if not recognized early and repaired...
ABRE clinical study 36-month data show ‘long-term durability’ of venous stent system
Medtronic has announced the 36-month final results from the ABRE clinical study. The purpose of the ABRE clinical study was to evaluate the safety and...
Six-month data from SWING below-the-knee, first-in-human trial presented at AMP Europe
Six-month data from the Surmodics SWING first-in-human (FIH) study of the company’s Sundance sirolimus drug-coated balloon (DCB) were shared at the 2022 Amputation Prevention Symposium (AMP) held Oct....
Interacting with EMR best practice advisory ‘significantly’ improves AAA screening rates
Positively interacting with best practice advisory notifications is correlated with an increased rate of abdominal aortic aneurysm (AAA) screening, according to an analysis of...
Vascular surgeons step up for PAD awareness campaign in September
Walking is instrumental to keeping the 60,000 miles of blood vessels in the human body healthy—especially for patients with peripheral arterial disease (PAD). That...
Roundtable for treating CLTI: GLASS will make it clear
The final of three roundtables on treating Chronic Limb-threatening Ischemia (CLTI) will cover the Global Limb Anatomic Staging System—GLASS.
The virtual roundtable, on GLASS staging...
Terumo Aortic announces new technology add-on payment for Thoraflex Hybrid device in US
The Centers for Medicare and Medicaid Services (CMS) has granted approval of a new technology add-on payment (NTAP) for Terumo Aortic’s Thoraflex Hybrid device—used...
FLASH results demonstrate ‘excellent safety profile’ of the FlowTriever system in full US cohort
Results of the FLASH registry demonstrate the “excellent safety profile” of the FlowTriever system (Inari Medical) in 800 real-world patients.
This is according to Catalin...
New study indicates cost-effectiveness of Denali IVC filter over Option device
Tilting or hooking occurred significantly less often in the process of retrieving the Denali inferior vena cava (IVC) filter than with the Option IVC...
VEITHsymposium to include world federation session
The World Federation of Vascular Societies (WFVS) is set to hold a session in November during the VEITHsymposium in New York City. The 90-minute session...
Trainees step up to learn coding, reimbursement
The Society for Vascular Surgery’s (SVS) efforts in coding and reimbursement work have taken another step forward, with four new doctors now in training...
Ukrainian surgeons present clinical update on Human Acellular Vessel in vascular trauma at ESVS...
Humacyte recently announced the presentation of a clinical update on the Human Acellular Vessel (HAV) for the treatment of vascular trauma. The update was...
SVS launches program to ‘REACH 535’ lawmakers
To leverage the power of direct engagement with lawmakers on the part of constituents, the SVS advocacy team is launching a grassroots advocacy plan...
ESVS publishes ‘pioneering’ clinical practice guidelines on radiation safety
The European Society for Vascular Surgery (ESVS) has released clinical practice guidelines on radiation safety, which the writing committee notes are the first guidelines...
No time like the present: The moral imperative for advocacy in vascular surgery
“I’m so sorry but we have to cancel your surgery”—10 words any warm-blooded surgeon dreads uttering. This time around, it was not for the...
Corner Stitch: Audible Bleeding cuts down to vascular core
Many Corner Stitch readers subscribe to Audible Bleeding, the vascular surgery podcast for updates on all things vascular—from vascular knowledge, to reviewing key Journal...
SVS advocacy in action: Protecting and advancing the interests of vascular surgery
Deep in to the second half of the year, there is no rest for the weary regarding Society for Vascular Surgery (SVS) advocacy initiatives....
Experts establish international standard set of outcome measures for patients with VTE
The International Consortium for Health Outcomes Measurement (ICHOM) venous thromboembolism (VTE) working group has developed a standard set of outcome measures for patients with...
WVS 2022: Study probes who benefits from EVAR among patients with chronic kidney disease
Patients with advanced chronic kidney disease (CKD) represent a high-risk group who may not benefit from elective endovascular aneurysm repair (EVAR) for abdominal aortic...
Annals of Vascular Surgery announces special issue dedicated to original work by women
The Annals of Vascular Surgery peer-review journal has announced an upcoming special issue dedicated to original work by women that is set to be...
Society for Vascular Surgery Vascular Quality Initiative celebrates one million procedures
The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI) clinical registry announced this week it has now collected more than one million procedures...
Aortobifemoral grafting in the endovascular era: An exploration of the open procedure and its...
Aortobifemoral grafting for aortoiliac occlusive disease (AIOD) probably remains “very safe” in the era of endovascular repair, according to the senior author behind a...
WARRIORS randomized trial aims to examine early EVAR in women
This month a multinational collaboration of researchers received endorsement from the Global Cardiovascular Research Funders Forum (GCRFF) Multinational Clinical Trials Initiative for the WARRIORS...
Treating PAD: ‘Run, don’t walk, to sign up for this incredible course’
No matter if you’re a surgeon with a few years—or a few decades—of experience, faculty members of a new, upcoming Society for Vascular Surgery...
PAD: Endovascular revascularization ‘superior or not significantly different’ in terms of outcomes versus open...
A real-world analysis of peripheral arterial disease (PAD) patients in Canada indicated open revascularization may not offer a long-term benefit over endovascular intervention. In...
Black patients wait more than twice as long as White patients for rAAA repair,...
Black patients saw significantly delayed care for ruptured abdominal aortic aneurysms (rAAAs), with a Vascular Quality Initiative (VQI) analysis showing a median time from hospital...
TCAR: First patient enrolled in ROADSTER 3 post-approval study
Silk Road Medical has announced enrollment of the first patient in ROADSTER 3, which the company claims is the the first prospective, multicenter, single-arm...
The top 10 most popular Vascular Specialist stories of August 2022
The top 10 most-read stories on the Vascular Specialist website in August included a look at the state of diversity, equity and inclusion (DEI)...
Trial supports full-dose anticoagulation to prevent blood clots in COVID-19 patients
Treatment of critically ill COVID-19 patients with full-dose anticoagulation lowers the risk of venous and arterial clotting complications by 44% compared with the standard dose, according to late...
SVS meets AMA membership requirement, retains House of Delegates seat
The Society for Vascular Surgery (SVS) has exceeded the necessary compliance threshold required to retain its seat in the American Medical Association (AMA) House...
Clinical outcomes of the ClotTriever system in DVT set to be evaluated in RCT
Inari Medical has announced planned enrollment of the DEFIANCE randomized controlled trial (RCT), which is designed to compare the clinical outcomes of patients with...
Researchers study role of frailty in post-discharge mortality
Society for Vascular Surgery (SVS) members have developed new methods and tools to assess patient frailty and possible surgical outcomes more simply before patients...
Shape Memory Medical completes enrollment in the AAA-SHAPE early feasibility study
Shape Memory Medical has announced the completion of patient enrollment in AAA-SHAPE, the company’s prospective, multicenter early feasibility safety study of the Impede-FX RapidFill...
Retrospective study is ‘first to systematically explore predictors of venous stent occlusion’
New data indicate that venous stent failure “may be predicted by low peak flow velocity and post-thrombotic changes in inflow veins” and that endovascular venous...
A brilliant plan to increase vascular surgeons’ income—and decrease the incidence of stroke!
I have come up with a brilliant plan that will decrease the incidence of stroke nationwide, provide an excellent source of income for vascular...
VQI analysis links high levels of neighborhood deprivation to more severe PAD
Patients categorized as living in neighborhoods with high levels of disadvantage under the Area Deprivation Index (ADI) measure of community adversity have more advanced...
Engaging with primary care providers ‘critically important’ to improving AAA screening
Matthew Mell, MD, has spent a lot of time looking into issues around screening for abdominal aortic aneurysms (AAAs). The problem, says the chief...
Study is first to elucidate lower-limb amputation epidemiology in a Latin American low- and...
A study recently published in the World Journal of Surgery claims to be the first to provide comprehensive population-level data on the epidemiology of lower-extremity...
Maximize reimbursement: Learn latest in coding at SVS workshop
When it comes to coding, information gaps can lead to revenue gaps. Proper coding and documentation are integral to receiving appropriate reimbursement for vascular...
Tying healthcare waste and spending to productivity incentives
A 74-year-old woman was recently hospitalized for a pulmonary embolus from acute deep vein thrombosis (DVT) of the mildly edematous left lower leg. She...
SVS charts its course ahead for diversity, equity and inclusion
Society for Vascular Surgery (SVS) President Michael Dalsing, MD, has added two more liaisons—Vincent Rowe, MD, and Palma Shaw, MD—to the SVS Executive Board...
Navigating EMRs: SVS webinar to demonstrate how to make them work for vascular surgery
Vascular surgeons can learn how to make electronic medical records (EMRs) work for them at a webinar Sept. 7. The webinar, sponsored jointly by...
DEI initiatives in vascular surgery: How are we doing?
The 2022 Vascular Annual Meeting (VAM) has been touted as the most diverse to date. As attendees ourselves, we can attest to the increased...
Diversity gains momentum at JVS
The addition of a diversity, equity and inclusion (DEI) editor at the Journal of Vascular Surgery (JVS) was found to be associated with more...
Key differences in presentation, outcomes for distal versus proximal DVT uncovered
A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep...
SVS addresses pair of critical payment-related proposed rules
In July, the Centers for Medicare and Medicaid Services (CMS) released two critical payment-related proposed rules for CY2023—the highly anticipated Medicare Physician Fee Schedule...
Limb salvage in focus: New VAM lectureship, born of a pioneering spirit, thrills honoree
It all started around the late 1970s, early 1980s. Back then, recalls Frank J. Veith, MD, the notion of aggressively pursuing limb salvage in...
CX Aortic Vienna: Cardiac, vascular surgeons collaborate at the vanguard of aortic care
CX Aortic Vienna returns in October for its third edition (Oct. 24–26, Digital), bringing together world-leading specialists from the cardiac and vascular fields...
Innovation within the Veterans Health Administration
If one were to ask the average citizen where cutting-edge technology is developed, the most probable answer would be “private industry”; think Apple, Tesla,...
AngioDynamics announces FDA clearance of expanded indications for Auryon atherectomy system
AngioDynamics recently announced receiving Food and Drug Administration (FDA) 510(k) clearance of an expanded indication for the Auryon atherectomy system to include arterial thrombectomy.
The FDA recently...
Vascular experts establish appropriate use of IVUS in peripheral interventions
Royal Philips today announced an important milestone in the evolving standard of care for treating patients with peripheral vascular disease: the establishment of the first-ever...
Patient-reported outcomes in vascular surgery are here to stay
In 2022, the Centers for Medicare and Medicaid Services (CMS) is again emphasizing the importance of patient-reported outcomes (PROs) through legislation regarding the Quality...
Selution SLR receives second FDA IDE approval
Selution SLR, MedAlliance’s sirolimus-eluting balloon, has received conditional Food and Drug Administration (FDA) investigational device exemption (IDE) approval to initiate its pivotal clinical trial...
CLTI: Translating guidelines into practice
Clinical practice guidelines (CPG) are integral to helping achieve optimal patient care. The Society for Vascular Surgery (SVS) clinical guidelines are evidence-based and the...
Gore acquires InnAVasc Medical
Gore has announced the acquisition of InnAVasc Medical, a privately held medical technology company focused on advancing care for patients with end-stage renal disease...
JACC study makes case for expanding coverage for carotid artery stenting
Research from Ochsner Health published in the Journal of the American College of Cardiology (JACC) is likely to influence expanded insurance coverage for carotid artery stenting.
The...
Compression duration affects pain during superficial venous intervention, study finds
Postprocedural compression of one to two weeks after superficial venous incompetence (SVI) treatment is associated with reduced pain compared with a shorter duration. This...
Confessions of a dual-trained, dual-practicing vascular-trauma surgeon
Like most of the other readers of Vascular Specialist, I look forward to perusing each release for not just useful information but also insightful...
SVS Vascular Health Step Challenge asks surgeons to walk the walk
Most American adults take an average of 5,000 steps per day. In fact, this simple act—getting out and moving—can be the key to prevention...
Vascular Specialist@VAM–July/August Review Edition
In this VAM 2022 conference review issue:
Diversity gains momentum at the Journal of Vascular Surgery (p. 1 and 4)
SVS walking challenge—Vascular Health...
New data suggest patients at AAA repair thresholds can be safely deferred
Data from the PROVE-AAA cluster-randomized trial (Preferences for open versus endovascular repair of abdominal aortic aneurysm) of a novel decision aid to assist...
APDVS president reflects on training challenges of COVID-19, ‘supply and demand’ conundrum of the...
"There are not enough vascular surgeons to do the work our specialty provides." Those are the stark words of Jason T. Lee, MD, president...
Corner Stitch: A letter to new vascular interns
Every intern starting vascular surgery this year is incredibly talented, and soon to be a member of a tight-knit, supportive, and fiercely passionate group...
Proposals sought for VAM 2023
Members are still raving about the 2022 Vascular Annual Meeting (VAM) even while organizers seek topics for educational sessions for the 2023 edition. Proposals...
Leadership program applications due by Aug. 15
Learn to be a leader or enhance your leadership skills—applications to be part of the fourth cohort of the Society for Vascular Surgery (SVS)...
Pioneering center reports ‘moderate’ success rate with Fiber Optic RealShape technology in first 50...
Vascular surgeons from the medical center that pioneered use of the radiation-lowering Fiber Optic RealShape (FORS) imaging modality reported a 62% technical success rate...
Enrollment begins in PERSEVERE clinical trial of hybrid prothesis for aortic dissection
Artivion announced today that it has initiated enrollment in the PERSEVERE clinical trial to determine if patients with an acute DeBakey Type I aortic dissection...
Intraoperative vascular mapping during hemodialysis access ‘should be incorporated into routine practice’
Intraoperative ultrasonographic venous mapping is a useful tool to evaluate vessel suitability for arteriovenous fistula (AVF) creation, Yana Etkin, MD, associate professor of surgery...
Black adults treated for common arterial disease are at greater risk of amputation, death...
About 6.5 million Americans over the age of 40 suffer from peripheral arterial disease (PAD). In the U.S., Black adults in their 50s are...
Female sex is associated with reintervention and mortality following elective EVAR
Women are more likely to die within five years of having elective surgery to repair an abdominal aortic aneurysm (AAA) or need repeat surgery, according to...
Prepare for Board exams at UCLA/SVS review course
Planning to take the upcoming Vascular Surgery Board (VSB) exams? Prepare for them at the “Seventh Annual UCLA/SVS Symposium: A Comprehensive Review and Update...
SVS PA Section seeks Steering Committee members
The Society for Vascular Surgery (SVS) Physician Assistant (PA) Section seeks applicants for its Steering Committee. The committee will be developing content for section...
SVS looks to maintain AMA House of Delegates representation
To maintain its seat in the American Medical Association (AMA) House of Delegates—and, importantly, be able to provide information that impacts physician reimbursement—a 20%...
Female sex is associated with additional treatments following surgery for intermittent claudication, study shows
A new U.S. study has found that female sex is associated with more reinterventions after surgical treatment for intermittent claudication. Additionally, guideline-directed medical therapy,...
Cordis announces start of enrollment in RADIANCY clinical study in Europe
Cordis has announced the start of the European RADIANCY premarket clinical study of a stent system designed for radial access in the treatment of...
AVeVA study confirms benefit of covered stent placement in graft-vein anastomotic stenosis treatment
A prospective, multicenter study involving the Covera vascular covered stent (BD) has confirmed the benefits of immediate, post-percutaneous transluminal angioplasty (PTA) placement of the...
The top 10 most popular Vascular Specialist items of June 2022
June's top stories spanned a range of presentations from the 2022 Vascular Annual Meeting (VAM) in Boston (June 15–18), covering topics including burnout...
PAD: Ra Medical Systems receives FDA 510(k) clearance for the Dabra 2.0 catheter
Ra Medical Systems has announced receipt of Food and Drug Administration (FDA) 510(k) clearance for the company’s Dabra 2.0 catheter as part of the...
First patient enrolled in Wrapsody endoprosthesis registry study
Merit Medical has announced the successful enrollment of the first patient in its WRAP registry study in a press release. The study will evaluate...
